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1  Introduction. 
 
 Malaria, caused by Plasmodium spp afflicts an estimated 300 million to 500 million people 
per annum. Plasmodium falciparum is the etiologic agent of the most pernicious form of human 
malaria and is responsible for 1.5 - 2.7 million deaths yearly, more than 1 million of which occur 
in children younger than 5 years (WHO, 1997; WHO, 2000). The significance of malaria as a 
disease is best documented by the fact that the entire issues of Nature (October 3, 2002) and of 
Science (October 4, 2002) were devoted to the genomic analyses of the parasite and the Anopheles 
vector respectively.  Plasmodium spp are members of the Phylum Apicomplexa which consists of 
roughly 350 genera and more than 4500 parasitic protozoan parasites (Levine, 1988). Other 
prominent members of this Phylum are Toxoplasma gondii, Cyrptosporidium parvum and Babesia 
spp, which are causative agents of human disease, and Eimeria, Theileria, Sarcocystis and 
Perkinsus species, which infect livestock and which are responsible for considerable economic 
losses (Ruff, 1999; de Graff et al.,1999; Dubey, 1999). 
 P. falciparum exhibits a complex life cycle (Figure 1), going through a sexual phase in the 
insect vector, the Anopheles mosquito, and multiplying asexually within the human host to 
precipitate its morbid and lethal sequelae. Sporozoites are inoculated into the host’s blood stream 
by the bite of infected female Anopheles mosquitoes. The sporozoites invade hepatocytes where 
they undergo asexual division (exo-erythrocytic schizogony) to release merozoites. The 
merozoites invade erythrocytes within which they complete the asexual life cycle inside a 
parasitophorous vacuole, enclosed by the parasitophorous vacuole membrane (PVM). While in the 
red cell, the parasite undergoes three distinct stages of development: the ring (0-24 h post 
invasion), the trophozoite (24-36 h post invasion), and the schizont stage (36-48 h post invasion) 
(Figure 2), During erythrocytic schizogony, mature trophozoites undergo multiple nuclear 
divisions to form schizonts.  This is followed by cytoplasmic division, resulting in mature 
schizonts  (segmenters) that contain between 16 and 32 merozoites. Approximately 48 h after 
infection, the infected erythrocyte rupture and release merozoites into the blood stream where they 
infect new cells and repeat the cycle in the erythrocytes. Some merozoites undergo differentiation 
into sexual stages, immature macrogametocytes or microgametocytes. These mature but do not 
undergo further development until a feeding mosquito takes them up. In the mosquito gut, 
microgametocytes undergo rapid DNA replication and cell division to form eight flagellated male 
gametes. These are released and one fertilizes a macrogametocyte to form a diploid zygote. The 
zygotes undergo meiosis and each develops into an elongated form called an `ookinete´. The 
ookinetes penetrate the epithelial lining of the stomach of the mosquito and develop into oocysts, 
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which undergo sporogony to produce a large number of haploid sporozoites. These migrate to the 
salivary glands of the mosquito from where they are injected into a human host when the infected 
female Anopheles bites.  
 The asexual stage of the parasite is responsible for the most severe pathogenesis of the 
disease. Severe malaria occurs after parasite proliferation inside erythrocytes and consequent 
binding of infected erythrocytes to the vascular endothelium (cytoadherence) and to noninfected 
erythrocytes (rosetting). These bindings eventually lead to the accumulation of parasitized cells in 
the local post-capillary microvasculature and block the blood flow, limiting the local oxygen 
supply. The most common clinical symptoms of severe malaria are high fever, progressing 
anemia, multi-organ dysfunction, and unconsciousness, i.e., coma, which is a sign of cerebral 
malaria and one of the causes of death (Miller et al., 1994).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Life cycle of Plasmodium falciparum. The  infective sporozoites are introduced into the 
human host by the bite of an infected  Anopholes mosquito. The sporozoites undergo schizogony in 
hepatocytes to produce merozoites which are released into the blood stream where they invade erythroyctes. 
After  repeated erythrocytic schizogony steps some merozoites differentiate into sexual gametocytes which 
mature and are taken up by a feeding mosquito. After sporogony more infectious sporozoites are produced. 
Adopted from Atlas of Medical Parasitology, Carlo Denegri Foundation 
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RBCM 
Food 
Vacuole 
Figure 2. Asexual erythrocytic stages of Plasmodium falciparum.  Giemsa  stain of P.falciparum 
infected erythrocytes from in vitro culture. Panel A shows ring stages of the parasite. Panel B shows a mixture of  
trophozoites and young schizonts. 
A B 
Figure 3. Ultrastructure of  P. falciparum  in permeabilized  erythroyctes. The infected 
erythrocytes were treated with  streptolysin O and the host cell cytoplasm extracted before processing them for 
electronmicroscopy. Electron dense structures `knobs´ are found on the red blood cell membrane (RBCM).  The 
parasite is enclosed within a vacuole surrounded by the parasitophorous vacuole membrane (PVM). The food 
vacuole is indicated with an arrow and it contains haemozoin crystals  (HZ). 
PVM
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1.1     Morphology of Plasmodium falciparum and the infected host cell. 
1.1.1. The Parasite. 
Most of the apicomplexans, including Plasmodium spp. are obligate intracellular protozoa 
that actively invade the host cell in which they propagate and live within the parasitophorous 
vacuole (PV) formed during invasion (Figure 3). The apicomplexan parasites, as exemplified by 
P. falciparum above, have complex life cycles involving transmission within and between hosts 
by specialized cell-invasive stages (generically termed zoites). These show directional gliding 
motility, relative to their anterior-posterior axis and they characteristically possess three sets of 
secretory compartments, the apical organelles at their leading (apical) end (Aikawa, 1971; 
Scholtyseck and Mehlhorn 1970). Two of these, the rhoptries and micronemes, secrete their 
contents apically, whilst the third, the dense granules, release their contents elsewhere on the 
zoite’s surface, and are not necessarily apical in position depending on stage and species  (Sam-
Yellowe, 1996; Carruthers and Sibley 1997; Perkins 1992; Lingelbach and Joiner 1998; Preiser et 
al., 2000). The apical organelles secrete substances that enable zoites to adhere selectively to and 
invade host cells and once within, to cause further modifications and eventually escape.  
The rhoptries are the largest apical organelles, they are club shaped (hence their name from 
the Greek letter rho). The rhoptries contain densely packed granular material and their number 
varies with stage of life cycle and species. Plasmodium falciparum merozoites and sporozoites 
possess two rhoptries, the ookinetes appear to have none at all  (Aikawa and Seed 1980). Theileria 
parva merozoites have up to six  (Shaw and Tilney 1992) and Toxoplasma gondii has eight or 
more per tachyzoite while Cryptosporidium sporozoites are reported as having only one (Tetley et 
al., 1998). The size and shape of the rhoptries also vary within the different genera. In Babesia and 
Theileria spp they are relatively small (Kawai et al., 2000; Shaw and Tilney 1992). In contrast 
Plasmodium sporozoites and zoites of T. gondii have very elongated rhoptries and there is a 
correlation between the size of the zoites and their sizes, where large zoites have large rhoptries, 
their size and number probably being important in the invasion process and creation of the 
optimally sized vacuole within which they eventually reside.  The merozoite rhoptries of P. 
falciparum and P. knowlesi, as in zoites of T. gondii (and probably all rhoptries) have two distinct 
regions: a basal bulbous portion and a narrow apical duct differing in detailed structure and protein 
composition (Bannister et al., 1986; Crewther et al., 1990; Sam-Yellowe et al.,1995; Bannister et 
al., 2000). Rhoptries change their appearance during invasion after they discharge their contents, 
most noticeably they collapse and various membranous vesicles and tubules becoming apparent 
(Bannister et al., 1986). 
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Micronemes resemble rhoptries in being membrane-bounded and in having dense granular 
contents. However, they are smaller than rhoptries, flask-like in shape and usually occur in larger 
numbers. In P. falciparum merozoites they are small and few (Langreth et al.,1978) and they seem 
to be absent in T. parva merozoites (Shaw and Tilney 1992). In Plasmodium sporozoites and 
zoites of Toxoplasma and Eimeria they are numerous and can secrete large amounts of protein 
onto  the zoite’s surface possibly assisting in the gliding movement (Scholtyseck and Mehlhorn 
1970; Aikawa and Seed 1980; Aikawa and Sterlin 1974). The micronemal proteins are involved in 
host cell recognition, binding and, possibly motility. Recent biochemical studies have shown that 
the penetration of host cells by Toxoplasma gondii is an  active process involving the parasites 
own actomyosin system and it is distinct from phagocytosis (Herm-Götz et al. , 2002).  Proteins  
secreted by micronemes share extensive domains of  homology between members of 
Apicomplexa, supporting the hypothesis of a common molecular mechanism for host recognition, 
attachment and invasion (Tomley and Soldati, 2001) 
Dense granules are membrane-bounded vesicles with densely packed granular contents 
found in apicomplexans. They vary in number, size and shape with stage and species. In P. 
knowlesi and P. falciparum merozoites they are spheres, about 80nm in diameter (Bannister and 
Mitchell 1989; Bannister et al., 1975; Torii et al., 1989). In Plasmodium spp the contents of the 
dense granules are released after merozoites enter the erythrocyte and they play a role in the 
extension of the PVM (Aikawa et al.,1990; Culvenor et al., 1991; Bannister and Mitchell 1989; 
Torii et al., 1989). The same sequence of events has been described in other apicomplexans 
including Toxoplasma (Leriche and Dubremetz, 1990) and Sarcocystis  (Entzeroth, 1985). 
More recently an additional compartment, the plastid has been identified in the 
Apicomplexan parasites including P. falciparum (Wilson et al.,1996; Mc Fadden et al.,1996). This 
organelle contains a self-replicating circular genome comparable to that of chloroplast in plants. 
All plastids including the apicomplexan plastid (apicoplast) arose by endosymbiosis of a 
cyanobacterial-like prokaryotic cell. Engulfment of this cell, referred to as  primary endosymbiosis 
generated a plastid characterized by two membranes, such as those found in red and green algae, 
and plants.  Following this primary endosymbiosis, plastids were presumably transferred laterally 
into several eukaryotic lineages that normally lacked plastids, by a process known as secondary 
endosymbiosis. In secondary endosymbiosis, plastid-containing primary endosymbionts, were 
themselves engulfed and retained by other eukaryotes (Mc Fadden et al., 1996; McFadden et 
al.,1997; McFadden and Waller, 1997). The ultimate function of the relict plastid is thought to be 
anabolic synthesis of some component(s) possibly a fatty acid or lipid (Waller et al., 1998). Since 
the pathways are bacterial in nature they are sensitive to antibacterial compounds. It has been 
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demonstrated that ciprofloxacin kills T. gondii by blocking apicoplast-DNA replication (Fichera 
and Roos, 1997), is  ciprofloxacin also moderately active against C. parvum (Woods et al., 1998) 
thus proving that the plastid is unique compartment  and an effective drug  target which may offer 
new avenues in the development of  parasiticidal drugs. 
 
1.1.2. The infected erythrocyte. 
The invasion of erythrocytes by merozoites occurs very rapidly (Dvorack et al., 1975) and 
to date, the molecular mechanisms involved in the process are not well understood. Morphological 
studies at the light and electron microscope levels have revealed that invasion is a sequential, 
multi-step process (Dvorack et al., 1975; Bannister and Dluzewski, 1990; Aikawa et al., 1978; 
Miller et al., 1979). Upon contact with an erythrocyte, the merozoite attaches and orients its 
anterior end towards the erythrocyte. A region of tight association (Aikawa et al., 1978), develops 
between the membranes of the two cells. Compartments at the anterior end of the merozoite, the 
rhoptries, discharge their contents onto the erythrocyte surface, which begins to indent at the point 
of contact. The junction transforms from a localized patch to an orifice, through which the 
merozoite penetrates into a progressively deepening, membrane bound vacuole. The membrane 
surrounding the fully internalized parasite is known as the parasitophorous vacuole membrane 
(PVM). The asexual stage of development of the parasite is completed within the parasitophorous 
vacuole (PV). 
 The differentiated erythrocyte appears to be incapable of receptor-mediated endocytosis  
(Haberman et al., 1967; Schekman and Singer, 1976; Zweig and Singer, 1979), and the formation 
of the PVM is not yet fully understood. It has been reported that erythrocyte proteins (McLaren et 
al., 1977; Aikawa et al., 1987; Atkinson et al., 1987; Dluzewski et al., 1989) and lipids 
(Dluzewski et al., 1992) are excluded from the PVM, leading to the suggestion that the PVM is 
formed from proteins and lipids stored in the rhoptries and secreted into the erythrocyte membrane 
during invasion (Bannister and Dluzewski, 1990; Dluzewski et al., 1992; Joiner, 1991). Using 
fluorescent   probes and low-light-level video fluorescence microscopy, Ward et al., 1993 
investigated PVM formation and found that while erythrocyte membrane proteins are indeed 
excluded from the PVM, the lipids forming the PVM are indistinguishable from those of the host 
cell membrane. The observation by Pouvelle et al., 1994 also indicate that the PVM lipids are to a 
great extent derived from the erythrocyte plasma membrane. 
 As the parasite grows and replicates within the vacuole, changes occur in the infected RBC 
cytoplasm. These changes have been related variably to either inward or outward trafficking 
between parasite, RBCs and the extracellular medium (Aikawa et al.,1986). Various studies using 
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either electronmicroscopy (EM), confocal microscopy or immunofluorescences have attempted to 
visualize the structures involved with somewhat conflicting results. Structures unique to P. 
falciparum- infected erythrocytes, including Maurer’s clefts and membranous whorls that are 
somewhat reminiscent of Golgi compartments have been detected by EM (Aikawa, 1977; 
Langreth et al.,1978). Lipidfluorescence assays have revealed a network of tubovesicular 
membranes (called the tubovesicular network, TVN) extending from the PVM  membrane to the 
RBC membrane (Elmendorf and Haldar, 1993; Behari and Haldar,1994; Elmendorf and Haldar, 
1994). The enlargement of the membrane most likely are due to metabolic processes by the 
parasite since mammalian erythrocytes do not synthesize lipids or proteins de novo.  
 The tubular elements projecting from the PVM to the red cell have been imaged by 
advanced digitized fluorescence microscopy (Haldar et al.,1989; Grellier et al., 1991; Elmendorf 
and Haldar, 1994) and these studies suggest that the PVM and TVN are all interconnected 
compartments with other intraerythrocytic structures such as the Maurers clefts. However there is 
an alternative view that the PVM is distinct and that other intra-erythrocytic compartments such as 
Maurers clefts form different entities. Experiments by Waller et al., 2000; Wickham et al.,2001 
using chimeric proteins fused to the green fluorescent protein (GFP), show that the distribution of 
the protein that is exported show a restricted localization within the vacuole. If the two 
compartments, the PVM and the TVN were continuous the GFP should also distribute into the 
TVN. Since this does not happen it seems that the two structures are not interconnected. The 
trafficking of PfEMP-1 through the Maurer’s clefts suggests that they are not connected to the PV 
(Wickham et al.,2001). 
 The most prominent ultra structural change of the surface of infected erythrocytes is the 
appearance of electron-dense protrusions with a diameter of approximately 100µm generated by 
the parasite, called knobs. (Luse and Miller, 1971). These structures are only found on the infected 
erythrocyte surface and are thought to be composed of several polypeptides (one of which is 
PfEMP1) synthesized and transported from the intracellular parasite.  Knobs have been confirmed 
to be to the sites where infected erythrocytes bind to other cell surfaces, including the surface of 
normal erythrocytes (e.g., in a rosette). Knobs were also determined to the sites of attachment of 
infected erythrocytes to brain endothelium of patients who died of severe malaria (Aikawa, 1988; 
Aley et al.,1984). 
 
1.2 Physiological alterations of the infected erythrocyte. 
 In the IRBC the PVM forms a barrier between the host cell cytosol and the parasite surface. 
It prevents the host cell proteins from having access to the vacuolar space. However the parasite 
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enclosed in the parasitophorous vacuole still relies on nutrients from extracellular sources, 
principally from human serum. The nutrients include some amino acids, fatty acids and other 
important molecules such as pantothenic acid and purine bases. Unlike mammalian cells which are 
capable of synthesizing purine nucleotides de novo, all protozoan parasites studied to date (Berens 
et al., 1995) including Plasmodium spp. (Gero and Sullivan, 1990) are incapable of making the 
purine ring and the purines must be salvaged from the host. These nutrients generally must be 
transported across the erythrocyte membrane (RBCM), the parasitophorous vacuolar membrane 
(PVM), and the parasite plasma membrane (PPM). These nutrient permeation pathways may 
involve a variety of complex and novel pathways including transporters, channels, and the 
tubovesicular membranes (TVM) (Gero and Kirk 1994; Haldar 1994; Upston and Gero 1995; 
Lauer et al., 1997; Ginsburg and Kirk 1998; Kirk et al., 1999; Kirk, 2001).  
 The pathways by which these different molecules gain access to the erythrocyte and 
eventually to the parasite are still unknown but there are three models that have been suggested to 
try to explain the phenomenon. According to the direct access model, suggested by Pouvelle et al., 
1991, the PVM fuses with the plasma membrane and allows free access of molecules, including 
proteins, via a so called `parasitophorous duct´. Further studies by Goodyer et al., 1997 also 
support this model to be involved in the transport of macromolecules in infected erythrocytes. An 
alternative model suggests that nutrients gain access to the erythrocyte cytosol owing to an 
increased permeability of the erythrocyte plasma membrane (Ginsburg, 1994), however proteins 
that could be responsible for the changes in the plasma membrane’s permeability are yet to be 
identified. Once the nutrients are in the erythrocyte cytosol, access to the parasite surface would 
occur through non-selective pores postulated to be present in the PVM and allowing the free 
exchange of molecules up to 1300 Da (Desai and Rosenberg, 1997). However these two models of 
transport into the PV are essentially incompatible: If a direct connection (“duct”) existed together 
with the pores in the PVM, then the host cell would leak low molecular weight solutes into the 
extracellular space. A third model by Lauer et al., (1997), postulates that extensions of the PVM 
come into close proximity with the erythrocyte plasma membrane, fusion does not occur but the 
contact site acts as a molecular sieve which allows the selective uptake of small molecules but 
excludes macromolecules. To date there is no conclusive experimental data confirming the basis 
of nutrient acquisition between the external medium, through the PVM and ultimately to the 
parasite. But there is evidence that infected erythrocytes show increased permeability for a number 
of small molecular weight substances with preference for anionic molecules as compared to no 
infected erythrocytes (Ginsburg, 1994; Penny et al., 1998). The access of these molecules into 
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infected erythrocyte is non-saturable and it can be inhibited by various anion selective inhibitors 
such as furosemide among others (Upston and Gero 1995; Kirk et al., 1994).  
  Apart from nutrient acquisition from the host cytosol the PVM may have other functions 
including protecting the parasite from a potentially unfavorable environment. Initially it has been 
proposed that the possession of the PVM would avoid the presentation of parasite proteins by 
major histocompatibility complex (MHC) class I molecules. However there are now reports that 
show lysis of   T. gondii-infected professional antigen presenting cells by parasite-specific CD8+ 
T-cells of both human and murine origin (review Lüder and Seeber, 2001). The implication is that 
parasite antigens are able to pass through the PVM and that the classical pathway of MHC class I 
presentation operates in the parasite. However, there is no conclusive evidence to explain how the 
mechanism is modulated. Nonetheless it would mean that protection of the obligate intracellular 
parasite by the PVM might not be complete in Toxoplasma gondii. The most obvious difference 
between T. gondii and Plasmodium spp is that the latter infect non-nucleated cells and the 
presentation of antigens in a MHC I context may probably not apply in the erythroyctic stages but 
possibly to the liver stages. 
 However, in P. falciparum, as the parasite develops within the erythrocyte, several parasite 
encoded proteins which mediate the most severe form of pathogenicity of the disease become 
associated with the erythrocyte cytoskeleton or are inserted into the host cell membrane. The 
proteins are exported across the parasite plasma membrane and the parasitophorous vacuole 
membrane to achieve extensive modifications of   both the cytoplasm   and the plasma membrane 
of the host erythrocyte (Lingelbach 1993; Foley and Tilley 1995). As discussed in the previous 
section, in mature stages of the intra-erythrocytic cycle, the membrane of the erythrocyte becomes 
distorted with knobby protrusions that are involved in cytoadherence of these cells to the vascular 
endothelium (Kilejian, 1979). These adhesive structures are formed by deposition of parasite 
proteins below the erythrocyte membrane and insertion of parasite proteins into the erythrocyte 
bilayer. The major components of these “knobs” are a peripheral membrane protein the knob 
associated histidine-rich protein (KAHRP), which forms the major structural element of the knob 
(Kilejian et al.,1986; Pologe et al., 1987; Triglia et al., 1987), an integral membrane protein, the P. 
falciparum erythrocyte membrane protein-1 (PfEMP-1), which is inserted into the erythrocyte 
membrane and which acts as the ligand for binding to endothelial cell receptors (Baruch et al., 
1995; Smith et al.,1995 and Su et al.,1995) and P. falciparum erythrocyte membrane protein-3 
(PfEMP3) (Pasloske et al., 1993). KAHRP is essential for the formation of the knobs that deform 
the erythrocyte surface, and deletion of the corresponding gene results in the loss of knobs. (Crabb 
et al.,1997a). This does not completely prevent the expression of PfEMP1 on the erythrocyte 
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surface, but it reduces cytoadherence of infected cells under continuous flow (Crabb et al., 1997b). 
The function of PfEMP3 is unknown although truncation of the protein has been shown to affect 
the trafficking of PfEMP1 to the plasma membrane of the infected erythrocyte leading to a 
reduction in the density of PfEMP1 on the erythrocyte surface and also cytoadherence (Waterkeyn 
et al., 2000). PfEMP1 is an antigenically-variant protein family and there are 50-150 var genes (Su 
et al 1995). This polypeptide of high molecular mass (200-400kDa) is trypsin sensitive, insoluble 
in nonionic detergents and is readily labeled by conventional surface iodination techniques. 
PfEMP1 is purported to be composed of several extracellular Duffy binding-like domains (DBL 1 
to 5), with one or two cystein-rich interdomain regions (CIDRs) distributed in between the DBLs, 
a transmembrane (TM) region, and an intracellular acidic segment (ATS) (Smith et al.,1995 and 
Su et al.,1995). The most conserved regions are located in both the N-and C- terminal domains. 
DBL-1α together with CIDR1α  are thought to form a semi conserved head structure in which at 
least six regions in DBL-1α  and several cysteine residues in CIDR1α are almost 100% conserved 
(Su et al 1995). The common structures harbored in different PfEMP1 molecules indicate that they 
mediate similar binding activities, yet their multiple and polymorphic nature also suggest an 
effective role in immune evasion. When using different receptors, CD36, TSP and ICAM-1, only 
PfEMP1 could be precipitated from SDS soluble fraction of infected erythrocytes, suggesting that 
PfEMP1 is indeed the adhesive ligand involved in binding to those receptors (Baruch et al., 1997).  
  These observations demonstrate a specific distribution of parasite proteins within the 
infected erythrocyte. Therefore even though the PV and PVM form a barrier between the parasite 
and the erythrocyte cytoplasm, parasite-encoded proteins have been shown to translocate through 
these compartments to sites outside the parasite.  
 
1.3 Secretory pathways in  Plasmodium  falciparum. 
  In a typical eukaryotic cell there are several thousands of different proteins. For the proper 
functioning of the cell these proteins must be incorporated into  different compartments. Protein 
trafficking is the process by which proteins reach their destinations either within a cell or outside  
cells. The proteins that are synthesized on cytosolic ribosomes are released into the cytosol; some 
remain there while others are specifically incorporated into organelles such as the mitochondrion, 
the nucleus and peroxisomes. However a large class of proteins is synthesized on ribosomes bound 
to the rough endoplasmic reticulum and they enter the secretory pathway. This class includes both 
integral membrane proteins that become inserted in the ER membrane and proteins that become 
soluble in the lumen of the ER. These proteins are subsequently sorted to their different 
destinations. Protein sorting involves `retention signals`, which result in the retention of a 
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polypeptide within a compartment and `sorting signals` which facilitate forward sorting. The 
classical protein secretory pathway in eukaryotic cells involves the transport of proteins between 
intracellular organelles by the budding and fusion of small vesicles and it  requires a very complex 
machinery.  
 While the basic principle applies to protein trafficking within the parasite. Trafficking within 
the infected erythrocyte poses a number of conceptual problems. Other than its plasma membrane 
the parasite is enclosed by the PVM and the host cell plasma membrane. The proteins that are 
exported out of the  infected erythrocyte have to transverse the three membranes. The parasite 
must have novel mechanisms  of  achieving this since the host cell is devoid of organelles. 
 Other than the adherence antigens that are exported to the surface of the infected 
erythrocytes, a number of parasite encoded proteins are exported to different destinations 
including  (i) the cytoplasmic face of the erythrocyte membrane (such as KAHRP, Wickham et al 
2001),  (ii) the Maurer’s clefts (Hui and Siddiqui, 1998; Etzion and Perkins, 1989; Stanley et al., 
1989; Li et al., 1991; Albano et al., 1999; Blisnick et al., 2000; (iii) the parasitophorous vacuole, 
the serine rich protein (SERP) Knapp et al., 1989; ABRA, Weber et al., 1988); (iv) the host 
cytoplasm, where the histidine rich protein (HRP) is localized (Howard et al., 1986).The 
glycophorin binding protein (GBP) is also localized in the cytoplasm (Kochan et al., 1986) and it 
was  been demonstrated that the protein is  released into the parasitophorous vacuole before it is 
translocated across the PVM into the host cell cytosol  (Ansorge et al.,1996). These results suggest 
that in addition to GBP and KAHRP (Wickham et al., 2001), it is possible that other proteins 
destined for the erythrocyte cytosol, are first released into the vacuolar space before they are 
translocated across the PVM. (v) EXP1 and EXP2 are targeted to the PVM as integral and 
peripheral membrane proteins, respectively (Simmons et al., 1987; Günther et al., 1991; Johnson 
et al., 1994). Other parasite proteins such as the ATP-binding cassette protein (PfGCN20) and a 
fatty acid acyl coenzyme A synthetase-1 (PfFACS-1) are delivered to less-defined   membranous 
structures in the host cytosol (Bozdech et al., 1998; Matesanz et al., 1999). The distribution of the 
parasite proteins in infected erythrocytes is shown in figure 4. 
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Figure 4. Destination of secreted parasite proteins in Plasmodium falciparum infected 
erythrocytes. The proteins are targeted to secretory organelles within the parasite including the rhoptries, 
micronemes, dense granules and the apicoplast. The proteins are also exported out of the parasite to the PV, PVM, 
TVN, erythrocyte cytosol (RBCC) and the erythrocyte plasma membrane (RBCM).  
 
 In eukaryotes the main mechanism to export proteins is to allow their recruitment into the 
secretory pathway. The first step requires a polypeptide signal that targets the protein to the ER  
membrane. The signal targets nascent or complete proteins from the cytosol to translocation sites 
in the membrane of the ER. After membrane insertion, signal sequences can be cleaved from the 
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precursor protein by a membrane bound signal peptidase. The characteristic feature of signal 
sequences is a hydrophobic core (h-) region comprising, for cleavable signal sequences, six to 
fifteen amino acid residues. Analysis of signal sequences mutants showed that this h-region is the 
most essential part required for targeting and membrane insertion (von Heine, 1985). The h-region 
is flanked on its C-terminal side by a polar (c-) region which often contains helix-breaking proline 
and glycine residues as well as small uncharged residues in positions –3 and –1 that determine the 
site of signal peptide cleavage (von Heine, 1990). On its N-terminal side, the h region is flanked 
by a rather polar n-region, which usually has a net positive charge. Comparative analysis of a large 
number of signal sequences reveals substantial variability in their overall length, ranging from 15 
to more than 50 amino acid residues (von Heine 1986). The n-region contributes most to the 
variation in overall length. Signal sequences can be located within a protein or at its C-terminal 
end (Kutay et al.,1995). Additional targeting signals are used to divert proteins to other 
compartments (e.g. to the lysosome or to a regulated secretory compartment, (Keller and Simons 
1997). 
  Analyses of protein sequences of P. falciparum proteins that are exported out of the parasite 
have shown some unusual characteristics. The ER located protein, PfERC, has a classical 
hydrophobic N-terminal signal sequence (La Greca et al.,1997). Similarly, the S-antigen and 
SERP that are exported to the parasitophorous vacuole have N-terminal hydrophobic signals 
(Knapp et al., 1989b). Proteins destined for the PPM, such as the merozoite surface protein 1 
(MSP1) (Holder et al., 1985), or EXP-1 which is present in the PVM (Kara et al.,1990; Günther et 
al., 1991) also have classical N-terminal signal sequences.  
 In eukaryotes, after translocation of the precursor protein, the N-terminal stretch of 
hydrophobic amino acids is cleaved by a signal peptidase within the ER lumen. This cleavage site 
is often N-terminal to an acidic or basic residue and often has small amino acids (glycine or 
alanine) at positions –3 and –1 (von Heijne,1986) A similar system appears to operate in 
Plasmodium and the secretory signal of Exp-1 has been shown to be cleaved by the malaria 
parasite at a site adjacent to aspartate 23 (Kara et al., 1990). EXP-2 is cleaved at a site N-terminal 
to aspartate 25 (Fischer et al., 1998). 
 However, a number of parasite proteins that are directed across the PPM and PVM to the 
host cell cytosol do not have classical N-terminal signals. GBP and KAHRP and RESA have a 
stretch of hydrophobic amino acids starting 20-50 amino acids from the N-terminus (Favaloro et 
al., 1986; Kilejian et al., 1986; Nolte et al., 1991). This internal hydrophobic signal does not 
appear to be recognized by the translocation machinery of higher eukrayotes as it has been shown 
that neither KAHRP nor protein 41-2 are translocated across the ER membrane in cell-free 
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systems using mammalian microsomes (Hinterberg et al.,1994). Another group of proteins are 
exported into the erythrocyte cytosol but they do not have an N-terminal signal sequence, i.e. no 
hydrophobic patch within the first 100 amino acids, these include PfGCN20  (Bozdech et al., 
1996), falciparum erythrocyte serine threonine kinase (FEST) and Pfsar1p (Albano et al 1999). 
The pathway of export of these proteins is unknown. PfEMP1 which is exported and  inserted into 
the erythrocyte membrane does not have an obvious N-terminal signal sequence (Taylor et al., 
1987; Baruch et al., 1995). 
 The study of protein trafficking to organelles within the parasite especially the apicoplast, 
has also provided interesting results. The apicoplast is a secondary endosymbiont and has attracted 
attention due to its evolutionary origin and also as a novel drug target since the organelle is unique 
to the parasites and is absent in the hosts (McFadden and Roos, 1999). As with a primary 
endosymbiont, many proteins targeted to the apicoplast are nuclear encoded and need signals for 
their proper delivery to the organelle. The first direct evidence that an ER type signal sequence 
results in protein release at the parasite plasma membrane came from studies on protein transport 
to the apicoplast (Waller et al., 2000). Since the parasite is a secondary endosymbiont, transport to 
the apicoplast is a two step process mediated by a bipartite signal that comprises an ER type 
secretory signal followed by a plastid targeting signal (SS-PTS). It has been demonstrated that a 
bipartite signal is necessary in plastid targeting in secondary endosymbiont (Sulli and 
Schwartzbach, 1995; Wastl and Maier, 2000). This signal was shown to be both necessary and 
sufficient for transport of apicoplast proteins in T. gondii and P. falciparum (Waller et al., 1998; 
2000). In P. falciparum the ER signal alone targeted the peptide into the PV.  
  In mammalian cells, once a soluble protein has entered the secretory pathway, the failure to 
retain it in a compartment or target it to an endosomal or lysosomal destination, results in its 
release into extra cellular medium (Pfeffer and Rothman, 1987). This is termed the default 
secretion. Components of this `classical´ vesicle mediated secretory pathway for the export of 
proteins are present within the cytoplasm of the malaria parasite and appear to be involved in the 
transport of proteins to the parasite plasma membrane. Homologues of a number of trafficking 
components have been found including the ER molecular chaperone, Pfgrp (Kumar et al., 1991), 
the P. falciparum ER calcium-binding protein (PfERC) which is a reticulocalbin homologue (La 
Greca et al., 1997), a homologue of the KDEL- binding protein, PfERD2 (Elmendorf and Haldar 
1993) and homologues of trafficking associated GTPases, PfRab6  (Alves de Castro et al., 1996; 
Van Wye et al., 1996) and PfRab11 (Langsley and Chakrabarti, 1992). Despite evidence for a 
classical secretory pathway, P. falciparum lacks a stacked cisternal Golgi (Van Wye et al., 1996), 
its Golgi apparatus shows unusual dynamics (Elmendorf and Haldar, 1994) and there is no 
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conclusive evidence for N-glycosylation (Dieckmann-Schuppert et al., 1993). This makes it 
difficult to detect secretory transport by following post-translational protein modifications or 
movement through the Golgi. However recently, a single gene coding for the enzyme N-
acetylglucosamine-1-phosphate transferase, the first enyzme in the N-linked glycosylation 
pathway has been shown to present in the recently published P. falciparum genome (Gardner et 
al.. 2002). 
  In eukaryotic cells, brefeldin A (BFA) inhibits the secretion of polypeptides of proteins by 
redistributing the cis-Golgi components in the ER (Lippincott-Schwartz et al.,1989). In 
mammalian cells, secretion of proteins can be arrested at the cis-Golgi level by incubating the 
cells at 15° C (Saraste and Kuismanen 1984). The best evidence for the existence of a classical 
secretory pathway is the inhibition of protein secretion in infected erythrocytes with BFA and at 
low temperature (Benting et al.,1994). ). In the ring stages, brefeldin A can be added for extended 
periods of time, which arrests parasite development in the ring stage (Benting et al.,1994). In later 
stages treatment of parasites with BFA for more than 2 hours is lethal.  The drug BFA disrupts the 
Golgi and proteins are redistributed to the ER, possibly by the retrograde transport mechanism 
(Lippincott-Schwartz et al., 1990). The accumulated evidence confirms that the export parasite 
proteins involve a classical secretory pathway and the effects of Brefeldin A are rapidly and fully 
reversible upon removal of the drug. However there are reports of some parasite proteins being 
secreted despite the presence of BFA (Elmendorf et al., 1992). 
   At a molecular level, the drug interferes with the exchange of GDP for GTP on ADP-
ribosylation factors (Donaldson et al., 1992; Helms and Rothman, 1992 Randazzo et al., 1993).  
Recently the target of BFA, namely plasmodial ARF-GEF was detected in a BFA resistant parasite 
line obtained after selective pressure. The mutant protein has a single methionine-isoleucine 
substitution in the sec 7 domain, a conserved structure of guanine nucleotide exchange factors 
(ARF-GEF). The mutation confers resistance to the drug (Baumgartner et al., 2001). 
  The observation that many paraiste proteins which are transported beyond the PVM do not 
conatin hydrophobic N-terminal signal sequences has led to the suggestion that  these proteins are 
secreted via an laternative secretory pathway (Wiser et al., 1997). However this hypothesis has 
been  challenged by others (Mattei et al., 1997), and the mechanism of translocation  of proteins to 
destinations beyond the confines of the parasite is still under  investigation.  
 
1.4 The parasitophorous vacuole- a transit compartment? 
 The final step in the secretory pathway is the fusion of transport vesicles with the plasma 
membrane and the release of soluble proteins into the extracellular space or, in the case of 
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membrane proteins insertion into the plasma membrane. Some parasite proteins such as the serine 
rich protein (SERP), are released into the vacuolar space, whereas other proteins, such as GBP are 
transported beyond the vacuolar membrane into the erythrocyte cytosol. Initially two models for 
protein transport had been proposed to explain protein transport across the parasite plasma 
membrane and the parasitophorous vacuole membrane (Howard et al.,1987; Haldar, 1996). 
 In the single-step model, proteins destined for the parasite plasma membrane are targeted to 
specific sites, where the parasite plasma membrane fuses with the PVM. The proteins are then 
translocated across both membranes in single step. This model would suggest the presence of two 
set of secretory vesicles in the parasite, those with a vacuolar destination and others destined for 
locations beyond the PVM. To date there is no experimental evidence for the existence of 
transport vesicles that differ with respect to the final destination of their cargoes. 
  In the two-step model, proteins are secreted into the vacuolar space in a first step and 
proteins destined for the erythrocytic cytosol are subsequently translocated across the PVM in a 
second step. Since secretory proteins are already in a folded conformation, the second step of 
translocation across the PVM would not occur spontaneously. Therefore a prediction would be 
that proteins destined for the erythrocytic cytosol have no complex conformation or that, 
alternatively, chaperone-like molecules in the vacuolar space assist in the unfolding of such 
polypeptides prior to translocation (Lingelbach, 1997). In contrast to the single step model, 
proteins destined for the vacuolar space and erythrocyte cytosol can be transported within the 
same vesicle, and sorting would occur in the vacuole (Lingelbach, 1997). 
 In contrast to the above, an alternative model proposes that the sorting of proteins that are 
normally exported beyond the parasite (to the parasitophorous vacuolar membrane, the host cell 
cytoplasm and the host cell plasma membrane) takes place at the level of diversion into a 
specialized secretory organelle (Wiser et al., 1997).  The authors showed that proteins exported to 
the red cell accumulate in a specialized region near the periphery of the parasite cytoplasm in 
Plasmodium berghei and Plasmodium chaubadi in the presence of brefeldin A. They proposed 
that this compartment might represent a secondary ER, and that proteins targeted to destinations 
within the parasite or the parasite plasma membrane traffic through the classic ER-Golgi pathway, 
while proteins destined for export are targeted to and translocated across the membrane of the 
secondary ER from which they are transferred across the parasite membrane (Wiser et al., 1997; 
Wiser et al., 1999). The conclusion was based on the observation that this site appeared to be 
distinct from the perinuclear location in which a other exported parasite proteins accumulate upon 
BFA treatment (Benting et al.,1994;Wiser et al., 1999), leading to the conclusion that two 
independent secretory pathways operate in parallel in the parasite.  
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 BFA is known to induce multiple morphological changes in mammalian cells (Lippincott-
Schwartz et al., 1990). These include the redistribution of Golgi components into the ER  
(Lippincott-Schwartz et al., 1990; Wood and Brown, 1992) and the formation of ´BFA bodies´, 
derived from ER membranes (Orci et al., 1993). BFA also induces the fusion of the trans-Golgi 
network and early endosomes; this fused compartment remains functional, capable of recycling 
and delivering material (Lippincott-Schwartz et al., 1990; Wood and Brown, 1992). Therefore, 
BFA can induce different morphological changes in distinct subcellular compartments depending 
on cell type (Pelham, 1991). And in the absence of sufficient data to support the presence of the 
secondary ER, as proposed by Wiser et al., (1997), the BFA-induced peripheral localization of 
exported proteins may reflect altered membrane organization induced by the drug, rather than a 
specialized organelle.  
 Using streptolysin O permeabilized P. falciparum infected erythrocytes Ansorge et al.,1996, 
provided the first evidence that translocation of GBP across the parasite plasma membrane and the 
parasitophorous vacuole membrane is a two step process. In the first step, the protein is secreted 
into the vacuole. The second step translocates the protein across the PVM and  one reason for the 
ATP-requiremnt may be an ATP-dependent putative translocator located within the PVM 
(Baumeister et al., 1999). In contrast the serine rich protein (SERP) is secreted into and retained 
within the vacuolar space (Knapp et al., 1989b; Ragge et al.,1990). The two-step translocation 
mechanism has since been confirmed using foreign reporter proteins (Wickham et al., 2001; 
Burghaus and Lingelbach 2001).  
  Therefore a mechanism appears to exist which discriminates between proteins that are 
destined to reside within the PV and those that are targeted to specific locations outside the 
vacuole. Therefore the PV is a compartment  where protein sorting occurs. There are resident 
vacuolar proteins such as SERP whereas other proteins such as GBP and KAHRP transit through 
the vacuole across the PVM to the erythrocyte cytosol. In the case of GBP the process has been 
shown to be dependent on the availability of ATP (Ansorge et al., 1996).  If translocation of 
proteins across the PVM occurs via a default pathway, a mechanism that retains vacuolar resident 
proteins would have to be postulated, involving a retention signal. Alternatively, translocation 
across the PVM could be mediated by a specific signal contained within an amino acid sequence 
motif in the proteins that are translocated across the PVM. In the case of GBP there is no evidence 
for the cleavage of the putative signal sequence during or after its translocation across the PVM. 
 Experiments using transfected parasites expressing  chimeric proteins comprising the N-
terminal of  a number of  secreted Plasmodium falciparum proteins fused to reporter proteins have 
been used to try to characterize the secretion pathway in the infected erythrocytes. The 
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translocation of  a hybrid protein comprising the N-terminal sequence of KAHRP fused to the 
green fluorescent protein GFP has been studied. The translocation is  postulated to occur in two 
steps, the first step being co-translocation into the lumen of the ER, followed by cleavage of the 
signal sequence at the predicted amino acid sequence, then trafficking to the parasitophorous 
vacuole. Outward transport from the PV presumably requires recognition of the appropriate 
sequence element(s) within the histidine region of KAHRP (Wickham et al., 2001).  Further 
studies showed that the N-terminal sequence of KAHRP, which is considered to be a non-classical  
N-terminal signal sequence allows for protein release at the PPM (Wickham et al., 2001). The data 
further shows that in the presence of exon I + exon II there is transport across the PV, while exon I 
results in the release of the protein into the PV. Therefore it is possible that the sequences in exon 
II act in conjunction with exon I to facilitate the translocation. However it has not been 
demonstrated that exon II alone does confer translocational activity (Wickham et al., 2001). Exon 
II is histidine rich but as the sequences of many exported proteins are not histidine rich, it is 
unlikely that these sequences provide the signal for the export to the erythrocyte. The authors 
conclude that proteins destined for a location within the erythrocyte require additional sequences 
for translocation across the PVM. However in the case of KAHRP this can only be confirmed by 
fusing the Exon II sequence to a reporter protein and analyzing the subsequent localization. In 
contrast another study proposes that no specific protein sequences are required for translocation 
across the vacuolar membrane (Burghaus and Lingelbach, 2001). Using transfected parasites 
expressing a chimeric protein comprising the N-terminal of the Plasmodium falciparum exported 
protein-1, (which has a classical signal sequence) fused to luciferase, the reporter protein was 
exported into the PV as well as to the erythrocyte cytosol (Burghaus and Lingelbach, 2001). 
Despite these different observations  it is clear that protein sorting occurs within the vacuole and 
the mechanisms that determine retention and forward sorting still need to be addressed. 
 Recent work in P. falciparum suggests that import into the apicoplast is stage regulated 
and that apicoplast-targeted proteins can be are released into the PV during the early stages of the 
development of the parasite. And more intriguing the plastid-targeting signal can signal retrograde  
transport from the PV to the apicoplast (Cheresh et al., 2000). This suggests that the PV is an 
important compartment for sorting proteins that are destined for export to the host erythrocyte and 
also for the endocytic uptake of some proteins back into the parasite. All these studies confirm that 
the parasitophorous vacuole is an important transit and sorting compartment in the secretory 
pathway in Plasmodium falciparum.  
 In the recently published genome sequence of P. falciparum the authors tried to identify 
additional proteins that may have a role in protein translocation and secretion (Gardner et al., 
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2002). The P. falciparum database was searched with S. cerevisae proteins with Gene Ontology 
assignments for proteins involved in protein export. The authors identified potential homologues 
of important components of the signal recognition particle, the translocon, the signal peptidase 
complex and many components that allow vesicle assembly, docking and fusion, such as COPI 
and COPII, clathrin, adaptin, v- and t-SNARE and GTP binding proteins. The presence of Sec62 
and Sec63 orthologues raises the possibility of post-translational translocation of proteins as found 
in  S. cerevisae (Gardner et al., 2002). However as discussed earlier, the unusual features of the 
secretory  pathway of the parasite, where some proteins which lack signal peptide sequences are 
targeted beyond the PVM still remains to be solved. With the expanded list of protein-transport-
associated genes identified in the P. falciparum genome new approaches should be developed to 
further elucidate the intra-and extracellular compartments of the parasites protein transport system. 
  
1.5.  Additional functions of the parasitophorous vacuole.  
 It is clear that the vacuolar space contains specific parasite proteins which are not found in 
other locations in infected erythrocytes and thus it represents a compartment which is clearly 
distinct from the erythrocyte cytosol and from the parasite cytosol respectively (Lingelbach, 
1997). The PV represents a compartment that acts as an interface between the parasite and the host 
cell. Apart from the proteins with chaperonic activity that may be involved in protein sorting, it is 
likely that other proteins with different functions that are essential for development and survival of 
the parasite within the infected erythrocyte are also found within the vacuole. The proteins found 
within this compartment can be postulated to be involved in nutrient acquisition among other 
functions. The intracellular parasites acquire nutrients from either the host cell cytosol, the 
extracellular medium or from both and the proposed mechanisms of acquisition are discussed in 
1.2. 
 A defining feature of merozoite release at the end of the asexual stage of development is its 
susceptibility to protease inhibitors (Lyon and Haynes 1986). To better characterize the events of 
merozoite escape at the end of erythrocytic schizogony, purified P. falciparum schizonts were 
cultured in the presence of a csyteine protease inhibitor L-transexpoxy-succinyl-leucylamido-(4-
guanidino)butane (designated E64). The result was the accumulation of the merozoites within a 
single membrane supposedly derived from the PVM (Salmon et al., 2001). Importantly, structures 
identical in appearance can be detected in untreated cultures at low frequency. These studies 
propose that exit is a two-step process, where merozoites enclosed within the PVM first exit from 
the from host erythrocyte and then rapidly escape from the PVM by a proteolysis-dependent 
mechanism (Salmon et al., 2001). Therefore the vacuole is most likely to contain proteins with 
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proteolytic activities, that are involved in the release of the merozoites at the end of the asexual 
intraerythrocytic stage of development. Indeed, P126 (SERA) also known as SERP has been 
shown to be a major component of the parasitophorous vacuole and is proteolytically processed 
upon release of merozoites into the culture medium (Delpace et al.,1988).   
  As described in 1.1.2 above the process of erythrocyte invasion involves several steps 
that are mediated by proteins on the surface of the merozoite. Merozoite surface proteins are 
important since they mediate the initial recognition and attachment to the erythrocytes, secondly 
the proteins are vaccine candidates because they are exposed in the plasma and therefore are 
potential targets for antibodies that prevent merozoite invasion or lead to opsonisation and parasite 
killing. The best characterized merozoite surface protein is MSP-1 which is synthesized during 
schizogony as a large precursor protein of approximately 195 kDa (Holder and Freeman,1984). 
The protein is anchored by glycosylphosphatidylinositol to the parasite plasma membrane (Gerold 
et al., 1996).  The precursor protein is proteolytically processed into smaller fragments in a two-
step procedure characterized by primary and secondary processing events within the vacuolar 
space (Holder et al., 1992).  Primary proteolytic processing occurs at the end of schizogony. It  
produces four major polypeptide fragments of approximately 83, 28-30, 38 and 42 kDa (denoted 
MSP-183, MSP-130, MSP-138 and MSP-142) (Holder et al.,1987). The 42 kDa C-terminal fragment 
is further processed to 33 and 19 kDa fragments at the time of merozoite invasion (Blackman et 
al., 1991). This secondary processing is catalyzed by a Ca 2+-activated serine protease, which 
results in the shedding of a soluble MSP-1 complex (Blackman and Holder, 1992). The remaining 
glycosyl-phosphatidylinositol-anchored 19 kDa (Gerold et al., 1996) contains two epidermal 
growth-like modules (Blackman et al., 1991) and is carried into the erythrocyte upon merozoite 
invasion (Blackman et al.,1990). This fragment has been shown to be the target of invasion 
inhibiting antibodies (Blackman et al.,1990).  Therefore the vacuolar space components are 
important in the processes that lead to the release of merozoites at the end of the asexual cycle and 
in the proteolytic processing of MSP-1, which is a prerequisite for the successful reinvasion of 
new erythrocytes. 
 
 1.6  From   genomics to proteomics 
 The genomic era of biomedical research has provided massive amounts of information on 
DNA sequences from many species including Plasmodium falciparum whose entire genome was 
recently published (Gardner et al., 2002). This wealth of data has been annotated and is continuing 
to be analyzed by new bioinformatic algorithms and the main biomedical research activities are 
shifting to the proteome, the protein complement of the genome. Proteomics may be defined 
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broadly as the study of all proteins (and alternatively spliced varieties) expressed by a genome, 
including the concomitant isolation, identification, structural determination (with post-
translational modifications), interaction with partners (other proteins, lipids, nucleic acids) 
development time courses, effects on biological responses, and functional properties (Kenneth and 
Lee 2002). Proteins are involved in virtually all biological processes, including enzyme catalysis, 
ion transport, immune protection and signal transduction. In practice, a proteomic approach will 
focus on limited aspects (e.g. identification and interactions) of this broad menu of protein 
attributes or may focus on a limited proteome from cell fractionation such as  the complement 
related to a cellular organelle (e.g. mitochondrion) or component (e.g. nucleosome) or 
compartment (e.g. parasitophorous vacuole). In the recent years new and sophisticated methods 
have been developed for proteome analysis, because it is at the protein level where biological 
processes including those relevant for disease can be modulated and studied (Broder and Venter 
2000; Banks et al., 2000; Chambers et al., 2000).   
 Two dimensional polyacrylamide gel electrophoresis (O´Farrell, 1975) is one of the most 
widely accepted methods for separating and comparing complex mixtures of thousands of proteins 
found in biological samples. By separating proteins on the basis of two independent variables 
isoelectric point and molecular mass (pI and Mr), 2-DE is capable of resolving thousands of 
proteins expressed simultaneously in a particular cell or tissues (Klose and Kobalz 1995; 
Berkelman and Stenstedt 1998). This makes 2-D PAGE the core method in comparative proteome 
studies. In particular, the introduction of immobilized pH gradients (IPG’s) has made the method 
robust and reproducible (Bjellqvist et al., 1982). The resolution of the target proteins can be 
further enhanced by selecting the appropriate pH range for IEF, or by adjusting the percentage of  
polyacrylamide in the 2-D gel (Berkelman and Stenstedt 1998).  
 Protein identification by peptide mass fingerprinting (PMF) usually involves digestion of gel 
separated proteins with trypsin, followed by mass measurement of the resulting peptides. Mass 
spectrometry is the key element of proteome analysis (Reviews by Petersons and Aebersold 1995; 
Yates, 1998; Quadroni and James 1999; Gevaert and Vandekerckhove 2000 and Roepstorff, 
2000). Basically a mass spectrometer could be considered as an instrument with three different 
parts: (a) the sample loading side;(b) the ion path, and (c) the detection side. The polypeptides can 
be loaded either by spraying the sample into the mass spectrometer out of a capillary with a micro- 
or nano-outlet or by desorbing and ionizing proteins from a  solid surface with laser shots. 
 Matrix-assisted laser desorption ionization (MALDI), developed by (Karas and Hillenkamp 
1988) is a `soft ionization´ method that is used to generate gas phase protonated molecules 
including peptides for mass spectroscopy. The trypsin digested protein sample is mixed with a 
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large excess of matrix material usually a carefully selected weak organic acid, alpha-cyano 
hydroxycinnamic acid. A submicroliter volume   of the mixture is loaded on a metallic surface and 
the mixture is allowed to dry. The resulting solid is then irradiated by nanosecond laser pulses, 
from small nitrogen lasers with a wavelength of 337 nm. This is the absorbance range for the 
matrix surface and for an unknown reason, a proton moves from the weak organic acid to the 
protein which gets “vaporized” at the same time. The finally volatile and positively charged 
polypeptides are accelerated to affixed amount of kinetic energy and they enter a flight tube. The 
smaller ions have a higher velocity and they are recorded on a detector before the larger ones, 
producing the time of flight (TOF) spectrum which give the masses and abundance of the flying 
ions.  
 Peptide mass mapping with MALDI-TOF-MS (Joubert-Caron et al., 2000) remains a 
practical method for rapidly identifying and partially characterizing numerous proteins in 
proteomic studies. The positive identification of proteins requires the measurement of enough 
peptide masses to obtain a definitive match with sequence information recorded in protein 
databases. Bioinformatics plays an essential role in all proteomic work and numerous proteomic 
virtual tools have been developed and many of them are accessible through the world wide web 
e.g.(http://www.expasy.ch/tools/;http://www.prospector.ucsf.edu/; www.matrixsciences.com; 
http://prowl.rockefeller.edu/cgi-bin/ProFound, http://www.ncbi.nlm.nih.gov/). The ultimate goal 
of proteomics is to complement genomic efforts to unravel biological processes and function.  The 
growing awareness that the PV forms an important interface between parasite and host cell cytosol 
highlights the significance the vacuolar proteome. The recent development of technical and 
bioinformatic tools should greatly facilitate the identification of vacuolar proteins. A major 
obstacle is the small volume of the PV, which constitutes only a 1:10,000 of the infected 
erythrocyte. Therefore the first and main objective of this project is the development of an 
experimental strategy that allows the selective identification of soluble vacuolar proteins, avoiding 
contamination with soluble proteins, either from the host erythrocyte or from the parasite cell. 
 
1.7 Biotin labeling of   proteins 
  Biotinylation is a highly sensitive method for labeling and analyzing proteins and the 
method has been used to characterize cell wall proteins of Candida albicans  (Casanova et al., 
1992) Borrellia burgdorfi (Luft et al.,1989) and Helicobacter pylori (Sabarth et al., 2002). 
Biotinylation is one of the most commonly used means of labeling proteins for easy detection, 
immobilization, and purification. The utility of biotin as a tag is a result of its interaction with   
egg white protein avidin and its bacterial analogue streptavidin. The two proteins share a similar 
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high affinity (Ka ~1015 M-1) for the vitamin biotin, this is several orders of magnitude greater than 
the constants for antigen –antibody or agglutinin- sugar complexes (Green,1990) and  the avidin-
biotin system has gained a great importance over the years both as a means of studying bio-
recognition phenomenon and as a tool for general application in many biotechnological 
applications. This powerful approach has facilitated the localization, identification and assay of an 
almost unlimited number of biological molecules (Wilchek and Bayer 1988; Wilchek and Bayer 
1990). Other than the high affinity constant, two other properties of this specific, ligand-protein 
interaction make it convenient for its applications. The biotin can be attached to target 
macromolecules by a varied of reactive derivatives (Liu and Leonard, 1979) frequently without 
altering the biological activity of the biotinylated moiety and secondly mixed conjugates may be 
prepared which consists of avidin chemically linked to a wide spectrum of perceptible probes (e.g. 
Feritin, fluorescein, alkaline phosphatase, horseradish peroxidase, and rhodamine), as well as to 
lectins or solid matrixes (Bayer and Wilchek, 1974).  
 Pierce, Rockford IL, USA has developed several biotin derivatives including 
sulfosuccinimidyl-6-(biotinamido)hexanaote (sulfo-NHS-LC-biotin) and Sulfosuccinimidyl-2-
(biotinamido)Ethyl-1-3dipropionate (sulfo NHS-SS-Biotin). These water-soluble biotin analogues 
react with primary amines in amino acids, mainly  the epsilon group  of  lysine of proteins. They 
have spacer arms between the biotin and the reactive ester molecules to reduce stearic hindrance 
when binding several biotinylated molecules to one avidin complex. The sulfo NHS-LC-Biotin 
has a hydrocarbon spacer arm whereas the sulfo NHS-SS-Biotin has a disulfide bond in the spacer 
arm. The biotin can be separated from the reactive group when the spacer arm is cleaved using 
reducing agents. This is ideal for use in reversible biotinylation reactions and in purification 
procedures where a reducing agent is used to release the labeled molecule from biotin bound to 
avidin or streptavidin fixed to a solid matrix. 
 The reaction of the primary amines with N-hydroxysulfosuccinimide (NHS) esters is best at 
neutral pH values and above. This is due to the fact that the target of the NHS ester is the 
deprotonated form of the primary amine. The amine reacts with NHS ester by nucleophilic attack 
forming a stable amide bond. The product of the reaction, N –hydroxysulfosuccinimide, is 
released and the biotin conjugate remains bonded to the protein as shown in figure 5. These 
derivatives are coupled to a -SO4 group, they are hydrophilic and they cannot permeate lipid 
bilayers (Pierce, USA) and they  have been used in selective labeling to identify surface proteins 
in different organisms (Luft et al., 1989; Manuel et al., 1992; Apoga et al., 2001;). The biotin 
labeled proteins can then be detected in western blot analysis by using alkaline phosphatase or 
horseradish peroxidase conjugated streptavidin. Recently Nyalwidhe et al., (2002), showed that 
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these derivatives do not enter non-infected erythrocytes but they enter trophozoite-infected 
erythrocytes probably through the novel permeation pathways since biotinylation of the 
cytoplasmic face peripheral membrane protein, spectrin which closely associates with the host cell 
cytoskeleton is inhibited by furosemide an inhibitor of the NPPs.  
 
1.8   Permeabilization of  P. falciparum infected erythrocytes with Streptolysin O  
 Pore-forming bacterial toxins are increasingly used by cell biologists as tools for controlled 
permeabilization of cell membranes (Bhakdi et al., 1993). The advent of using streptolysin O 
(SLO) among other bacterial pore forming toxins to permeabilize the erythrocyte membrane 
without affecting the PVM (Ansorge et al., 1996; Ansorge et al., 1997; Lingelbach, 1997) has 
made it possible to sequentially fractionate infected erythrocytes and thus investigate protein 
transport and the localization  of proteins in different compartments, for example, the erythrocyte 
cytosol, the parasitophorous vacuole and the parasite cytosol. Binding of the toxin occurs via 
interaction with cholesterol. SLO pores are generated when membrane-bound toxin monomers 
collide via lateral aggregation to form high-molecular-weight oligomers (Bhakdi et al., 1985). 
These can be seen in electron microscope as partially or fully circularized ring structures with 
heterogeneous internal diameters (Bhakdi et al., 1985). The pores formed by these polymers have 
diameters exceeding 30 nm, which allow free passage of substances thus allowing the introduction 
of proteases, drugs and many other substances making it possible to study their effect on the 
physiology of the parasite in a defined system. The toxin does not affect the PVM in infected 
erythrocytes. 
 The study of the topology of the PVM has also been achieved with respect to two exported 
membrane protein exp-1 and exp-2 that are associated with the PVM (Ansorge et al., 1996; 
Ansorge et al., 1997) using SLO permeabilization. In addition the study of the mechanisms of 
translocation of  GBP, an abundant parasite protein which is exported across the PVM  into the 
host cell cytosol has also been achieved after  the use of streptolysin O,. After the permeabilization  
process, host cell cytosol is extraction completely and the extra cellular milieu can be 
reconstituted and the study of the mechanisms involved in the translocation of proteins across the 
PVM in the selectively permeabilized infected erythrocytes is facilitated (Ansorge et al., 1996; 
Baumeister et al., 1999).  
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Figure 5. Structures of biotin derivatives and their mechanism of reaction with proteins. The 
sulfo-NHS-SS-biotin has a linker with a disulphide bond between the biotin molecule and the reactive ester containing 
group, which can be cleaved by reducing agents. The linker in the sulfo-NHS-LC-biotin is non-cleavable.  
      MW 606.9 
Na03S 
Na03S 
A. 
B. 
C. 
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 1.9 General objectives: 
The objectives of this study were 
i). To identify soluble Plasmodium falciparum proteins in the parasitophorous vacuole. 
 
ii) To characterize the proteins identified under (i). 
 
2. Materials and Methods. 
 
2.1 Materials 
2.1.1. Equipment 
Blotting Apparatus            Phase        Lübeck 
Confocal Microscope   Leica Laser Scanning TCS   
Incubator    Heraeus   Hanau    
Film                                                   Cassetes                         Rego 
Gel Drier    Biotech Fischer    Schwerte 
IEF Apparatus Multiphor II  Pharmacia Biotech  Sweden 
Labofuge III    Heraeus   Hanau 
Lab roller Spiromix      Denley     UK 
Magnetic stirrer   Ika Combimag   RCH 
MALDI- TOF                                    Voyager- DE STR                 Framingham, MA  
Orthoplan Microscope  Leitz    Wetzlar 
pH- Meter 766   Calimatic 
Power supply 2130   LKB Biochrom  St.Albans, UK 
Spectrophotometer   Beckman   Irvine, USA 
Speedvac centrifuge   Uni-Equip   Martinsried 
UNO- Thermoblock   Biometra   Göttingen 
Vortexer REAX 2000  Heidolph 
Waterbath 2219 Multitemp II  LKB    Bromma 
 
2.1.2  Disposable  Materials 
Culture flasks                                    Greiner                                   Frickenhausen 
Eppendorf reaction tubes  Eppendorf    Hamburg 
Falcon tubes    Greiner   Frickenhausen 
Films     New RX NIF, Fuji  Japan 
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Glass slides    IDL    Nidderau 
IPG IEF strips    Pharmacia Biotech  Sweden 
Micro concentrator   Millipore Corp.  Bedford USA 
Nitrocellulose membrane  Schleicher & Schuell  Dassel 
Pipettes    Gilson    Villiers-le 
         Bel, France 
Pipette tips    Greiner   Frickenhausen 
Whatman Paper   Schleicher & Schuell  Dassel 
Zip Tip gel loading column  Eppendorf    Hamburg 
 
 2.1.3 Chemicals and reagents 
Acetic acid       Roth    Karlsruhe 
Acetone                 Roth               Karlsruhe 
Acetonitrile       Merck                                  Darmstadt 
Ammonium hydrogen carbonate    Sigma 
Ammonium persulfate                Roth                         Karlsruhe 
ASB-14       Calbiochem 
BCIP 
(5-Bromo-4-chlor-3-indolyphosphat)   Biomol   Hamburg 
Bovine Serum Albumin Fract.5 BSA   Roth    Karlsruhe 
Brilliant blue G-colloidal concentrate  Sigma 
CHAPS       Sigma-Aldrich 
Coomassie Brilliant blue R 250    Roth    Karlsruhe 
Cyano-4-hydroxycinnamic acid           Sigma 
DTT         Fluka 
ECL- Reagent       AmershamPharmacia  
                                                              Biotech   Sweden 
EDTA        Merck                                  Darmstadt 
Ethanol       Roth    Karlsruhe 
Formic acid HPLC grade                      Sigma 
Gentamycin       Gibco   Eggenstein 
Giemsa solution      Merck   Darmstadt 
Glycerin       Roth      Karlsruhe 
HEPES       AppliChem   Darmstadt 
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Hydrochloric acid      Roth    Karlsruhe 
Iodoacetamide      Sigma 
IPG buffer       Amersham Pharmacia 
                  Biotech. 
Isopropanol       Roth    Karlsruhe 
L- [35S] Methionine      ICN                                      Irvine, California 
Magnesium Chloride      Roth    Karlsruhe                          
  Methanoic acid      Roth    Karlsruhe 
Methanol       Roth    Karlsruhe    
Milk powder       Fluka 
Monomeric avidin agarose beads         Pierce   USA 
Nitroblue Tetrazolium Chloride     Biomol   Hamburg 
Oligo R3                                               AppliedBiosytems 
Ponceau S pure      Serva   Heidelberg 
Poros R2                                               AppliedBiosytems  
Potassium Chloride      Roth    Karlsruhe 
RPMI 1640 medium      Life Technologies Inc. 
Sequenzyme   peptide markers              AppliedBiosystems 
Sodium Azide       Roth    Karlsruhe 
Sodium Chloride      Roth    Karlsruhe 
Sodium dihydrogenphosphate              Roth    Karlsruhe 
Sodium hydrogencarbonate     Roth    Karlsruhe  
Sodium hydrogenphosphate     Roth    Karlsruhe 
Sodium hydroxide      Roth    Karlsruhe   
Streptavidin conjugated agarose           Pierce          USA             
Streptolysin O       S. Bhakdi   Universität Mainz 
Sulfosuccinimidyl-2-(biotinamido) 
Ethyl-1-3dipropionate  
(sulfo NHS-SS-Biotin)                Pierce     USA 
Sulfosuccinimidyl -6- (biotinamide) 
-6-hexanamido hexanoate. 
 Sulfo NHS-LC- Biotin      Pierce    USA 
TEMED        Roth   Karlsruhe 
Trichloroacetic acid (TCA)      Roth   Karlsruhe 
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Trifluoroacetic acid  (TFA)                   Sigma 
Thiourea         Roth   Karlsruhe 
Trishydroxymethylaminomethane  
(Tris)                               Roth   Karlsruhe 
Trypsin modified sequence grade     Promega 
 
2.1.4 Solutions and buffers 
Acrylamide solution:   30% (w/v) Acrylamide 
    0.8% (w/v) Bisacrylamide 
 
AP developing buffer:  100 mM Tris-HCL, pH 9.5 
    100 mM NaCl 
                  5 mM MgCl2 
 
AP developing solution:  66µl NBT stock solution 
    33µl BCIP stock solution 
 
BCIP stock solution:   5% BCIP in 100% Dimethylformamide 
 
Coomassie destainer:   30% (v/v) Methanol 
    10% (v/v) Acetic acid 
    Distilled water 
 
Coomassie staining solution:  30% (v/v) Methanol 
    10% (v/v) Acetic acid 
     0.25% (w/v) Coomassie Blue R 250 
     Distilled water 
 
Electrophoresis buffer:  0.124 M Tris 
    0.96 M Glycin 
    0.05 % SDS 
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Gas mixture for   P. falciparum culture: 
    5% CO2 
        5% 02 
    90% N2 
 
Giemsa stain:    1%  (v/v) Giemsa solution 
    9%  (v/v) Giemsa buffer 
 
Giemsa buffer 10x, pH 6.8:  130 mM Na2HPO4  
    100 mM KH2PO4  
 
NBT stock solution:   5% NBT in 70% Dimethylformamide 
 
PBS, pH 7.2:    140 mM NaCl 
    6.5 mM KCL 
    2.5 mM Na2HPO4  
    1.5 mM KH2PO4 
 
PBS ++:    PBS containing 
    0.6 mM CaCl2 
    1 mM MgCl2 
 
Ponceau stain:   0.2% Ponsceau red 
    3% Trichloroacetic acid 
    100ug/ml RNase A 
 
Protease inhibitor cocktail Stock solution: 
     200 µg/ml of each of the inhibitors antipain, 
     chymostatin, aprotinine, pepstatin, trypsin, leupeptin 
     elastinal and Na-EDTA in PBS.   
Working solution 1:200 dilution   
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Rehydration buffer:   8M Urea 
    2M Thiourea 
    4% DTT 
    4% CHAPs 
    1.6% ASB-15 
    2% IPG buffer 
    Trace bromophenol blue 
 
RPMI 1640 Medium   31.784 g RPMI 1640 
    25 mM HEPES sterile filter 
    40 µg/ml Gentamycin 
    in 1litre distilled water 
 
RPS- Medium:   867 ml RPMI 
    33 ml 8.125% NaHCO3 
    100 ml   heat denatured human plasma 
 
SDS equilibration buffer:    50 mM Tris-HCl 
     6 M Urea 
     30% 8 (v/v) Glycerol  
     2 % (w/v) SDS 
     supplemented with either 
     64 mM DTT or 135 mM Iodoacetamide 
 
SDS-PAGE concentrating gel pH 6.8: 
     0.5 M Tris/HCL 
     0.4% SDS 
 
SDS sample buffer stock solution:     63 mM Tris/HCl 
    0.5 M sucrose 
    0.01% Bromophenol blue 
    5 mM EDTA 
                1%  L-methionine    
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SDS sample Loading buffer:             200 µl 0.5 M DTT 
    200 µl 20% SDS 
    600 µl SDS sample buffer stock solution 
SDS-PAGE separating gel pH 8.8:  
     1.5 M TrisHCl 
     0.4%  SDS. 
 
 
Western Blot Buffer:   48 mM TrisHCl 
     39 mM Glycin e 
     0.0375% SDS 
     20% Methanol. 
 
2.1.5   Host cells and parasite isolates 
 
Human erythrocytes, blood group A Rh +    University blood bank     Lahnberge       Marburg. 
                     
Plasmodium falciparum isolate FCBR          Philipps University   Marburg 
 
        
2.1.6 Antibodies and working concentrations 
 
Cy3 (red) goat anti rabbit  Sigma, Diesenhofen   Dilution 1: 200 
Cy5 goat anti mouse   Sigma, Diesenhofen  Dilution 1: 200 
Goat anti rabbit alkaline 
phosphatase (AP)   DAKO Glostrup  Dilution 1:2000 
Goat anti rabbit  
horse radish peroxidase (HRP) DAKO Glostrup  Dilution 1:2000 
Monoclonal anti biotin peroxidase 
Conjugate                                         Sigma, Diesenhofen  Dilution  1:4000 
Mouse anti band 3   DAKO Glostrup  Dilution 1:2000 
Rabbit anti aldolase   our laboratory   Dilution 1: 500 
Rabbit anti Bip   our laboratory     Dilution  1:500 
Rabbit anti GBP   our laboratory   Dilution  1:500  
Rabbit anti human HSP 90                 Santa Cruz Biotech. Inc.        Dilution 1:2000              
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Rabbit anti PfHsp 70              Dr. Tatu, India   Dilution 1:200  
Rabbit anti PfHsp 90              Dr. Tatu, India   Dilution 1:200  
Rabbit anti Mouse alkaline 
Phosphatase (AP)   DAKO Glostrup  Dilution 1:2000 
Rabbit anti mouse horseradish  
Peroxidase (HRP)   DAKO Glostrup  Dilution 1:2000 
Rabbit anti SERP   our laboratory   Dilution 1:500  
 
Streptavidin avidin  
alkaline phosphatase  (SAV-AP)  Pharmingen, USA  Dilution 1:10,000 
Streptavidin   horseradish  
Peroxidase (HRP)   Pharmingen, USA  Dilution 1:10,000   
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2.2 Methods  
2.2.1 Parasite Cultures 
 Parasites, P. falciparum FCBR were cultured in RPMI 1640 medium (Life Technologies, 
Inc.) supplemented with 10% heat in-activated (56°C, 30 min) human plasma and erythrocytes of   
blood A+ group (Marburg Blood Bank) using standard procedures (Trager and Jensen, 1976). 
Trophozoites-infected erythrocytes (iRBC) were enriched to a parasitaemia of  > 90% by gel 
floatation (Pasvol et al., 1978). For metabolic labeling of newly synthesized proteins, the enriched 
iRBC were washed twice in methionine free RPMI 1640 medium and cultured for 2 hours in 
methionine free medium without the plasma supplement in the presence of 50 µCi/ml L-[35S] 
methionine. 
 
2.2.2   SLO permeabilization of infected erythrocytes 
  Metabolically labeled iRBCs were permeabilized with SLO, (kindly provided by S. 
Bhakdi). Routinely, SLO was titrated as described by Ansorge et al., 1996. Briefly, 2 x108 iRBC 
were washed twice using RPMI 1640 medium before resuspension in 200 µl of the same media 
and incubation with various amounts of SLO at room temperature for 6 minutes. The solution was 
centrifuged for 5 min at 1300 g and the supernant analyzed spectrophotomerically at 412 nm to 
determine the amount of hemoglobin released. In parallel the same amount of cells were lysed 
completely in   200 µl of water by three cycles of freezing and thawing to determine the total 
hemoglobin content. The amount of SLO that resulted in release of 50% of the hemoglobin is 
defined as 1 hemolytic unit (Ansorge et al., 1997). Subsequent experiments were done using 2 x 
108 iRBC incubated in 200µl of RPMI containing 3-4 hemolytic units of SLO. The samples were 
centrifuged at 4000 x g for 5 minutes to extract the erythrocyte cytosol from the permeabilized 
host cells. This resulted in the release of all the hemoglobin within detectable limits as determined 
by spectrophotometry. The pellet containing intact parasites, the vacuolar content and membranes 
was washed twice with 200µl RPMI 1640 medium before biotinylation.  
 
2.2.3  Biotinylation of SLO permeabilized iRBC and extraction of soluble proteins 
 Permeabilized iRBC were washed with PBS containing 0.6 mM CaCl2 and 1mM MgCl2 pH 
7.6 (PBS++). The reaction of primary amines with N-hydroxysulfosuccinimide (NHS) esters is best 
at neutral pH values and above. This is due to the fact that the target for the NHS ester is the 
deprotonated form of the primary amine. For the biotin labeling of the total parasite proteins, 
permeabilized iRBC were routinely resuspended in 800 µl of distilled water containing the 
protease inhibitors antipain, chymostatin, aprotinin, trypsin-inhibitor, Na-EDTA, pepstatin, 
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leupepetin and elastatinal each at a concentration of 1 µg ml-1. The lysates were prepared by 3 
cycles of freezing and thawing. The soluble proteins obtained after centrifugation at 10,000x g for 
15 minutes were used for further analysis. The proteins were biotin labeled in PBS++, pH 7.6 
containing 1mg ml-1 of   Sulfo-NHS-LC biotin or Sulfo-NHS-SS biotin for 30min at 4° C with 
frequent light shaking. The incubation at 4° C reduces endocytic activity of the parasite and thus 
prevents the internalization of the biotin derivative by endocytosis. The solution was further 
centrifuged at 3,000 x g using a microconcentrator with a size exclusion of 5 kDa to remove any 
free biotin. This step was repeated two more times and the protein solution was stored at 4° C until 
use. 
 For the selective biotin labeling of soluble vacuolar proteins, permeabilized cells were 
incubated with Sulfo-NHS-LC biotin or with Sulfo-NHS-SS biotin as described above. The 
solution was centrifuged at 1300 x g for 5min at 4°C and the pellet was washed 3 times in PBS++ 
containing 100mM glycine to react with any unreacted biotin derivative that was still present in 
solution. After a final wash in PBS++, iRBC were lysed and processed as above.  
 
2.2.4   Biotin labeling of Bovine serum albumin  (BSA) 
 To investigate the effect of biotin labeling on the molecular mass and subsequent separation 
pattern on 1D SDS-PAGE, BSA was labeled with different mole ratios of the Sulfo-NHS-LC-
biotin derivative. In one experiment, 10 mg of BSA were dissolved in 1 ml of PBS++ before adding 
1 mg of biotin derivative to give a mole ratio of 12:1 excess of biotin. In a parallel experiment 2 
mg of biotin were dissolved in 1ml of PBS++ before adding 0.3 mg of the biotin derivative giving a 
mole ratio of 1:1 biotin to BSA. The mixtures were incubated at for 30 minutes at 4°C. The 
unreacted derivative was removed by using micro concentrators as described above and the BSA 
was subsequently analyzed by SDS-PAGE,  western blot and Coomassie staining.  
 
2.2.5 Affinity purification of biotin labeled proteins 
 Streptavidin   and avidin conjugated agarose beads were used in the affinity purification of 
biotin labeled proteins as follows. A total lysate comprising of non-biotinylated but radiolabeled 
soluble proteins of the SLO pellet from 2 x 108 iRBCs was incubated with washed streptavidin 
conjugated agarose beads, at 4°C for 2 hours under constant shaking. The beads were sedimented 
by centrifugation at 10,000 x g for 5min. The supernatant was collected and stored at –20° C until 
further use. The beads were sequentially washed in buffers (A10 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 0.2% NP40, 2 mM EDTA; B 10 mM Tris-HCl pH 7.5, 500 mM NaCl, 0.2% NP40, 2 mM 
EDTA; C 10 mM Tris-HCl pH 7.5 and finally with PBS++. The beads were then washed with 10 
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mM HEPES buffer pH 7.4 containing 20 mM MgCl2 and 5 mM ATP.  The bound proteins were 
eluted by boiling the beads in SDS-PGE sample buffer before analysis.  
 In a similar experiment a total lysate comprising soluble proteins of the SLO pellet from 2 x 
108 iRBCs was incubated with 1 mg/ml sulfo-NSH-LC-biotin at 4° C for 30 min. The unreacted 
biotin derivative was removed by using micro concentrators as described above and the 
biotinylated and radiolabeled proteins were incubated with washed streptavidin conjugated 
agarose beads, at 4°C for 2 hours under constant shaking. The beads were sedimented by 
centrifugation at 10,000 x g for 5min. The supernatant was collected and stored at –20° C until 
further use. The beads were processed as described above before analysis by SDS-PAGE. 
 
2.2.6   Immunoprecipitation of the marker proteins 
 The marker proteins SERP, GBP and aldolase were precipitated from the lysates as follows; 
soluble proteins from 2 x 107 permeabilized iRBCs were dissolved in 400µl of distilled water and 
500µl of solubilization buffer containing 50 mM Tris/HCl pH 7.5, 150 mM NaCl, 1% NP40 and 4 
µg/ml PMSF. 5 µl of the corresponding antisera were added and the mixture was incubated at 
room temperature for 30min after which 30 µl of 50% packed volume of the protein A sepharose 
beads were added for 1h. The beads were sedimented by centrifugation and the supernatant was 
collected. The Protein A sepharose beads were washed sequentially with buffers A, B and C and 
PBS++ as outlined above and the precipitated proteins were eluted by boiling the beads in SDS-
PAGE sample buffer before analysis. Proteins were precipitated from the supernatant with 10% 
trichloroacetic acid on ice for 10 minutes. The samples were centrifuged at 10,000 x g at 4°C for 
15 minutes, the precipitate was washed using cold acetone and dissolved in SDS-PAGE sample 
buffer before analysis. The protein A sepharose beads were washed sequentially with buffers A, B 
and C and PBS++ as describe in 2.25 above and the bound proteins were eluted by boiling the 
beads in SDS-PAGE sample buffer and analysed. 
 
2.2.7 Gel Electrophoresis 
 For 1D SDS-PAGE protein samples were dissolved in SDS-sample buffer and separated on 
7.5%, 10%, 12% or 5%-20% gradient gels under reducing conditions. The protein bands were 
visualized by Coomassie staining before exposure to X-ray film for the detection of radiolabeled 
proteins.  
 For two-dimensional (2-D) PAGE, two different approaches were used. In the first 
procedure 2 x 109 infected RBCs were labeled metabolically with [35S] methionine, permeabilized 
with SLO and treated with Sulfo NHS-SS-biotin. After cell lysis and processing as described in 
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2.2.3 above the soluble fraction was incubated with washed streptavidin agarose beads at 4°C 
overnight under constant shaking. The beads were sedimented by centrifugation at 10,000 x g for 
5min. The supernatant was collected and stored at –20° C until further use. The beads were 
sequentially washed as described in section 2.2.5. Two compounds Tris (carboxyethyl) phosphine 
Hydrochloride (TCEP.HCl, Sigma-Aldrich) or dithiothreitol, DTT were used to elute the bound 
biotin labeled proteins from the beads. They act by reducing the sulphide bond between the biotin 
molecule and the protein, thereby releasing the proteins from the avidin-biotin complex. 
TCEP.HCl, a tri-aklyphosphine has been shown to be a more effective reducing agent compared to 
DTT (Han et al., 1994). The beads were incubated with TCEP at a concentration of 1mg/ml at 
room temperature for 2 hours and in parallel experiments the beads were incubated with 100 mM 
DTT at room temperature for 2 hours. The solutions were centrifuged at 10,000 x g for 30 minutes 
and the supernatants obtained were incubated with 3 volumes acetone at –20°C overnight to 
precipitate the eluted proteins. 
 The precipitate was dissolved in rehydration medium (8 M urea, 2M thiourea, 4% CHAPS, 
4%DTT, 2% ASB and 2% IPG buffer pH 4-7, Pharmacia Biotech, Sweden), vortexed and 
incubated at room temperature for 1h to solubilize the proteins. Dry linear precast immobilized pH 
gradient gel strips (IPG, 13cm, pH 4-7) were rehydrated for 24 hours with 250µl rehydration 
solution containing the dissolved protein. 
 In the second approach, 2 x 109 infected RBCs were labeled metabolically with 35S 
methionine, permeabilized with SLO and treated with Sulfo NHS-LC-biotin. After cell lysis 
processing as described above the soluble fraction was precipitated using 3 times volume 10% 
TCA in acetone containing 20mM DTT at –20° C for 1 hour. The proteins were sedimented by 
centrifugation and the pellet was washed 3 times with cold acetone containing 20 mM DTT before 
drying and dissolving in 250  µl of rehydration medium (8 M urea, 2M thiourea, 4% CHAPS, 
4%DTT, 2% ASB and 2% IPG buffer pH 4-7, Pharmacia Biotech, Sweden) and rehydrating linear 
precast immobilized pH gradient gel strips (IPG, 13cm, pH 4-7, Pharmacia Biotech) for 24 hours 
under low viscosity paraffin oil to prevent evaporation and subsequent crystallization of the urea 
from the rehydration medium. After the passive rehydration the IPG strips were rinsed with a 
minimal amount of distilled water to remove any crystals on the surface before isoelectricfocusing 
(IEF) in a Multiphor II apparatus (Pharmacia Biotech.), for a total of 28,800 volt hours with a 
maximum of 50 µA per strip.  
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Table 1. Rehydration and isoelectricfocussing conditions for 4-7 linear immobilized pH 
gradient strips. 
 
Step                                Voltage                            Duration (h)                 Gradient Type 
 
Rehydration                       -     24                                      - 
1                                      300                                       1                                   Stepped 
2                                      500                                       1                                   Stepped 
3                                    3500                                       8                                   Stepped 
___________________________________________________________________________ 
 
  After focusing the individual IPG strips were consecutively incubated in SDS equilibration 
solutions A and B  (50 mM Tris-HCl, pH 6.8, 8 M urea, 30 % v/v glycerol, 2 % w/v SDS and 
trace of bromophenol blue) complemented with 20mg ml-1 DTT (solution A) or 25 mg ml –1 
iodoacetamide instead of DTT solution B)), each for 15 min with a distilled water rinse between 
the incubations. The iodoacetamide alkylates and prevents the re-oxidation of the cysteine 
residues. The equilibrated strips were transferred to a 10% or 12% slab gel (1mm thickness x 15.5 
cm width x 17 cm), sealed with 0.5% (w/v) agarose before separating the proteins in a second 
dimension. The separated protein spots were either visualized by colloidal Coomassie blue stain or 
by silver staining or transferred to nitrocellulose membranes for western blot analysis. Parallel 
gels were dried and radiolabeled spots were visualized by autoradiography. The images of gels 
were acquired using Photoshop 3.5 software (Adobe Inc.) on a Vistascan flatbed scanner. 
 
2.2.8 Western Blot Analysis  
 Proteins separated by SDS-PAGE were transferred to nitrocellulose membranes. For 
detection of biotin labeled proteins, the membranes were blocked using 2% BSA in PBS pH 7.4 
for 1 hour at room temperature. Filters were then incubated at room temperature for 20 minutes 
with streptavidin alkaline phosphatase-conjugate diluted 1:10,000 in 2% BSA in PBS, pH 7.4. The 
membranes were washed in 10 mM Tris/HCl pH 7.4, 150 mM NaCl for 5 min, then in the same 
buffer containing 0.05 % Triton-X 100 for another 5 min and finally in the buffer without Triton-
X 100. The filters were then incubated for 5 minutes in the alkaline phosphatase detection buffer 
and the biotin labeled proteins stained with nitro blue tetrazolium and 5-bromo-4 chloro-
indolylphosphate following standard procedures. The same membranes were then incubated with 
specific rabbit antisera at a dilution of 1:500 at 4° C overnight. Specific marker proteins were 
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detected after incubation with horseradish peroxidase-conjugated anti-rabbit IgG  (Dako) for 1h at 
room temperature and development of the filters using the ECL system (Amersham Biosciences) 
following standard procedures. 
 
2.2.9  Indirect Immunofluorescence  
 Permeabilized and biotin treated iRBC were spread on glass slides and air dried. 
Subsequently, they were fixed in acetone-methanol (1:1) for 10 min at –20 °C. The slides were 
incubated with the primary antibodies for 2 hours at room temperature. The monoclonal anti-band 
3 IgG was diluted 1:20, and the polyclonal rabbit antisera specific for SERP and aldolase, were 
each diluted 1:10 in PBS, pH 7.2. After 3 washes with PBS, pH 7.2, slides were probed with a 
mixture of the corresponding secondary antibody (1:100) and Cy3-conjugated streptavidin (1:200) 
for 30 min at room temperature in the dark. Autofluorescence levels were determined by viewing 
control samples of either biotin-treated or untreated iRBCs not incubated with Cy3-conjugated 
streptavidin and secondary antibodies. The cells were mounted in glycerol containing 0.1% of the 
antifade reagent 1,4-diazobicyclo (2,2,2)-octane. Fluorescence microscopy was performed using a 
Leica TCS SP2 scanning microscope. 
 
2.2.10 Immunoelectronmicroscopy 
 Permeabilized and biotin treated iRBCs were fixed overnight at 4° C in 1% gluteraldehyde 
in 0.1 M phosphate buffer, pH 7.4, then washed with 0.1 M phosphate buffer. The fixed cells were 
dehydrated by incubating them in successively increasing ethanol concentrations from 30% 
through 50%, 70%, 80%, 90% and finally 100% allowing 10 min for every step. The cells were 
then suspended in 1:1 ethanol / Lowicryl resin overnight in open eppendorf tubes to allow the 
evaporation of the ethanol. The cells were pelleted by centrifugation and the pellet mixed with 
fresh lowicryl and placed overnight under UV light overnight to allow the polymerization of the 
resin in a gelatin capsule. Ultra thin sections were cut with a diamond knife and mounted onto   
copper grids.  Sections were blocked with 2% BSA in PBS before incubation with  a 1: 800 
dilutions of streptavidin conjugated with 10 nm gold particles. The sections were contrasted and 
examined under electronmicroscope. 
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2.2.11 Processing of proteins for analysis by MALDI-TOF 
 Proteins separated by two dimensional gel electrophoresis were fixed for one hour in 7% 
glacial acetic acid and 40% methanol before staining overnight in colloidal Coomassie blue   
containing 20% methanol to visualize the spots. The gel was destained in 10% acetic acid, 25% 
methanol for 60 seconds with shaking, and then rinsed with 25% methanol overnight to remove 
excess stain.  
 Protein digestion was performed according to the method of Hellman et al., 1995 with minor 
modifications. Briefly, protein spots were precisely cut out of the gels using an eppendorf blue 
pipette tip to minimize the collection of unstained gel and placed in micro centrifuge tubes 
(Eppendorf, Germany) containing 200 µl washing/ destaining buffer (200 mM NH4HCO3; 50% 
CH3CN). The gel pieces were incubated at 37 °C for 30 min with continuous shaking. The buffer 
was aspirated and the gel pieces dried under vacuum for 30 minutes. 10 µl of the in gel digestion 
solution containing 10% CH3CN, 40 mM NH4HCO3 pH 8.1 and 0.02 µg ml-1 sequencing grade 
trypsin was added to the gel and incubated for 45 min at room temperature to allow the gel pieces 
to soak in the solution. A further 5 µl of the solution was added and the mixture was incubated for 
1 hour to ensure that the gel pieces were fully saturated with the digestion solution. The 
supernatant was then aspirated and the gel pieces incubated at 37 °C for 18 hours for in-gel trypsin 
digestion. The eppendorf   micro centrifuge tubes were inverted to minimize evaporation of the 
digestion solution. Subsequently 15 µl of diffusion solution, 10% CH3CN in 1% trifluoroacetic 
acid were added and the mixture was sonicated at 37 °C for 45 minutes. The supernatant 
containing the tryptic digests was transferred to a gel loader tip with a 5mm high column of 
reverse phase material consisting of POROS 50 R2 and Oligo R 3(AppliedBiosystems), 1:1 in 
50% acetonitrile to desalt and concentrate the peptides. Before loading, the column was washed 
sequentially with 10µl methanol then 10µl methanoic acid. After loading the tryptic digests, the 
column was again washed with 10µl methanoic acid before adding 0.7 µl the elution medium 
consisting of the MALDI matrix and marker peptides (2 mg α-Cyano-4-hydroxycinnamic acid 
(Sigma) in 170 µl 70% CH3CN in 0.1 % trifluoroacteic acid complemented with 0.25 µl of 
calibration mixtures I and II (AppliedBiosystems) diluted 1:500) and directly loading the eluted 
peptides directly on to the gold or steel plated MALDI target. The analytes were dried before 
loading the target to the MALDI apparatus.   
 Mass spectrometry was performed using a Perseptive Biosytems Voyager DE-STR 
(Framingham, MA). The instrument employs nitrogen at 337nm as the laser source and it has a 20 
kV accelerating voltage. Briefly, the digested peptides co-crystallized with the matrix were 
irradiated by laser beam, leading to sublimation and ionization of peptides. About 150 ns after the 
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laser pulse, a strong electric field is switched (delayed extraction), which imparts a fixed kinetic 
energy to the ions produced by the MALDI process. These ions travel along a flight tube and are 
turned around in an ion mirror (reflector) to correct for initial energy differences before being 
directed to the detector. The mass-to-charge ratio is related to the time it takes an ion to reach the 
detector; the lighter ions arrive first. The ions are detected by a channeltron electron multiplier that 
gives the mass and the abundance of the flying ions. Peptide mass fingerprint data were acquired 
in the reflector mode with delayed extraction (150ns) using approximately 100 laser shots and 
calibrated using internal standards I and II (Applied Biosytems). The spectrum obtained was an 
average of the spectra obtained from the 100 laser shots. Typically the performance of the mass 
spectrometer is in the range of a few parts per million in mass accuracy as shown by the masses 
obtained from the internal standards. 
 
2.1.12   Peptide sequencing by tandem mass spectrometry 
 The sequences of some peptides were determined by interpreting data resulting from 
fragmenting the peptides in a tandem mass spectrometer (Bieman and Scoble 1987; Hunt et al., 
1987). This technique was used to determine the presence of the biotin label on the peptides. The 
peptides that showed the presence of biotin in the first mass spectrometer were selected and then 
dissociated with a higher laser strength 355 nm nitrogen lasers or fragmented in a second collision 
cell using argon as a laser source. The resulting fragments were separated in the second part of   
the tandem mass spectrometer, producing the tandem mass spectrum, or MS/MS spectrum. 
Multiple collisions impart energy onto the peptide until it fragments. The ions are produced due to 
the fragmentation of the amide bond with charge retention on the N or C terminus, which leads to 
the formation of b and y ions respectively. Since the peptides were generated by trypsin digestion, 
and since they contain arginyl or lysyl residues as their C-terminal residues, y ions were the 
predominant ion series observed. 
  
2.1.13 Protein identification in database searches by peptide mass fingerprinting 
 A key  advance in biological mass spectrometry was the development of algorithms for 
the identification of proteins by mass spectrometry data matched to a database, originally using a 
set of peptide masses and now increasingly using fragmentation spectra of the original peptides. 
With the availability of the complete sequence of an increasing number of organisms including P. 
falciparum (Gardner et al., 2002) it is now possible to easily perform data base correlation with a 
great degree of automation.  
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 Peak harvesting and processing was done using P.E Biosytems Voyager Data Explorer 
software version 5.01 (Applied Biosystems). The peak resolution was calculated using the Data 
Explorer software, the raw data was subjected to baseline correction, before being re-calibrated 
manually using the internal mass standards (Applied Biosytems) to achieve a more accurate data 
determination of the peptide masses. The spectra were deisotoped and the resulting peptide masses 
were used in data base interrogation using the program MS-FIT 
(prospector.ucsf.edu/ucsfhtml/msfit.htm)http://www.prospector.ucsf.edu/;  
http://prowl.rockefeller.edu/cgi-bin/profound, www.matrixsciences.com and the recently 
completed annotated Plasmodium genome data base at www.Plasmodb.org;  The  search  used all 
P. falciparum  proteins in the NCBI nonredundant data base. The modifications considered were; 
peptide N-terminal glutamine to pyroglutamine carbamidomethylated cysteines, artifactual 
oxidations of methionines and acrylamide modified cysteines, protein N-terminus acetylated. The 
modification by sulfo-NHS-LC-biotin derivative which brings in the following set of atoms 
C12H26O3N3S when   biotin labeling occurs at a lysine residue (see fig.2 section1.1.4) was also 
included as a possible modification. A maximum of one missed cleavage site following trypsin 
digestion was allowed. The monoisotopic masses were used with a mass tolerance of  +/- 50.000 
ppm and a minimum number of matched masses set as 4 matches. Plasmodium falciparum peptide 
mass finger print data were considered unambiguous when there was a minimum of 4 peptides and 
10% sequence coverage (Mann et al., 2001). The Mr and pI values of the analyzed spots were 
obtained from the Coomassie stained 2-dimensional gels and compared to the those obtained in 
the searches to further confirm the accuracy of the results of the data base searches. 
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3. RESULTS 
3.1  Experimental rationale 
 The use of SLO to selectively permeabilize and the subsequent fractionation of infected 
erythrocytes is a valuable technique in the study of protein trafficking in P. falciparum (Ansorge 
et al., 1996; Ansorge et al., 1997). The permeabilization occurs on the erythrocyte membrane with 
the  production of  pores with size exceeding 30 nm.The of the host cell cytosol is extracted after a 
centrifugation step and during the entire procedure the integrity of the PVM is maintained, thus 
the contents of the vacuolar space are retained.  
 On the basis of results obtained from electrophysiological studies it  has been previously 
proposed that proteinaceous pores exist within  the PVM  of P. falciparum infected erythrocytes 
(Desai et al., 1993; Desai and Rosenberg, 1997). These pores are postulated to allow the bi-
directional passage  of molecules with molecular mass less than 1300 daltons across the PVM. If 
indeed these pores are  present,  after SLO  treatment  of iRBCs  and the extraction of the host cell 
cytosol it should be possible to introduce small molecules, including biotin derivatives to the  
external milieu of  the permeabilized cells, these molecules should access the vacuolar space after 
passing through the  SLO pores on the erythrocyte plasma membrane and the proposed pores in 
the PVM .  
 This experimental rationale was used and iRBCs were permeabilized before biotinylation 
with a non-permeant biotin derivatives.  These derivatives have a mass of about 600 daltons and 
they are highly hydrophilic. If the proposed pores are present in the PVM,  the biotin derivatives 
are small enough and they should pass through these pores to access and react exclusively with the 
PV resident proteins. The hydrophilicity of the derivatives renders them non-permeant to the 
hydrophobic parasite plasma membrane. This should prevent the biotin derivatives from entering 
the parasite thus preventing the biotinylation of the internal parasite proteins.The  biotin labeled 
PV proteins can be isolated and characterized using molecular and biochemical approaches. The 
experimental procedure is summarized in figure 6. 
  The conceptual problem with the approach is to ensure the removal of the host cell cytosol 
and to ensure that  biotinylation of internal   parasite proteins does not occur. 
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Figure 6. Experimental rationale. Infected erythrocytes are permeabilized with SLO, which forms pores  
on the erythrocyte membrane (EM). The erythrocyte cytosol is extracted before incubating the infected cell with a  
non-permeant biotin derivative (B) which penetrates the parasitophorous vacuole membrane (PVM) through the  
postulated proteinaceous pores (P) to selectively biotin label the proteins within the parasitophorous vacuole. The 
 biotin derivative does not permeate the parasite plasma membrane (PPM) and the internal parasite proteins  
are not biotin labeled. 
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3.2 Permeabilization of infected erythrocytes with SLO preserves the integrity of the 
vacuolar membrane, and removes the erythrocyte cytosol.  
 The bacterial pore-forming toxin SLO has been shown to selectively permeabilize the 
erythrocyte plasma membrane and to preserve the integrity of the PVM (Ansorge et al., 1996). 
This is one prerequisite for the experimental strategy employed in this project. In initial 
experiments a careful study based on two parasite marker proteins, SERP and aldolase, was 
carried out to reproduce and assess this experimental approach. Aldolase is an abundant glycolytic 
enzyme localized in the parasite cytosol and SERP is located in the parasitophorous vacuole. 
  In this study 2x10 8 infected erythrocytes were SLO permeabilized and the supernatant and 
pellet fractions, each equivalent to 107 IRBC processed and subjected to SDS-PAGE. The proteins 
were transferred onto nitrocellulose membranes and the filters detected for SERP and PfAldolase. 
The results from the fractionation after SLO treatment show that the two proteins are exclusively 
found in the pellet fraction (Figure 7) confirming that the PVM remains intact during SLO lysis as 
previously reported by Ansorge et al., (1996). When 0.15% saponin was used to lyse infected 
erythrocytes SERP was exclusively detected in the supernatant while aldolase remained 
predominantly in the pellet (section 3.14). Some aldolase is released into the supernant after 
saponin treatment, demonstrating that the saponin treatment is more difficult to control than 
treatment with SLO. This clearly shows that during SLO lysis the PVM remains intact and the 
pellet contains intact parasites and the contents of the parasitophorous vacuole stilled enclosed by 
the PVM. Saponin lysis on the other hand results in a pellet containing intact cells without the 
contents of the parasitophorous vacuole. This confirms the suitability of using SLO to fractionate 
infected erythrocytes by extracting the host cytosol and creating a direct interface between the 
PVM and the external milieu. The results also confirm the suitability of using SERP as a PV 
marker and aldolase as a maker of the internal parasite proteins. 
 The quantitative removal of the erythrocyte cytosol is important in this experimental 
approach since this eliminates contamination by host proteins. Hemoglobin is the most abundant 
erythrocyte protein and the SLO pellet fraction was analysed spectrophotometrically for the 
presence of the protein. No detectable levels of hemoglobin were present in the permeabilized 
erythrocytes. These results not only confirm that the PVM remains intact during the 
permabilization process but also that the erythrocyte cytosol is quantitatively removed during the 
process. 
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    Figure 7.  The PVM remains intact during SLO lysis but not during saponin lysis. Infected 
erythrocytes were SLO permeabilized  (lanes 1 and 2) or lysed with 0.15% saponin (lanes 3 and 4). The pellet (P) and 
the fraction  of released proteins (S) were analyzed by SDS-PAGE and immunoblotting using antisera against SERP a 
vacuolar space marker and aldolase an internal parasite protein. The primary antibodies were visualized by using 
alkaline phosphatase conjugated secondary antibody. 
 
3.3 Biotin accumulates in the parasitophorous vacuole in SLO permeabilized infected 
erythrocytes. 
 The vacuolar membrane forms a barrier between the parasite surface and the host cell 
cytosol from which it must acquire nutrients that are essential for its survival. Therefore it is 
almost certain that the PVM is adapted to allow the transportation of these nutrients. Indeed Desai 
et al., (1993) reported the presence of high conductance channels that are permeable to organic 
and inorganic cations, using a patch-clamp technique. In bilayers, this channel allows passage of 
molecules up to 1,400 Da (Desai and Rosenberg 1997), which is similar to the non-selective pores 
discovered in the PVM of the taxonomically related parasite Toxoplasma  (Schwab et al., 1994). 
The existence of these pores in Plasmodium-infected erythrocytes has not been verified, but if 
they exist, they should allow access of membrane-impermeable biotin derivatives that are ~600 Da 
in size. 
 Initially it was investigated at the morphological level whether biotin derivatives gain access 
to the PV.  Infected  erythroyctes were  permeabilized using SLO  to completely remove the host  
cell cytosol before incubation with the membrane-impermeable sulfo-NHS-LC-biotin. Confocal 
immunofluorescence microscopy was used to localize the biotin derivative using a fluorescent 
conjugated streptavidin. The fluorescence clearly showed a distinct ring around the periphery of 
the intracellular parasite (Figure. 8). The biotin co-localizes with the vacuolar marker SERP. This 
location is clearly different and distinct from the location of the erythrocyte membrane protein 
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band 3 and from the location of the parasite cytosolic protein aldolase. In some parts, the 
streptavidin and the antibody to band 3 co-localize; this is due to the fact that proteins of the 
erythrocyte plasma membrane also react with the biotin. Little if any biotin was detectable in the 
erythrocyte cytosol and parasite cytosol respectively. The ring-like staining around the periphery 
of the parasite can be attributed to a reaction of the biotin with the membrane proteins of the PVM 
and with the soluble vacuolar proteins.  
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Figure 8. Biotin accumulates in the parasitophorous vacuole in SLO permeabilized infected 
erythrocytes.  Trophozoite-infected erythrocytes were permeabilized with SLO. Biotin labeled and spread onto 
microscope slides. Cells were fixed and incubated with antibodies to SERP (A), a vacuolar resident protein. 
Conjugated secondary antibodies (green colour) colocalize with Sav-Cy3 (red colour). B and C show dual labeling of 
biotin and the erythrocyte membrane protein band 3 (B) or of biotin and the parasite cytosolic protein PfALD (C). 
Cells were imaged using a laser scanning confocal microscope. The left panels (TM/nomarski) show the transmission 
images of the respective fields, and the right panels (merge) show an overlay of fluorescence images for each of the 
antibodies used. 
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3.4 Streptavidin agarose beads specifically bind biotinylated parasite proteins. 
To determine the suitability of streptavidin agarose beads for the affinity purification of 
biotinylated proteins, infected erythrocytes were cultivated for 30 min in the presence of L-[35 S] 
methionine and subsequently permeabilized with SLO to release the soluble contents of the host 
cytosol. The integrity of the PVM was confirmed as described in section 3.1. Since mammalian 
cells do not synthesize proteins de novo, the radiolabeled amino acids in this experiment are 
incorporated exclusively into parasite proteins. The soluble proteins from the parasite-containing 
vacuoles were obtained by centrifugation at 13,000 x g after three cycles of freezing and thawing 
in distilled water containing protease inhibitors. One aliquot of the lysate was treated with 1 mg 
ml-1 sulfo-NHS-LC-biotin at 4 °C for 30 min and another aliquot remained untreated after which 
both samples were incubated with SAv-agarose beads at 4 °C overnight. The beads were washed 
and the bound proteins eluted in SDS sample buffer and analysed by SDS-PAGE and 
autoradiography (Figure 9). No radiolabeled proteins from the non-biotinylated sample bound to 
SAv-agarose (Figure 9, lane 2), whereas after biotinylation, most radiolabeled proteins were found 
in the fraction of bound proteins (Figure 9, lane 4). The overall separation pattern was different 
between the two samples with the bands in the biotinylated sample appearing to be less focused.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Streptavidin agarose beads specifically bind biotinylated proteins. Infected erythrocytes 
were metabolically labeled with L-[35S] methionine  and permeabilized with SLO, and the erythrocyte cytosol was 
extracted and the cellular fraction consisting of intact parasites and the intact PVM and PPM  was  then lysed and the   
soluble fraction obtained was divided into two aliquots. One aliquot was treated with sulfo-NHS-LC biotin a (lanes 3 
and 4) and the other was untreated  (lanes 1 and 2). Proteins that bound to SAv –agarose beads (lanes 2 and 4) were 
analyzed by SDS-PAGE and autoradiography. 
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The poor focusing of the biotin labeled proteins is due to the differential degrees of biotinylation 
of individual polypeptide chains. Since a given polypeptide may have several possible 
biotinylation sites it is possible that the degree of biotinylation varies within a protein species 
leading to differential migration of the identical peptides in the gel. Therefore the effects of biotin 
incorporation on electrophoretic mobility of proteins was studied using BSA as described below 
 
3.5 Electrophoretic mobility of BSA is affected by biotinylation. 
 To assess the effects of biotin incorporation on the electrophoretic mobility of proteins, BSA 
was incubated with different molar ratios (12:1 and 1:1 respectively) of sulfo-NHS-LC-biotin, for 
30 minutes at room temperature. The excess unreacted biotin was removed by size exclusion 
centrifugation and the mobility of the treated samples was compared to a non- treated sample by 
SDS-PAGE. As shown below  (Figure 10) the electrophoretic mobility of BSA is altered 
depending on the degree of biotinylation. Increased biotinylation leads to a decrease in the 
mobility of the protein. This is due to the increase in the molecular size since each biotinylation 
with the sulfo-NHS-LC-biotin derivative increases the total mass by 339 Daltons. The poorly 
focused protein bands seen in Figure 9 lane 4 above is therefore consistent with differential 
biotinylation of individual polypeptide chains leading to polypeptides of different masses. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Extensive biotin labeling increases the molecular size of proteins. BSA was treated 
with sulfo-NHS-LC biotin at different molar ratios and analyzed by SDS-PAGE and Coomassie  staining (lanes 1-3) 
or by reaction with alkaline phosphatase-conjugated SAv on nitrocellulose filters (lanes 4-6). 
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3.6 The marker proteins SERP, GBP and PfALD can be biotinylated. 
 The biotinylation of soluble marker proteins of the parasite was determined under different 
conditions to demonstrate that they are biotinylatable and that there is compartment specificity of 
biotinylation as shown by immunofluorescence microscopy in section 3.2.  The soluble parasite 
proteins GBP, SERP and aldolase are located in different compartments of the infected 
erythrocytes and were used as markers. Aldolase is restricted to the parasite cytosol  (Benting et 
al., 1994), SERP is restricted to the vacuole (Knapp et al., 1989), and GBP is found both inside 
the vacuole and within the erythrocyte cytosol (Ansorge et al., 1996). If the biotin derivatives have 
access to these proteins then they should be biotinylated and subsequently bind to SAv-agarose 
beads. In this experiment infected erythrocytes were SLO permeabilized and, after the complete 
removal of the host cytosol, a lysate containing soluble proteins of the parasite cytosol and the PV 
was prepared after freezing/ thawing and centrifugation. One aliquot of soluble proteins was 
treated with sulfo-NHS-LC-biotin and the other aliquot remained untreated. The samples were 
incubated overnight with SAv-agarose, and the bound and unbound proteins were analysed 
separately by SDS-PAGE and immunoblotting using antisera to the respective marker proteins 
(Figure 11). In the sample of non-labeled proteins, the three marker proteins were recovered in the 
fraction of unbound proteins (Figure 11, compare lanes 1 and 2). After biotin treatment, the three 
marker proteins SERP, GBP and PfALD were recovered in the fraction of bound proteins (Figure 
11, compare lanes 3 and 4). In the case of GBP and SERP, recovery was almost complete and 
quantitative. The recovery of PfALD was not complete, however these results demonstrate that the 
marker proteins can be biotinylated and can be isolated by affinity chromatography on SAv-
agarose. These experiments also further confirm that the marker proteins do not bind to the SAv-
agarose unless they are biotinylated.  
 
 
 
 
 
 
 
 
 
 
 
 51
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11.  The marker proteins SERP, GBP and aldolase are biotinylatable.  To confirm that 
the marker proteins can be biotin labeled when they are in solution, infected erythrocytes were permeabilized with 
SLO and the erythrocyte cytosol was extracted. The remaining fraction consisted of intact parasites including an intact 
PVM and parasite plasma membrane.  The PVM and the parasite plasma membrane were then lysed, and membrane 
proteins and soluble proteins were separated. One aliquot of soluble proteins corresponding to 2 x 108  cells was 
treated with sulfo-NHS-LC-biotin (lanes 3 and 4), and one aliquot remained untreated (lanes 1 and 2). Proteins that 
bound to SAv-agarose beads (lanes 1 and 3) and unbound proteins (lanes 2 and 4) were analyzed by immunoblotting 
for the presence of the marker proteins SERP, GBP and PfALD. 
 
3.7 Biotinylation of SLO permeabilized infected erythrocytes is compartmentalized. 
 The results from immunofluorescence microscopy in section 3.2 suggested a compartment-
specific biotinylation. However it does not provide evidence that cytosolic proteins of the parasite 
are not biotinylated. Neither does it provide positive evidence that soluble vacuolar proteins are 
biotinylated. Therefore after the confirmation that all the marker proteins are biotinylatable a 
biochemical approach was used to ascertain the specific biotinylation of the vacuolar proteins and 
non-biotinylation of internal proteins. IRBC were SLO permeabilized and washed to completely 
remove the contents of the host cell cytosol before incubating with sulfo-NHS-LC-biotin. The 
excess biotin was removed and the soluble fraction obtained after centrifugation. The soluble 
proteins were immunoprecipitated using antisera against SERP and GBP respectively. The 
precipitated proteins were separated by SDS-PAGE and transferred to nitrocellulose filters. 
Initially, the filters were probed with SERP and GBP antibodies, and their binding was detected 
using an alkaline phosphatase-conjugated secondary antibody (Figure 12a, lanes 1and 3). 
Subsequently, the filters were reprobed with peroxidase-conjugated streptavidin and analysed by 
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chemiluminescence (Figure 12a, lanes 2 and 4). The same analysis was carried out for PfALD, but 
because the antiserum against aldolase does not immunoprecipitate the protein, the total lysate was 
separated by SDS-PAGE and analyzed (Figure 12, lanes 5 and 6). The antisera specifically 
recognized the marker proteins. The bands that were detected with SAv were of identical sizes as 
GBP and SERP, indicating that under these conditions both proteins were biotinylated. However 
no biotin-labeled band corresponding in size to aldolase was detectable; a protein band of a 
smaller size reacted with SAv, but not with the aldolase-specific antibody (Figure 12a, lane 6). 
 To further analyze the biotinylation status of the marker proteins the biotinylated proteins in 
the soluble fraction obtained above were isolated by affinity chromatography using streptavidin-
agarose beads and subsequently analysed by immunoblotting. In permeabilized cells, PfALD was 
not biotin labeled and did not bind to the streptavidin beads. The other two proteins, GBP and 
SERP, were found in the bound fraction. GBP was quantitatively labeled with biotin and the 
protein was recovered bound to the beads; on the other hand the labeling of SERP was incomplete. 
All the biotin labeled SERP was bound to SAv-agarose beads (figure. 12b) but a substantial 
proportion of the SERP molecules remained unbound, obviously because these molecules were 
not  labeled with biotin as shown by the chemiluminescence using SAv-HRP (figure 12b, lane 2). 
This is different from the results obtained with total lysates in which SERP is released. Under 
these conditions the protein was labeled and precipitated quantitatively.  These results confirm that 
the biotin derivative gains access only to the PV does not enter the parasite. Therefore there is 
specific biotinylation of the soluble proteins of the PV but internal parasite proteins are not 
biotinylated. 
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Figure 12a.  Selective biotinylation of vacuolar marker proteins.  Infected erythrocytes were 
permeabilized with SLO. After complete extraction of the erythrocyte cytosol, the cellular fraction consisting of intact 
parasites and the intact PV was incubated with sulfo-NHS-LC biotin and lysed after the removal of free biotin. 
Proteins were immunoprecipitated using antisera against GBP and SERP, respectively, separated by SDS-PAGE and 
transferred to nitrocellulose filters (lanes 1-4). The filters were first probed with antisera that were detected in a color 
reaction using alkaline phosphatase-conjugated secondary antibodies (lanes 1 and 3). The same filters were reprobed 
with peroxidase-conjugated SAv, which was subsequently detected by a chemiluminescence reaction (lanes 2 and 4). 
The incorporation of biotin into aldolase was analysed in the same way (lanes 5 and 6), except that soluble proteins 
were separated electrophoretically without prior immunoprecipitation. 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 12b.  Selective biotinylation of vacuolar marker proteins. Infected erythrocytes were 
permeabilized with SLO. After complete extraction of the erythrocyte cytosol, the cellular fraction consisting of intact 
parasites and the intact PV was incubated with sulfo-NHS-LC biotin and lysed after the removal of free biotin. The 
lysate was incubated with SAv-agarose beads. Fractions of bound (lanes 1and 3) and unbound (lanes 2 and 4) were 
analyzed for the incorporation of biotin (lanes 1 and 2) and the presence of the respective maker proteins (lanes 3 and 
4). 
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3.8 The molecular chaperone PfBip interacts with biotinylated proteins. 
 After biotinylation of proteins in permeabilized cells, the streptavidin agarose bound fraction 
of soluble proteins was analyzed for the presence of PfBip, the plasmodial homologue of 
immunoglobulin binding protein, a molecular chaperone and endoplasmic reticulum resident 
protein in eukaryotic cells (Kumar et al., 1991). This was done with the view of having another 
abundant internal marker protein in addition to aldolase for which an antiserum was available. 
Secondly, since the vacuole is a protein sorting compartment it  is conceivable  that the PV 
contains molecular chaperones required for protein translocation  across the PVM. Therefore it 
was investigated whether PfBip is biotinylated. Infected erythrocytes were permeabilized, one 
aliquot was treated with sulfo-NHS-LC-biotin and the other remained untreated. Lysates of cells 
were prepared and incubated with SAv-agarose beads. The fraction of unbound proteins and 
bound proteins were analyzed for the presence of PfBip using a specific antiserum.  The results 
show that the protein does not bind non-specifically to the SAv agarose beads in the absence of 
biotin and it is detected only in the unbound fraction (Figure 13a lanes 1 and 2). However in the 
biotin treated sample the protein was present in both the unbound and bound fractions suggesting 
that the protein was biotin labeled (Figure 13a lanes 3 and 4). This observation was unexpected 
since Bip is an ER resident protein with the SDEL retention signal.  It is possible that some of this 
protein may not be retained within the parasite’s secretory pathway and hence may be transported 
into the vacuole, for example as a complex with other proteins that are translocated in the classical 
secretory pathway. Indeed there is a recent report (Akampong et al., 2002) suggesting that Bip can 
be translocated to the food vacuole in a complex together with other proteins such as such as 
plasmepsin I which has a signal sequence and is transported through the ER via the classical 
secretory pathway. To verify its biotinylation status, the protein was immunoprecipitated from the 
biotin treated lysate using specific anti-PfBip antisera. The precipitated proteins were separated by 
SDS-PAGE and transferred to nitrocellulose before incubation with an antiserum against PfBip. In 
a first step the binding of the anti-PfBip antiserum was determined using an alkaline phosphatase-
conjugated secondary antibody (Figure 13b, lane 1). In a second reaction biotin was detected by 
chemiluminescence using peroxidase-conjugated SAv (Figure 13b, lane 2). Under these 
conditions, biotin was not detected. This suggests that the recovery of Bip in the fraction of 
proteins that bound to SAv-agarose was due to an interaction of the chaperone with other biotin 
labeled proteins. PfBip did not bind to SAv-agarose beads in the absence of biotin (figure 13) 
confirming that the protein does not directly interact with the streptavidin or the agarose. 
 
 
 55
 
 
 
 
 
 
 
 
 
Figure 13.  Molecular chaperone Bip interacts with biotinylated proteins. Infected erythrocytes 
were permeabilized, and one aliquot of the cells was treated with sulfo-NHS-LC-biotin the other was not treated. 
Lysates of cells were prepared and incubated with SAv-agarose beads. The fraction of unbound proteins (lanes 1 and 
3 ) and the fraction of bound proteins (lanes 2 and 4) were analyzed for the presence of PfBip using a specific 
antiserum. Lanes 1 and 2, untreated sample; lanes 3 and 4.  In B, infected erythrocytes were SLO permeabilized and 
treated with sulfo-NHS-LC-biotin. PfBip was immunoprecipitated from the sample and analyzed by immunoblotting 
using either the specific the specific antiserum A, (lane 1) or the peroxidase-conjugated SAv (lane 2). 
 
 Experiments were further done to characterize the location of Bip in infected erythrocytes by 
subjecting the cells to saponin lysis and SLO permeabilization. Infected erythrocytes were SLO 
permeabilized or lysed with 0.15% saponin, after sedimentation the soluble proteins were 
collected and the pellets were divided into two one aliquot of each was trypsin treated and the 
other one remained untreated. Proteins contained in the soluble fraction and pellet, respectively, 
were separated by SDS-PAGE and subsequently transferred to nitrocellulose filters. The filters 
were incubated with anti-PfBip antiserum. While SLO preserves the integrity of the PVM saponin 
lysis disrupts the integrity of the PVM and exposes the vacuolar contents to proteolysis by trypsin. 
These results clearly show that when iRBC are subjected to lysis by both agents Bip is retained 
within the parasite and since it is not released by the lysis procedure it is not degraded by trypsin. 
Therefore the protein is not likely to be present in the vacuolar space (Figure 14 lanes 1 and 4).  It 
is most likely that Bip and possibly other intraparasite chaperones associate with the SAv-agarose 
beads through interactions with misfolded proteins including biotinylated proteins of the vacuole.  
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Chaperones are released from their substrates in a process that requires the hydrolysis of 
ATP (Young and Hartl 2000)..To investigate whether PfBip was associating with the biotinylated 
proteins due to its  chaperonic activity iRBC were SLO permeabilized and treated with sulfo-
NHS-LC-biotin. The soluble fraction after lysis was affinity purified using SAv beads. The beads 
were washed with either HEPES buffer, HEPES buffer containing  Mg2++ or HEPES buffer 
containing Mg2++ and 5 mM ATP. The bound and unbound fractions were analysed for the 
presence of SERP and PfBip. SERP was consistently detected in the bound fraction in contrast 
PfBip was released from the beads in the presence of ATP (Figure 15). The addition of ATP led to 
the elimination of the of the co-isolation of Bip and possibly other non-biotinylated molecular, 
with the biotin labeled proteins bound to the SAv-agarose beads. The inclusion of ATP  did not 
have an effect on the binding of SERP  and/or  possibly other  biotin labeled proteins  that are 
bound to the SAv beads. (Figure 15 lane 6). 
 
 
 
 
 
Figure 14. Localization of Bip in infected erythrocytes. Infected erythrocytes were SLO 
permeabilized or lysed with 0.15% saponin and the soluble proteins were collected and one aliquot of each pellet
was trypsin treated and the other remained untreated. The lysates (lanes 1 and 4) and the pellets without trypsin 
treatment (lanes 2 and 5) and with trypsin treatment (lanes 3 and 6) were analyzed by SDS-PAGE and 
immunoblotting using antisera against PfBip; and the bound antibody were visualized by using alkaline
phosphatase conjugated secondary antibody.
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Two important conclusions can be drawn from these experiments; first there is no positive 
evidence for vacuolar location of PfBip, which is shown by the lack of biotin label in the 
immunoprecipitated Bip after biotinylation of SLO permeabilized cells.Secondly  PfBip is not 
released by treatment with either SLO or saponin. The inaccessibility of the protein to trypsin after 
both treatments also confirms the internal localization of the protein. The experiments also show 
that Bip, an ER localized chaperone, binds to the putative vacuolar proteins in lysates. Therefore 
extreme care must be taken to avoid binding of chaperones to other proteins after preparation of 
cell lysates. To avoid mistaking the identification of chaperones as vacuolar located, ATP was 
included in subsequent experiments. 
 
 
Figure 15.  ATP releases Bip from streptavidin beads. Infected erythrocytes were SLO permeabilized and 
treated with sulfo-NHS-LC-biotin. Biotinylated proteins were bound to SAv beads and the beads were washed with
HEPES buffer  (lanes 1and 2), HEPES buffer containing  Mg2++  (lanes 3 and 4) and HEPES buffer containing Mg2++ 
and 5 mM ATP (lanes 5 and 6). Proteins that remained bound to beads (lanes 2, 4, and 6) and unbound proteins (lanes
1,3 and 5) were analysed for the of SERP and PfBip. 
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3.9 Immunoelectronmicroscopy of SLO permeabilized and biotinylated IRBCs. 
  The localization and distribution of biotin  was investigated using non-biotinylated iRBC 
as  a control. Thin sections of SLO permeabilized iRBC  were incubated with gold conjugated 
streptavidin and  the localization of the gold particles observed under electron microscopy. The 
plasma membrane of the infected erythrocyte was clearly delineated with electron dense regions 
characteristic of the knobs clearly visible (Figure 15). The erythrocytic cytosolic space showed no 
evidence of the presence of hemoglobin which is usually observed in electronmicrographs of 
infected erythrocytes as a dark staining region (Dluzewski., 1989). The presence of an apparently 
intact erythrocyte plasma membrane but with the total absence of hemoglobin provides further 
evidence that the host cell cytosol, which predominantly comprises hemoglobin, is extracted after 
SLO permeabilization and the subsequent washing steps 
  Biotinylation of the compartments in the permeabilized IRBC was evaluated by the 
localization of the gold label particles as shown in the electron micrograph (Figure 14). The gold 
particles localized on both the external and internal surfaces of the erythrocyte plasma membrane. 
There was also labeling on the surface of the PVM and the vacuolar space. However, the PVM 
and PPM were in most areas in very close apposition to one another making the visualization of 
the vacuolar space difficult. Most importantly there were no gold particles visualized inside the 
parasites observed, in few cases a very small number of the gold particles localized within the 
parasites, probably non-specifically. These results confirm that after SLO lysis, the erythrocyte 
cytosol is extracted and the biotin derivative gains access to the erythrocyte cytosolic space, the 
PVM and the vacuolar space. Biotin labeling of the PVM and vacuolar space occurs but there is 
no obvious internal biotinylation. 
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Figure 16. Electron micrographs of Streptavidin-immunogold-labelled sections of SLO 
permeabilized and biotinylated infected erythrocytes.  IRBC, permeabilized with SLO and biotinylated 
with sulfo-NHS-LC-biotin embedded in Lowicryl and labeled with gold conjugated Streptavidin.  
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3.10 Analysis of biotinylated soluble proteins by SDS-PAGE. 
  The previous experiments showed selective biotin labeling of vacuolar proteins as shown by 
the vacuolar markers SERP and GBP. To analyze the abundance and diversity of the biotin 
labeled, putative vacuolar proteins, iRBC were incubated with L [35S] methionine for 2 hours 
before SLO permeabilization and incubation with sulfo NHS-LC- biotin. Since the host 
erythrocytes do not synthesize proteins, the L [35S] methionine is incorporated only into parasite 
protein and it is possible to identify them in autoradiographs. Cell lysates were prepared by 
freezing and thawing. Subsequently, the fraction containing soluble proteins was incubated with 
SAv agarose beads. Proteins bound to the beads and unbound proteins were separated by SDS-
PAGE. The gel was stained with colloidal Coomassie, and subsequently dried and exposed to X-
ray film to visualize the separated protein bands by autoradiography. There is a difference 
between the protein bands in the two fractions as shown by the autoradiography (Figure 17).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Analysis of biotinylated soluble proteins by SDS-PAGE. Infected erythrocytes were 
metabolically labeled with L-[35S] methionine  and permeabilized with SLO. The erythrocyte cytosol was extracted 
and the cellular fraction consisting of intact parasites and the intact PVM and PPM was treated with sulfo-NHS-LC 
biotin and  then lysed  by freezing and thawing. The soluble fraction obtained was incubated with SAv agarose beads 
and the unbound (lane 1) and bound fractions (lane 2) were analyzed by SDS-PAGE. Some of the proteins that are 
abundant in the unbound fraction but absent in the bound fraction are marked with arrowheads.    
 
   As one would expect fewer proteins are detectable in the bound fraction  than in the 
eunbound fraction. However there was no protein band that was exclusively in the bound fraction, 
by definition an exclusively vacuolar space resident protein. There were proteins that are not 
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bound at all to the SAv-agarose beads, these are indicated by the closed arrows. The proteins that 
are abundant in the unbound fraction were also the most prominent in the bound fraction. It is 
important to note that since the vacuolar space is a sorting compartment it contains at least two 
categories of proteins, the vacuolar resident proteins such as SERP, and the transit proteins which 
are outward bound such as GBP and KAHRP (Ansorge et al., 1996; Wickham et al., 2001) and 
also possibly the proteins that are re-imported into the parasite (Cheresh et al., 2001). 
 A second experiment was designed to demonstrate that the proteins that are bound are 
actually biotinylated and that there are no chaperonic protein-protein interactions that may lead to 
non-biotinylated proteins being co-isolated with biotin labeled proteins. Three batches of IRBC 
were prepared for analyses as follows. The first aliquot was incubated for with L [35S] methionine 
for 2 hours before SLO permeabilization. The parasite and the vacuolar contents were subjected to 
3 cycles of freezing and thawing, before sedimentation to obtain the soluble fraction for further 
analysis. The second aliquot was prepared in a similar way but the soluble proteins were 
biotinylated with sulfo NHS-LC-biotin at a concentration of 1mg ml-1 for 30 min at 4°C. The third 
aliquot was treated as the second but without the initial labeling with L [35S] methionine. 
 The three aliquots were analyzed as follows; equal amounts of the first and second aliquots 
were incubated with SAv-agarose beads overnight at 4 °C. The bound and unbound fractions were 
analyzed by SDS-PAGE Coomassie staining and autoradiography. The results (Figure 18a lanes 1, 
2, 3 and 4) clearly show that non-biotinylated proteins do not bind to the SAv-agarose beads. In a 
second analysis, an aliquot of non-biotinylated radiolabeled soluble proteins was mixed with an 
equal amount of biotinylated non-radiolabeled soluble proteins. The mixture was incubated 
overnight with SAv-agarose beads and the bound and unbound fractions were analyzed by SDS-
PAGE and autoradiography. No radioactive signal was detected on the bound fraction clearly 
indicating that the non-biotinylated proteins do not interact with the SAv-agarose beads nor with 
the bound biotinylated proteins (Figure 18a lanes 3 and 4) since a coomasie staining showed the 
presence of biotinylated but non-radiolabeled proteins in the bound fraction (Figure 18b). 
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Figure 18. The streptavidin beads specifically bind biotin labeled proteins.  Infected erythrocytes 
were metabolically labeled with L- [35S] methionine and permeabilized with SLO. The cellular fraction consisting of 
intact parasites and the intact PV was either I, mock treated or incubated with sulfo-NHS-LC biotin, II.  In a third 
analysis, III, an aliquot of non-biotinylated radiolabeled soluble proteins was mixed with an equal amount of 
biotinylated non-radiolabeled soluble proteins. The soluble fractions each corresponding to 2 x108 cells were 
incubated separately with SAv-agarose beads. The samples were then processed for SDS-PAGE and the separation 
patterns analysed after Coomassie staining (panel A). The unbound fractions are in  lanes1,3 and 5. The bound 
fractions in  lanes 2, 4 and 6. The gel was dried before exposing it  to X-ray film to obtain an autoradiograph (panel 
B).  
 
 8M urea is a strong chaotropic agent that dissociates most non-covalent protein-protein 
interactions. In an additional experiment 8M urea was used to wash the beads and any dissociated 
proteins analyzed as follows. IRBCs were incubated for 2 hours with L-[35S] methionine before 
SLO  permeabilization  and biotinylation. The soluble fraction was obtained by centrifugation 
after 3 cycles of freezing and thawing. Two aliquots, each containing  the equivalence of 2x108 
IRBC werw incubated overnight with SAv-agarose beads. In one aliquot, the beads were 
sequentially washed in buffers (A 10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.2% NP40, 2 mM 
EDTA; B 10 mM Tris-HCl pH 7.5, 500 mM NaCl, 0.2% NP40, 2 mM EDTA; C 10 mM Tris-HCl 
pH 7.5 and finally with PBS++. The beads were then washed with 10 mM HEPES buffer pH 7.4 
containing 20 mM MgCl2 and 5 mM ATP.  In the second the beads were washed in the same way 
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but with a final wash using 8M urea. The bound proteins were eluted with SDS-PAGE sample 
buffer and analyzed together with the unbound and the urea wash by SDS-PAGE and 
autoradiography (Figure 19). The urea does not release the proteins that are bound to the SAv-
agarose beads, and there is no detection of radiolabeled protein bands thus confirming that there is 
no noticeable release of proteins by washing the SAv-agarose beads with 8M urea.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18. The bound proteins are specifically biotin labeled and are resistant to urea 
extraction from the beads.  Infected erythrocytes were metabolically labeled with L-[35S] methionine. IRBC 
were permeabilized with SLO. After complete extraction of the erythrocyte cytosol, the cellular fraction consisting of 
intact parasites and the intact PV was incubated with sulfo-NHS-LC biotin and lysed after the removal of free biotin. 
Two aliquots of the lysate each corresponding to 2 x108 cells were incubated separately with SAv-agarose beads. The 
samples were then processed and for SDS-PAGE and analysed by autoradiography.  One aliquot was analysed 
directly for the unbound (lane1) and bound fraction (lane 2). The second aliquot was analysed for the unbound 
fraction (lane 3) and the proteins that are eluted after a 8M Urea wash  (lane 4) and the bound fraction after the urea 
wash. 
  
These results show that bond formed between avidin and biotin is resistant to 8M urea. 
This is consistent with their high affinity (Ka ~1015 M-1 )  which can only be disintegrated using 
8M guanidine chloride (Pierce Product Catalogue). This further confirms the suitability of the 
biotin-avidin system in affinity purification when using the sulfo-NHS-LC-biotin which has a non-
cleavable spacer between the biotin molecule and the reactive NHS group.  
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3.11 Two-dimensional Gel electrophoretic analysis of Biotin labeled proteins. 
 The results from the analysis of the soluble proteins in the preceding sections show that 
there is selective biotin labeling of the putative vacuolar proteins. However the separation by 
SDS-PAGE was not sufficient to clearly resolve proteins of slightly different molecular masses. 
Some of the very prominent bands  observed could be different polypeptides with the same 
molecular mass. Therefore a clearer and more accurate picture of the protein abundance and 
diversity could only be ascertained by using 2D gel electrophoresis where the proteins are 
separated on the basis of two different properties, pI in the first dimension and molecular mass in a 
second dimension. The net result is the resolution of individual proteins as single spots with a 
definitive pI and molecular mass.  
  The isolation and identification of novel vacuolar proteins required a high resolution of the 
separated and biotinylated proteins. Since the interaction between streptavidin and biotin is very 
tight (Ka ~1015 M-1 ) and since isoelectric focussing does not allow boiling of sample in SDS to 
release the biotin labeled proteins from  SAv agarose beads (as in the 1-D analysis) the most 
rational strategy is to use sulfo-NHS-SS-Biotin  and cleave biotinylated proteins from the beads 
before 2D gel electrophoresis. Infected erythrocytes were radiolabeled with L-[35S] methionine 
before SLO permeabilization and treatment with the sulfo-NHS-SS-Biotin. After lysis  of cells the 
soluble fraction obtained was incubated with SAv-agarose beads to bind the biotin labeled 
proteins. The bound proteins were traeted with incubating the beads with two reducing agents, 
DTT and TCEP before electrophoresis. These compounds act by reducing the disulphide bonds 
(S-S) in the spacer arm between the protein and the biotin derivative thus releasing the protein 
from the biotin avidin complex.  
 Numerous experiments with varied concentrations of these reducing agents were used but it 
was not possible to efficiently elute the proteins from the beads without the addition of SDS. This 
was apparent in 1D analysis where the biotin labeled proteins remained bound to the SAv agarose 
beads after incubation with the reducing agents. The bound proteins could only be eluted in a 
second step after boiling the beads in SDS sample buffer. The addition of SDS, a highly 
negatively charged detergent to the elution buffer proved to be highly disadvantageous in the 2D-
gel analysis. The SDS ´envelopes` all the polypeptides with a high negative charge which is much 
greater than their net intrinsic charge. The result was that the polypeptides could not be effectively 
used in 2D analysis because of their net negative charge and also due to the disruption of the pH 
gradient in the IPG strips by the detergent. Under these conditions isoelectric focussing does not 
occur. The resulting 2D gels showed very extensive horizontal streaking. It was not possible to use 
either dialysis or even higher concentrations other zwitterionic detergents such as TritonX-100 or 
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CHAPs to replace SDS in the elution assays. Competitive inhibition assays using low 
concentrations of D-biotin ( 5 mM) to elute biotin labeled proteins from the SAv agarose were 
also done but the amount  of  protein obtained  was not sufficient to allow analysis by  2D-gel 
electrophoresis. Therefore  the experimental approach was slightly changed, and sulfo-NHS-LC-
biotin was used instead of the sulfo-NHS-SS-Biotin. The affinity purification step using the 
reducing agents was left out altogether. Instead the total soluble fraction was used in 2D-gel 
electrophoresis and biotin labeled spots as identified in western blots were selected for further 
analysis. 
 IRBCs were labeled metabolically labeled with L- [35 S] methionine, permeabilized with SLO 
and treated with sulfo-NHS-LC-biotin. After cell lysis, soluble proteins were separated in triplicate 
on different two –dimensional gels using a pH gradient of 4-7 in the first dimension. Initial 
experiments were done using IPG strips with pH gradient 3-10. The results showed very few 
proteins in the alkaline regions, confirming that most of the P. falciparum proteins have a low pI 
and they focus in the acid regions of the gradient. Subsequent separations were done using 13cm 
pH 4-7 IPG strips.  To estimate the relative abundance of proteins in permeabilized erythrocytes, 
one gel was silver stained (figure 18A), and another was stained with Coomassie (figure 20B) The 
silver staining, which has a sensitivity of up to 1ng per spot revealed the more complex protein 
pattern. The sensitivity of the Coomassie is down to 20 ng and the most abundant proteins were 
well detected.  There were fewer protein spots in the higher molecular weight regions, this is 
probably due to the fact that because of their large size, the high molecular weight proteins do not 
move into the IPG strip since they do not penetrate the pores in the IPG gel during the rehydration 
step. Alternatively this could also be due to inefficient transfer of the bigger polypeptides from the 
IPG strip to the second dimension SDS-PAGE. In an attempt to improve on this, the rehydration 
time was increased from 12 hours to 24 hours and the SDS concentration in the equilibration 
buffer after the first dimension was increased from 2% to 4%. The second dimension run was also 
started and maintained at low voltage (70 volts) for 2 hours to improve on the sample entry. The 
reproducibility of sample preparation, gel electrophoresis and gel staining was investigated by 
running sequential replicate gels with protein prepared from different batches of   parasites on 
different days. The majority of protein spots could be resolved with a high degree of 
reproducibility.even though there are slight differences as indicated with the circles.The outcome 
of a typical experiment is shown in figure 21, each panel (i-iii) represents a magnified inset of  
Coomassie stained gels from 3 different batches of parasites run on different days, thus 
introducing the maximum number of potential variables. To compare biotinylated proteins to the 
total parasite proteins, proteins of a third gel were transferred to a nitrocellulose filter. The filter 
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was exposed to X-ray film to analyze the pattern of radiolabeled proteins (figure 20C). 
Subsequently, biotin-labeled proteins were detected using alkaline-conjugated SAv (Figure 20D). 
A comparison of the biotin-labeled proteins and the radiolabeled proteins clearly demonstrates that 
the pattern of biotin-labeled proteins is less complex and that it does not simply reflect the pattern 
of the most abundant radiolabeled   proteins. 
 In contrast, the most intensely radiolabeled proteins appear not to be biotin labeled. Most 
non-biotin labeled protein spots appear as single spots in the two-dimensional pattern. In contrast, 
most biotin-labeled protein species appeared as horizontal spot series, which could represent the 
same protein with slight modifications that alter the pI. This was later confirmed for some of the 
identified spots (see section 3.13.2). Probably, a variable number of amino groups react with the 
sulfo-NHS-LC-biotin derivative resulting in a differential loss of protonable residues and stepwise 
decreasing pI values. This shift was also accompanied by a slight increase in molecular size since 
every biotin labeling at a free amino groups lead to a mass increase of 339 Daltons. A detailed 
comparison reveals 12 prominent spots (circled in Figure 19B), which represent highly abundant 
parasite proteins that are detectable by Coomassie Blue staining the same spots were also 
identified on the autoradiograph (20C) In the western blot analysis of biotinylated proteins, 9 of 
these spots appeared as a negative stain (Fig 20D) presumably because of the high local 
concentration of non-biotinylated protein. Thirty-nine protein spots were identified that were both 
biotinylated and radiolabeled and therefore fulfill the criteria expected for vacuolar proteins. Some 
of these spots may represent identical polypeptides that are biotinylated differentially. 
 Initial MALDI-TOF experiments, as described in more detail in section 3.13.2, identified the 
two most abundant protein spots (I and II)    (Figure 20 A-D) as P. falciparum enolase (EC 
4.2.1.11) 2-phosphoglycerate dehydratase (I) a glycolytic enzyme and (II) P. falciparum ornithine 
amino transferase (EC 2.6.1.13) an enzyme that catalyzes the transfer of an alpha-amino group 
from an amino acid to an alpha-keto acid. These are cytosolic housekeeping enzymes that are 
highly abundant and the fact that they are non-biotinylated confirms that the biotin  derivarive has 
no  access to the parasite cytosol. 
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Figure 20. Protein pattern of putative vacuolar proteins.  Proteins in intact infected erythrocytes were 
metabolically labeled, and cells were permeabilized and treated with sulfo-NHS-LC-biotin. The fractions of soluble 
proteins. Each corresponding to 2 x 109  infected erythrocytes was subjected to two-dimensional gel electrophoresis 
using a pH gradient of 4-7 in the first dimension and 12% SDS-PAGE in the second dimension. A, silver-stained gel. 
B, Coomassie Blue stained gel. C and D. proteins from a third gel were transferred to a nitrocellulose filter.   The filter 
was first exposed to x-ray film to visualize metabolically labeled parasite proteins and subsequently reacted with 
alkaline phosphatase-conjugated SAv to visualize biotinylated proteins (D). The most prominent spots that were 
identified as parasite proteins are marked with circles. Proteins that are both biotinylated and radiolabeled are 
indicated by Arabic numerals; spots that may represent identical peptides at various degrees of biotinylation are 
marked with lowercase letters. I, P. falciparum enolase; II P. falciparum  ornithine aminotransferase. 
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Figure 21. Reproducibility of 2-DE gels. Reproducibility of sample preparation, gel electrophoresis and 
staining. The panels (i-iii) represent the same enlarged region of  Coomassie-stained gels. Each of  the three gels were 
run independently on different days using different batches of  parasites after SLO permeabilization and biotinylation 
and using different batches of poured second dimension gels.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                      i                                                 ii                                           iii 
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3.12 Biotinylation   pattern of the membrane proteins. 
   In infected erythrocytes the parasite is enclosed by 3 different membranes, the erythrocyte 
membrane, the parasitophorous vacuole membrane and the parasite plasma membrane. Other than 
the pores that are formed during SLO permeabilization, the erythrocyte membrane probably 
remains structurally stable surrounding the intact PVM, the vacuolar contents and the parasite. 
The erythrocyte membrane is clearly discernable in electron micrographs of SLO permeabilized 
cells (section 3.8) and band 3 an integral membrane protein of the erythrocyte was shown to be 
biotin labeled by immunofluorescence assay (Figure 5A). Other than the erythrocyte membrane 
proteins, with experimental approach the biotin should label parasite proteins that are present on 
the PVM and on the external face of the parasite plasma membrane. Figure 20 shows the expected 
biotinylation pattern of membrane proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 22. Schematic diagram of the membranes surrounding SLO permeabilized 
infected erythrocytes.  RBCM, erythrocyte membrane protein, PVM parasitophorous vacuole membrane and 
PPM, the parasite plasma membrane. The parasite is shown in blue color and the vacuolar space in yellow. The biotin 
is readily accessible to the proteins of the EMP and both the internally and externally exposed proteins can be 
biotinylated after SLO permeabilization. The biotin derivative is depicted by closed arrow heads. Biotin should access 
the PVM after the extraction of the erythrocyte, and the proteins in both sides of the membrane can be biotinylated if 
the biotin access the vacuolar lumen through the proteinaceous pores are postulated to be on the PVM. The proteins 
on the external face of the erythrocyte membrane can also be biotinylated. However the non-permeant biotin 
derivatives do not penetrate the membrane and the internal proteins are not biotinylated. 
 
RBCM
PVM
PPM
Parasite
Proposed pores on PVM 
SLO pores on RBCM
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 To study the extent of biotin labeling of membrane proteins, iRBC were labeled 
metabolically labeled with L- [35 S ] methionine, permeabilized with SLO and treated with sulfo-NHS-
LC-biotin. After cell lysis, insoluble membrane proteins were obtained by sedimentation at 10,000 
x g and separated in duplicate on different two-dimensional gels using a pH gradient of 4-7 in the 
first dimension. One gel was stained with Coomassie (figure 22A) and proteins of the second gel 
were gel were transferred to a nitrocellulose filter. The filter was exposed to x-ray film to analyze 
the pattern of radiolabeled proteins (Figure 22B). Subsequently, biotin-labeled proteins were 
detected using alkaline-conjugated SAv (Figure 22C) after which the filters were incubated with 
antisera against the marker proteins of the PVM exp-1 and exp-2 before visualization by ECL 
(Figures 22D i and D ii). A comparison of the biotinylation pattern with the antibody localization 
of the two proteins indicated a stronger biotin label for exp-1 compared to exp-2. This is expected 
since exp-1 is an integral membrane with the C-terminus exposed on the outer face of the PVM 
(Ansorge et al., 1997) and since the protein is therefore accessible to the biotin derivative after 
SLO lysis. In contrast exp-2 lacks a typical hydrophobic transmembrane domain and it has been 
suggested that the protein associates with the vacuolar membrane via an amphipathic helix located 
in the N-terminal half of the protein (Fischer et al., 1998). The tight association of EXP-2 with the 
PVM as demonstrated by its resistance to extractions with high salt or alkaline solutions (Johnson 
et al., 1994) would imply that there is a very strong and close interaction between the protein and 
the PVM. Since the protein does not have a transmembrane domain it is possible that the tight 
association   the protein has with the PVM may be due strong electrostatic interactions that cause a 
helix orientation parallel to the to the membrane (Johnson et al., 1994). This may limit the access 
of biotin molecules to the protein resulting in its poor biotinylation as seen in the western blots. 
Since it has been shown that SERP, a soluble PV resident protein is biotin labeled (Figure. 5 and 
10) it is possible that the conformation of exp-2 in the vacuole does not have many free accessible 
amino groups to allow more extensive biotin labeling to occur. Electron micrograph studies 
showed a very close association between the parasite plasma membrane and the PVM (Figure 16). 
It has been previously suggested that the two membranes form regions of very close association. 
Taken together with the possibility of biotinylation blocking the proposed proteinaceous pores on 
the PVM, the consequence could be a reduction in the efficiency in the biotinylation of the 
vacuolar space proteins and the PVM associated proteins that are exposed to the lumen of the 
vacuole.   
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Figure 23.  Biotinylation pattern of the membrane proteins. Proteins in intact infected erythrocytes 
were metabolically labeled, and cells were permeabilized and treated with sulfo-NHS-LC-biotin. The fractions of 
membrane proteins, each corresponding to 2 x 109  infected erythrocytes were subjected to two-dimensional gel 
electrophoresis using a pH gradient of 4-7 in the first dimension and 12% SDS-PAGE in the second dimension. A, 
Coomassie Blue stained gel. B and C, proteins from a second gel were transferred to a nitrocellulose filter.   The filter 
was first exposed to x-ray film to visualize metabolically labeled parasite proteins (C) and subsequently reacted with 
alkaline phosphatase-conjugated SAv to visualize biotinylated proteins (B). The filter was divided into two parts (D) 
the upper portion was probed with antisera against exp-2 and the lower with antisera against exp-1 and subsequently 
reacted with horseradish-peroxidase secondary antibody to visualize the protein spots. The spots corresponding to the 
two marker proteins as identified after immuno detection are marked with the ellipses. 
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3.13 Mass spectrometry analysis results.  
3.13.1 Comparison of biotin labeled and non-biotin labeled bovine serum albumin. 
  MALDI-TOF analysis relies on a highly accurate molecular mass determination of the 
peptides generated after enzymatic treatment of proteins. The method allows to differentiate 
between peptides on the basis of their molecular masses in the Dalton range. The modification of 
amino acids by biotinylation leads to differences of the expected masses that would make accurate 
assessments impossible. Therefore the accurate mass added on to a peptide during the 
biotinylation reaction as shown in figure 5 and as described for BSA in section 3.5 was 
determined by mass spectrometry.  
  The effect of biotinylation on the mass of peptides was experimentally determined as 
follows, one portion of fraction V of bovine serum albumin BSA was biotin labeled using 12-fold 
higher mole ratio of biotin. The other portion was not biotin labeled. The two aliquots were 
separated by SDS-PAGE and the protein bands were cut and processed for the MALDI-TOF 
analysis. A section of the spectra obtained are shown in figure 24 below. Both samples of protein 
were identified by peptide mass finger printing as BSA, however a comparison of the spectra 
clearly showed some differences, with some  peaks present only in the biotin labeled sample. In 
the biotin labeled BSA sample, a peptide with mass of 1156.6593 Dalton and a high peak intensity 
is detected but it is absent in the non-biotin labeled sample. This peptide was further analyzed by 
post source decay fragmentation. The peptide was subjected to laser shots at a higher wavelength 
resulting in the fragmentation of the peptide into its constituent amino acids. The analysis 
determined the peptide sequence to be  –(R)SLGKVGTR(C)- with a theoretical mass of 817.4896 
compared to the observed mass of 1156.6507 Dalton as obtained by mass spectrometry (Figure 
25). The mass increase was 339 Daltons, and analysis of the ions obtained by post source 
fragmentation  identified a lysine amino acid with a similar increase in mass after modification by 
the biotin derivative as shown in figure 2. This mass can be accounted for by the biotin molecule 
and the spacer arm with a molecular formula (C16H25N3O3S) that is incorporated into the peptide. 
This can be described to have a sequence –LGBVGT- with a mass of 817.4896  Da where the B 
represents a lysine residue that is bonded to biotin through an amide bond at its epsilon amino 
group. The biotin molecule and spacer arm is added to a free amino group of a lysine when the 
biotinylation reaction occurs.  
 The increase in mass is responsible for the mass shift that is observed in figure 8, where 
there is reduced mobility for the biotin labeled BSA compared to the unlabeled. The biotin labeled 
BSA migrates at a higher molecular mass compared to the non-biotin labeled sample because of 
the incorporation of the biotin. Further analysis showed that the trypsin digestion did not occur 
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when the lysine residue was biotin labeled. The protease trypsin cleaves peptides at the carboxyl 
end of lysine and arginine residues and it is evident that biotinylation blocks its activity at these 
sites.   
 These results confirm that the biotinylation of proteins with the sulfo NHS-LC-biotin biotin 
derivative introduces an additional mass of 339 Daltons. Therefore this mass must be included as a 
possible modification when performing database searches during peptide mass finger printing 
using peptides that have been labeled with the derivative. The biotinylation did not prevent the 
identification of the protein and it was possible to identify both non-biotin labeled BSA and biotin 
labeled BSA by MALDI-TOF-MS. However the lack of trypsin cleavage at biotinylated lysine 
residues leads to reduction in the number of generated peptide peaks. The accuracy and 
probability of identification of proteins is greatly enhanced by having a high number of generated 
peptides. Therefore identification of highly biotinylated proteins may be impeded by the reduction 
of the number of peptides generated by trypsin digestion.  
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Figure 24A and B.  Comparison of biotinylated and non-biotinylated BSA samples. One portion 
of fraction V of bovine serum albumin BSA was biotin labeled using 12-fold higher mole ratio of biotin. The other 
portion was not biotin labeled. The two aliquots were separated on a SDS-PAGE and the protein bands were cut and 
processed for the MALDI-TOF analysis. A shows a section of the spectra obtained for the non-biotinylated protein, 
the spectra B is from the biotinylated BSA sample. The marked peak (mass 1156.6593) is present in the biotinylated 
sample but absent in the non-biotinylated sample. 
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Figure 25. MALDI-MS-MS identification of biotin label in BSA peptides. The peptide peak with 
mass 1156.6507 was subjected to post source decay fragmentation and the resulting ions were analysed to identify the 
amino acid residues. The parent peptide fragmented to generate ions that were analysed and found to correspond to 
the amino acid sequence -LGBVGT- where B corresponds to a lysine residue modified with the group (C16H25N3O3S) 
from the biotinylation reaction. The peaks show the masses of the generated ions and their relative intensities with the 
identity of  the respective amino acids above the ions.  
 
 
 
 
 
 
 
Biotinylated BSA -  1156.6507 
(R)SLGKVGTR(C) 
817.4896 + 339.1611  
(87.0433)LGBVGT(156.1099) 
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3.13.2 Identification of P. falciparum proteins using peptide mass fingerprint data from    
MALDI-TOF mass spectrometry to search protein databases. 
 The proteins analysed by 2D-gelelectrophoresis as described in section 3.12 can be 
classified as follows, proteins detectable by Coomassie staining and Silver staining but not by 
autoradiography. These could be host cell proteins or proteins that are synthesized before the 
metabolic labeling with L-[35 S] methionine or alternatively parasite proteins that do not havea 
high number of methionine residues in their polypeptides. There are proteins that are 
metabolically labeled and those that are are metabolically labeled and biotinylated. 
 In order to assess the identities of a  represenative sample of proteins, several protein spots 
including the most abundant were excised  the 2D gels and  used in MALDI-TOF analysis. The 
searching of the NCBI protein database with the generated peptide masses enabled 75 % of the 
total number of samples analyzed to be characterized from their peptide masses and full gene 
sequences. For example enolase, ornithine amino transferase, actin I, and 1-cys- peroxidoxin were 
readily identified along with other proteins from the NCBI and PlasmoDb databases (table 2). In 
the majority cases, theoretical molecular weight and isoelectric points obtained in the database 
searches matched to the position of the protein spots on the 2-DE gels. For example a protein spot 
was identified to be actin by peptide mass finger printing. The protein has a theoretical mass of 
41870.9 Daltons and a calculated pI of 5.21. These values correspond closely to the position of the 
identified spot in the 2D gel. However in some samples the calculated pI values obtained in the 
database search and observed pI values from the spot position in the 2D gels were slightly 
different. The difference between the observed and calculated isoelectric focusing point may 
indicate the modification by the biotin derivative for the biotin labeled proteins and may also 
indicate co- and/or post-translational modification of the polypeptide within the parasite.   
 There were two prominent spots for both enolase and ornithine amino transferase, both 
abundant cytosolic proteins. Enolase (2-phospho-D-glycerate hydrolase, E.C.4.2.1.11) an enzyme 
that catalyzes the reversible dehydration of D-2-phosphoglycerate (PGA) to phosphoenolpyruvate 
(PEP) as a key step in both glycolysis and gluconeogenesis was the most abundant protein as 
shown by the Coomassie staining and autoradiographs of the 2D-gels. Ornithine amino transferase 
catalyses the transfer of an alpha-amino group from an amino acid to an alpha-keto acid was the 
second most abundant protein (figure 24). In the case of ornithine amino transferase there are two 
variants in the database with slightly different pIs and molecular masses. This is consistent with 
the results obtained in this study since two protein spots in the 2-D gel were positively identified 
by MALDI-TOF-MS to be ornithine amino transferase.  On the other hand there is only one 
expressed enolase gene described in the PlasmoDb database and   the two identified spots may be 
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due to modifications of the enzyme within the parasite since the spots are not biotinylated. The 
observed difference in pI between the two spots is too and large it may be due to other post 
translational modifications but not to biotinylation since each biotinylation reaction brings a pH 
change of approximately 0.05 units. Experiments done using non-biotinylated soluble parasite 
proteins showed the same result thus confirming that the two spots were not due to biotin 
modification. Indeed, experiments in yeast have shown that enolase complexes with Mg2+ for its 
enzymatic activity and further analysis demonstrated that an unprotonated histidine and a 
protonated lysine are important for substrate binding and catalysis. In the yeast enzyme the lysine 
396 and histidine 159 are proposed to be the catalytic acid –base pair in the yeast enolase (Vinarov 
and Nowak, 1998). Therefore it could be possible that the different populations of enolase as seen 
in the 2-D gel could be due to the different reaction states of the enzyme or due to other post 
translational modifications. 
  The other abundant proteins that were identified include actin I, guanine nucleotide-binding 
protein and1cys-peroxidoxin. Actin is an abundant protein that forms actin filaments in all 
eukaryotic cells. The monomeric form is sometimes called globular or G-actin; the polymeric 
form is filamentous or F-actin  which is formed by  polymerization of globular actin molecules. 
Since the samples analyzed by 2-DE were the soluble fraction obtained after centrifugation at 
100,000 x g it is most likely the soluble globular form is what was identified. The actin was 
identified as a single prominent spot which was not biotinylated as confirmed by western blot 
analysis and tandem mass spectroscopy. The two other proteins, guanine nucleotide-binding 
protein and 1cys-peroxidoxin were also not biotin labeled.  
 On the basis of the experimental rationale, the results propose the vacuolar presence of the 
following proteins, a cysteine protease (spot 20), Hsp90 (spot 19.0), Hsp70 (spot 18) and 
hypothetical proteins (spots 5,7 and 8). The identified cysteine protease is most likely PfSERP; 
sequence analysis revealed 97% identity and their molecular weight and pI of the protein were 
also identical. The N-termini of all identified proteins were analyzed to ascertain the presence of 
hydrophobic residues which could constitute putative signal sequences. Internal hydrophobic 
motifs that could also serve as signal sequences were also analysed. Table 4 shows the results 
obtained after subjecting the proteins to the Psort program (Nakai and Kanehisa 1992: 
http://psort.nibb.ac.jp/) for locating signal motifs and the Plasmodium data base at 
www.PlasmodB.org which uses the SignalP www server at 
http://www.cbs.dtu.dk/services/SignalP/output.html for signal peptide location and prediction. 
Analysis of these proteins for signal peptides revealed a N-terminal signal sequence for the 
cysteine protease, Hsp90 and the hypothetical protein spot 5 using the Psort program while the 
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Hsp90 was predicted not to have a signal peptide when using the SignalP server. No ‘internal’ 
signal sequences were detected for these proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. Pattern of proteins identified by MALDI-TOF analysis. Proteins in intact infected 
erythrocytes were metabolically labeled. Cells were permeabilized and treated with sulfo-NHS-LC-biotin. The 
fractions of soluble proteins, each corresponding to 2 x 109  infected erythrocytes was subjected to two-dimensional 
gel electrophoresis using a pH gradient of 4-7 in the first dimension and 12% SDS-PAGE in the second dimension 
and Coomassie Blue stained gel.  A parallel gel was transferred to a nitrocellulose filter. The filter was first exposed to 
X-ray film to visualize metabolically labeled parasite proteins and subsequently reacted with alkaline phosphatase-
conjugated SAv to visualize biotinylated proteins.  Spots were excised and analysed by MALDI-TOF. The spots are 
numbered 1-20. The spots that are possible isoforms are numbered together with decimal and the ones that were biotin 
labeled as assessed by western blot analysis are marked with an asterix* and those that could not be identified are 
marked with a question mark ?. 
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 The spectra shown in Figure 25 were generated in the MALDI-TOF analysis for spot 11. The 
peptide mass peaks were processed using DATA Explorer Software ® and the masses used to 
interrogate the NCBI database  using the search program at searchhttp://prowl.rockefeller.edu/cgi-
bin/ProFound. The protein was unambigously identified as ornithine amino transferase (Figure 
26). The detailed results for the matched peptides and sequence coverage are shown in figure 27. 
Figure 27. MALDI-TOF-MS  spectra of tryptic digests of protein spot number 11. A piece of 
gel was excised from spot 11 (figure 23) and trypsin treated and analysed by MALDI-TOF. The spectra shows the 
peaks obtained, their m/z and intensity. The peptide peaks such as 904.4509, 1296.6936 and1570.7087 are molecular 
mass standards which were included in the analytes to be used in internal mass calibration. 
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Figure 28.  Identification of ornithine amino transferase. The masses of the generated peptides were 
used in peptide mass finger printing. The masses of the peptides were submitted to the Profound site at Rockefeller 
University (http://prowl.rockefeller.edu/cgi-bin/ProFound) and searched against the NCBInr data base. The protein 
was identified unambiguously to be ornithine amino transferase. The theoretical pI and molecular mass of the protein 
are similar to the observed values for spot number 11 in the 2D gel. 
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Figure 27. Detailed   database search results for ornithine amino transferase. In this analysis 19 
peptides were submitted for peptide match finger printing at http://prowl.rockefeller.edu/cgi-bin/ProFound and 
searched against the NCBInr database. 12 peptides were matched to ornithine aminotransferase and these peptides 
covered 32% of the amino acid sequence of the protein. 
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_____________________________________________________________________________ 
Spot    masses      sequence         Mw (Da)       protein match                         Accession No. NCBInr       Mowse 
No.     matched    coverage %      pI                                                                     P. falciparum  annotated     Score  E 
_____________________________________________________________________________________________ 
 1        not  identified 
 2        not identified                      -                                                                                   -                                  - 
 3         8/50           50             23080.7 /5.08      Beta  3 proteasome subunit                PFA0400c                   1.69E+05 
 4        17/82           74            25164.2 / 6.31      1 cys peroxidoxin                              Pf08_0131                   2.16E+10 
 5        7/43             29            38834.7 / 6.06      Hypothetical protein                          PFD0955w                        478 
 6        9/ 47            52            35686.6 / 6.24      Guanine nucleotide binding protein  PF08_0019                  1.50E+07 
 7       11/79            34             37117.5 / 6.06      Hypothetical   protein                        MAL8P1.96                       151 
 8        7/17              25            39688.9 /5.62       Hypothetical protein                          PF_0457                            177 
  9       not identified                                                                                                                                                                                      
10      17 /71            48            46055.4 / 6.47       Ornithine amino transferase              MAL6P1.91                  1.79E+12 
          13/33             38            46055.4 / 6.47        Ornithine amino transferase             MAL6P1.91                                                           
          13/71             37            44844.2 /6.28         S-adenosylmethionine synthetase    PFI1090w                       4.96E+05       
 11     13/33             38            46055.4 / 6.47        Ornithine amino transferase             MAL6P1.91                   1.51E+10 
                                38            46055.4 / 6.47        Ornithine amino transferase              MAL6P1.91                   1.51E+10           
12      22/48             55            48678.0 / 6.21        Enolase                                              PF10_0155                     3.81E+16 
13      22/48             55            48678.0 / 6.21        Enolase                                              PF10_0155                     9.09E+11 
14      12/47             37            41870.9 / 5.21         Actin                                                 PFL2215w                     8.43E+09 
15       not identified      
16       8/ 66             15             64574.3 /5.05        Hypothetical protein                          PFB0775w                     1.41E+03   
           7/ 54             17            55067.3 / 4.73        Hypothetical protein                          PF08_0109                          93.8 
17       21/50            30            73915.3 /5.50         Heat shock protein 70 kda protein      PF08_0054                     1.91E+11 
18_0    21/40           30             73915.3 /5.50        Heat shock protein 70 kda protein     PF08_0054                     2.64E+11                      
18_1    not identified                   
18_2    not identified                     
18_3    6/ 40             13            73915.3 /5.50          Heat shock protein 70 kda protein      PF08_0054                 526 
18_4    8/ 29             13           73915.3 /5.50           Heat shock protein 70 kda protein      PF08_0054            5.50E+04      
19_0    18/53            30           86166.8 / 4.94           Heat shock protein 90                         PF07_0029           1.68E+12 
19_1    14/44            22           86166.8 / 4.94           Heat shock protein 90                         PF07_0029           1.34E+08 
19_2    10/44            21           86166.8 / 4.94           Heat shock protein  90                        PF07_0029           4.35E+06 
20         9/111           10          111768.8/ 5.26           Cysteine protease                                PFB0340c             1.51E+06 
21                              16           72460/5.1                     Bip                                                   gi 311895 
______________________________________________________________________________________________________ 
 
Table 2. Summary of   results of proteins identified by MALDI-TOF-MS. The proteins were 
identified by peptide mass  finger printing against the NCBInr database using the program MS-FIT  at 
http://www.prospector.ucsf.edu/;  
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_____________________________________________________________________________ 
Spot    Mw (Da)                   protein  match                        Biotin label by SAv        Biotin label by MALDI-TOF 
No.     pI                                                                               western blot detection                 MS                   
_____________________________________________________________________________________________ 
 1       Not identified              -                                      -            
 2       Not identified                                                                            -                            - 
 3       23080.7 /5.08       Beta  3 proteasome subunit                        No                                  No             
 4       25164.2 / 6.31      1 cys peroxidoxin                                       No                                  No                 
 5      38834.7 / 6.06       Hypothetical protein                                   Yes                                Yes                      
 6      35686.6 / 6.24      Guanine nucleotide binding protein             No                                 No 
 7      37117.5 / 6.06      Hypothetical   protein                                  Yes                                Yes                       
 8      39688.9 /5.62        Hypothetical protein                                   Yes                                Yes                    
  9       not identified                                                                           Yes                                Yes                                                               
10      46055.4 / 6.47       Ornithine amino transferase                       No                                 Yes                                
          46055.4 / 6.47       Ornithine amino transferase                                      
          44844.2 /6.28         S-adenosylmethionine  
 11     46055.4 / 6.47       Ornithine amino transferase                       No                                   No                                
          46055.4 / 6.47        Ornithine amino transferase                                     
12      48678.0 / 6.21        Enolase                                                      No                                  No                                                               
13      48678.0 / 6.21        Enolase                                                      No                                   Yes                                                             
14      41870.9 / 5.21         Actin                                                         No                                   No                                                
15     not identified                                                                               -                                        - 
16      64574.3 /5.05         Hypothetical protein                                  Yes                                  Yes                        
          55067.3 / 4.73        Hypothetical protein                                  Yes                                  Yes                                                
17      73915.3 /5.50         Heat shock protein 70 kda protein             No                                   Yes   
18_0   73915.3 /5.50        Heat shock protein 70 kda protein             Yes                                  Yes 
18_1   not identified                                                                            Yes                                  Yes 
18_2   not identified                                                                            Yes                                  Yes 
18_3   73915.3 /5.50          Heat shock protein 70 kda protein           Yes                                  Yes 
18_4    73915.3 /5.50         Heat shock protein 70 kda protein           Yes                                  Yes 
 19_0    86166.8 / 4.94        Heat shock protein 90                              Yes                                 Yes                        
19_1    86166.8 / 4.94        Heat shock protein 90                               Yes                                 Yes                              
19_2    86166.8 / 4.94        Heat shock protein 90                               Yes                                 Yes                      
20        111768.8/ 5.26       Cysteine protease                                      Yes                                 No 
21              72460/5.1         Bip                                                              No                                 not done 
______________________________________________________________________________________________________ 
Table 3. Summary of the results of biotin label analysis by western blot and by MALDI-TOF 
MS. The biotinylation status of the proteins was ascertained by western blot analysis of parallel gels and by mass 
spectroscopy. analysis of  the peptides generated after trypsin treatment .  
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___________________________________________________________________________ 
Spot                      Protein match                     N- terminal            “Internal”                other motifs 
No.                                                                   secretory signal       secretory signal  
___________________________________________________________________________________________ 
 1      Not identified                                              -                     
1 Not identified                                             - 
2 Beta  3 proteasome subunit                       No                          No 
 4      1 cys peroxidoxin                                       No                         No                               
 5     Hypothetical protein                                   Yes                         No                    No ER retention signal                            
 6     Guanine nucleotide binding protein           No                           No           
 7     Hypothetical   protein                                 No                           No                                  
 8     Hypothetical protein                                   No                           No                              
 9     Not identified                                              -                                                                                                                                          
10    Ornithine amino transferase                       No                           No                                           
        S-adenosylmethionine                                No                           No 
 11  Ornithine amino transferase                        No                           No  
12   Enolase                                                        No                           No  
13    Enolase                                                       No                           No  
14    Actin                                                           No                           No  
15     not identified                                               -                             
16    Hypothetical protein                                   No                           No  
        Hypothetical protein                                   No                           No  
17   Heat shock protein 70 kda protein               No                           No                        ATP binding domain 
18_0   Heat shock protein 70 kda protein           No                           No                        ATP binding domain  
18_1   not identified                                             -                                  
18_2   not identified                                             -  
18_3   Heat shock protein 70 kda protein            No                           No                      ATP binding domain 
18_4   Heat shock protein 70 kda protein            No                           No 
 19_0    Heat shock protein 90                            Yes                           No                      ATP binding domain 
19_1    Heat shock protein  90                             Yes                          No                      ATP binding domain 
19_2    Heat shock protein  90                             Yes                          No                       ATP binding domain 
20       Cysteine protease                                     Yes                           No                       No ER retention signal 
21       Bip                                                            Yes                           No                       ER retention signal 
______________________________________________________________________________ 
 
Table 4. Signal peptide analysis of the identified proteins and other functional motifs. The 
identified proteins were analysed for hydrophobic domains which can serve as signal peptides 
http://psort.nibb.ac.jp/) for locating signal motifs and the Plasmodium data base at www.PlasmodB.org which 
uses the SignalP www server at http://www.cbs.dtu.dk/services/SignalP/output.html for signal peptide. The peptides 
were also analysed to establish the presence of  other  functional motifs. 
 85
3.14 Analysis of western blots from two-dimensional gels. 
 The translocation of proteins across the parasite plasma membrane into the PV and then 
across the PVM into the erythrocyte cytosol is comparable to the import of proteins into the 
mitochondria. Most mitochondrial proteins are encoded in the nucleus and are synthesized as 
precursor proteins on cytosolic polysomes. The study of post-translational translocation of 
precursor proteins across mitochondrial membranes show that unfolding of most proteins is 
necessary before they are inserted into membrane (Eilers and Schatz 1986). It has been shown that 
some of the parasite proteins that are exported are secreted in two steps (Ansorge et al., 1996; 
Wickham et al., 2001). The proteins are first secreted in to the vacuole and then in a second step 
they are translocated across the PVM. The proteins that are released into the vacuolar space in the 
first step are most likely to be having a folded conformation. Lingelbach (1997), proposed the 
presence of chaperones within the PV. These chaperones are postulated to assist in unfolding the 
proteins before they are translocated across the PVM possibly through a membrane bound 
translocator. The translocation of proteins across the PVM inasfar as portein unfolding is 
concerned could be mediated by a process similar to that used in the import of proteins into the 
mitochondria. 
 The possibility of vacuolar location of  known plasmodial chaperones, HSP 90, HSP 70, and 
Bip for which antibodies were available, was analysed as follows. A section of the western blot in 
Figure 19 D was used to detect and analyze the biotinylation patterns of these proteins. The filter 
in which the biotin labeled spots were previously detected using alkaline phosphatase conjugated 
streptavidin was stripped with western blot stripping buffer before blocking the filter again with 
2% BSA and incubating it with the antisera against PfHsp90. The bound antibody was visualized 
by ECL after incubation with the secondary antibody conjugated to horseradish peroxidase. The 
PfHsp90 antiserum detected a protein spot that was biotin labeled confirming that indeed the 
protein is biotin labeled (Figure 30C). The filter was then stripped and the analysis repeated in a 
similar procedure but using an antiserum against Bip. The ER marker protein was detected as a 
clearly non-biotinylated spot, (Figure 30B) confirming the previous results obtained from the 
precipitation of biotinylated proteins using streptavidin beads which show that the protein interacts 
with the biotinylated proteins though it is not biotinylated and it can be washed out from the 
fraction by using ATP. This shows that the biotin derivative does not have access to Bip which is 
localized in the ER. The procedure was repeated for PfHSP70 and unlike the other two. Several 
protein spots were identified some which had a biotin label and others without (Figure 30D). 
There were also several spots detected as a chain with slightly differing pIs. This suggests that  
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Figure 30. Western blot analysis of   two-dimensional gels. A section of the nitrocellulose filter 
described in figure 17D was probed sequentially with antisera to PfHsp90 then with PfBip and finally with PfHsp70. 
Panel A, SAv –AP detection of biotin labeled protein; Panel B; detection of PfBip with horseradish–peroxidase 
Panel C detection of PfHsp90 with horse radish –peroxidase; Panel D detection of PfHsp70 with horseradish –
peroxidase. In E the same filter was incubated with antisera to SERP and the protein detected using secondary 
antibody conjugated to horse radish –peroxidase. 
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unlike PfHsp90 which appears to be completely biotinylated and to the same degree (shown by 
migration as a single biotinylated spot in this experiment). The biotinylation PfHsp70 is either 
partial or alternatively there could be different pools of this protein, some of which is biotinylated 
and part of  which is not accessible to the biotin. This could be the case since the Hsp70 protein 
family consists of a number of different proteins which are highly conserved in amino acid 
sequence but have different subcellular localization (Bianco et al., 1986; Adeshir et al.,1987 and 
Kumar et al.,1991). However only one Hsp70 species of the protein PF08_0054 was identified for 
all the spots that were analysed. 
 In subsequent experiments the same blot was incubated with antisera against the vacuolar 
space marker SERP. The results (Figure 30E) show that SERP is biotinylated and this providing 
further evidence that the protein is within the parasitophorous vacuole.  
 The western blot analysis data suggested biotinylation of Hsp90, in the case of Hsp70  the 
antibody reacted with a string of spots some of which also reacted with streptavidin conjugated to 
alkaline phosphatase implying that the protein is also biotinylated. These protein were analysed in 
more detail by MALDI-TOF-MS  to identify any peptides  modified by biotin labeling.  
 The detailed results in the following page show the masses of the peptides obtained  by 
MALDI-TOF analysis, these were used in searches against the NCBInr data base. The matched 
peptides are shown, together with the matching amino acid sequences and the modifications. The 
observed modifications include biotinylation and other  modifications that occur during the 2D-
electrophoresis these include oxidized methionine residues and carbamidomethylated cysteines. 
The peptides which were not matched are shown at the bottom of each set of results. 
For spot number 17, which was identified to be Plasmodium falciparum Hsp70, 21 out of 
the 50 peptide masses that were generated and submitted to the databases for peptide mass finger 
printing were matched. The matched peptides represented 209 amino acids covering 30 % of the 
protein that has a total of 677 amino acids. Three of the matched peptides were biotin labeled with 
one peptide (amino acids 125-140) being labeled by two biotin molecules. Therefore the protein 
was labeled with a total of 4 biotin molecules. Spot number 19 was identified as Plasmodium 
falciparum  PfHsp90. 18 out of the 53 peptide masses that were generated and submitted to the 
databases for peptide mass finger printing were matched. The matched peptides represented 226 
amino acids also covering 30 % of the protein which has a total of 745 amino acids. Three of the 
matched peptides were biotin labeled with one peptide (amino acids 669-676) being labeled by 
two biotin molecules. This protein was also labeled with a total of 4 biotin molecules. The 
schematic diagram (Figure 31)  shows the identified  peptides and the modifications that were 
detected. 
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Spot 17. 1. 21/50 matches (42%). 73915.3 Da, pI = 5.50           
 >Pfa3D7|chr8|PF08_0054|Annotation|Sanger (protein coding) heat shock 70 kDa protein  
m/z                 MH+             Delta          start        end             Peptide Sequence                               Modifications 
submitted      matched        ppm 
1217.6346  1217.6312        2.7664        172        183     (K)DAGTIAGLNVMR(I) 
1219.6640  1219.6588       4.2906         472        482     (K)FHLDGIPPAPR(K) 
1233.6468  1233.6261      16.7424        172        183    (K)DAGTIAGLNVMR(I)                           1Met-ox  
1270.6263  1270.6142       9.5351         249        258    (R)LVNFCVEDFK(R) 
1339.7422  1339.7334       6.5771         343        355     (K)SVHEVVLVGGSTR(I) 
1346.7716  1346.7571     10.7342         586        596     (K)TITTILEWLEK(N) 
1391.6337  1391.6306       2.2543         315        324    (R)FEELCIDYFR(D) 
1405.6796 1405.6462      23.7521         315        324    (R)FEELCIDYFR(D)                                     1Cys-am  
1405.6796 1405.6893       -6.9291         333        341    (K)VLKDAMMDK(K)                                  1Bio 1Met-ox  
1426.7249 1426.7153        6.7318         249        259     (R)LVNFCVEDFKR(K) 
1487.7136 1487.7018        7.9225           48          60     (R)TTPSYVAFTDTER(L) 
1593.7718 1593.7617        6.3664         609        622     (K)QKEAESVCAPIMSK(I)                         1Met-ox  
1618.7740 1618.7688        3.2199         313        324     (R)ARFEELCIDYFR(D) 
1657.8814 1657.8624      11.4884         125        138     (K)LFHPEEISSMVLQK(M) 
1673.8697 1673.8573       7.4269          125        138     (K)LFHPEEISSMVLQK(M)                         1Met-ox  
 1681.9523 1681.9277    14.6075          184        199     (R)IINEPTAAAIAYGLHK(K) 
2627.3066 2627.3110     -1.6579           125        140     (K)LFHPEEISSMVLQKMK(E)                     2Bio 2Met-ox  
2628.2974 2628.2946      1.0760           438         460    (K)SQIFTTYADNQPGVLIQVYEGER(A) 
2640.2307 2640.3094   -29.7916           315         332    (R)FEELCIDYFRDTLIPVEK(V)                  1Bio 1Cys-am  
2663.3027 2663.3676   -24.3685           575         596    (K)LQPAEIETCMKTITTILEWLEK(N)       1Met-ox  
2756.4576 2756.3895    24.6936           437         460    (K)KSQIFTTYADNQPGVLIQVYEGER(A) 
3004.4749 3004.5202   -15.0878              6           33    (K)GSKPNLPESNIAIGIDLGTTYSCVGVWR(N) 
29 unmatched masses: 1368.7488 1384.7465 1392.1814 1413.6456 1429.6793 1544.7315 1679.8415 1695.4531 
1703.9541 1787.9373 2153.0605 2221.1629 2225.1421 2298.2367 2408.0720 2634.1994 2651.2635 2678.3110 
2733.2913 2757.3195 2831.5277 2914.5947 2917.3554 2921.4347 2939.3859 3349.6849 3350.8931 3366.4200 
3516.7389  
  
Spot 19_0  18/53 matches (33%). 86166.8 Da, pI = 4.94 
 >Pfa3D7|chr7|PF07_0029|Annotation|Sanger (protein coding) heat shock protein 90  
  m/z            MH+               Delta        start     end             Peptide Sequence                                       Modifications 
 submitted    matched      
1142.491     1142.4941      -2.5115        366      374          (R)APFDMFENR(K)                                1Met-ox  
1204.6159   1204.6366    -17.2122        197      206          (K)HSEFISFPIK(L) 
1208.6219   1208.6315      -7.9835          56        65         (K)LSAEPEFFIR(I) 
1282.5872   1282.6003    -10.1869        365      374         (K)RAPFDMFENR(K) 
1298.5994   1298.5952       3.2494        365      374          (K)RAPFDMFENR(K)                              1Met-ox  
1313.7023   1313.7177    -11.7517          87        98          (K)NDLINNLGTIAR(S) 
1313.7023   1313.6862     12.2221        312      318          (K)QKPLWMR(K)                                    1Bio 1Met-ox  
1313.7023   1313.7074      -3.8619        651      658          (K)KIMEINAR(H)                                    1Bio  
1413.6472   1413.6650    -12.6155            1        13          (-)STETFAFNADIR(Q)                               Acet N  
1470.7196   1470.6609     39.9298        439      450           (K)CLDMFSELAENK(E)                        1Cys-am  
1504.7019   1504.7019       0.0178        277      289           (K)VEDVTEELENAEK(K) 
1513.7656   1513.7862   -13.6162        406       419           (K)GVVDSEDLPLNISR(E) 
1527.7363   1527.7443     -5.2673        334       346           (K)SLTNDWEDHLAVK(H) 
1527.7363   1527.7187    11.5034        669       676           (K)ADADKSDK(T)                                  2Bio  
1671.8659   1671.8780    -7.2397          14          27           (R)QLMSLIINTFYSNK(E) 
1671.8659   1671.8933  -16.3647        196        206           (K)KHSEFISFPIK(L)                               1Bio  
1687.8651   1687.8729    -4.6322          14          27           (R)QLMSLIINTFYSNK(E)                      1Met-ox  
1833.8434   1833.8547    -6.1540        319        333           (R)KPEEVTNEEYASFYK(S) 
2317.9998   2318.0213    -9.2795        140        160           (K)NNDDEQYVWESAAGGSFTVTK(D) 
2399.0706   2399.1012  -12.7369        611        631          (R)ITDSPCVLVTSEFGWSANMER(I) 
2415.1082   2415.0961     5.0219         611       631           (R)ITDSPCVLVTSEFGWSANMER(I)    1Met-ox  
2645.3726   2645.3350  14.1987          509       532          (K)DIYYITGESINAVSNSPFLEALTK(K) 
35 unmatched masses: 1036.1055 1049.4787 1207.6062 1209.1255 1222.6383 1311.6575 1314.7018  
1316.7245 1361.7226 1371.6605 1407.7314 1410.7099 1411.7094 1414.1948 1427.6880 1474.7466  
1538.7055 2084.0185 2183.0433 2221.1053 2225.1013 2301.1765 2353.4161 2356.0020 2368.0036  
2409.0176 2420.2220 2431.0598 2647.3469 2663.4157 2811.2282 2915.5519 2916.3741 2923.2410 3072.4651 
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Figure 31. Schematic diagram of the heat shock of the proteins identified in the 
vacuole, their sequence coverage and biotin labeled peptides.  The shaded sections depict the peptides 
that were identified by MALDI-TOF analysis and the biotin labeled peptides are indicated with a B and the other 
modifications are also indicated. 
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3.15  Localization of the heat shock proteins after cell fractionations. 
 The mass spectrometry data showed that two parasite chaperones Hsp90 and Hsp70 were 
 biotin labeled. Since the PV is protein sorting compartment (Lingelbach et al.1997; Wickham et 
al., 2001) and with previous postulations about the possible vacuolar localization of Hsp90  
(Jendoubi et al., 1985) the localization of these heat shock proteins in infected erythrocytes was 
analyzed.  IRBC were fractionated using either saponin or SLO, and the distribution of the heat 
shock proteins, PfHsp70, PfHsp90 and PfBip compared to the marker proteins SERP and Pf 
aldolase. Following treatment with  either saponin or SLO and subsequent centrifugation, the  
pellet fraction were divided into two for each preparartion. One aliquot of each was trypsin treated 
and the other was not. When the supernatant and pellet fractions were analyzed by western blot, 
none of the marker proteins was detected in the fraction of proteins released with SLO, all the 
proteins were in the pellet fraction and were not sensitive to trypsin treatment (Figure 32). After 
the saponin treatment, Hsp90 and SERP were released and detected in the supernatant, however 
considerable amounts of these proteins remained in the pellet fraction.. Upon trypsin treatment of 
the pellet fraction it seems  Hsp90 is protected from trypsin while SERP is not. PfBip and Hsp70 
were exclusively in the pellet fraction after saponin treatment and they were protected from 
trypsin digestion. In the case of aldolase, after saponin treatment a very small proportion was 
detectable in the supernatant. However the protein was insensitive to trypsin treatment. This result 
suggests that Hsp90 is in the vacuolar space, it does not rule out a dual location with a proportion 
of the protein within the parasite. Since Hsp70 was shown to be biotinylated  it would be expected 
to be in the fraction of the proteins that are released after saponin  treatment. However there are no 
detectable amounts of the protein in this fraction. Since a major spot that was analyzed and 
identified to be Hsp70 was not biotin labeled in the western blot it is possible that only a limited 
amount of the protein is released into the vacuole. It is probable that the amounts are not sufficient 
to be detected by western blot in a SDS-PAGE. The incomplete biotinylation of Hsp70 needs  
further investigation, there are several homologues of Hsp70 that have been reported in 
P.falciparum (Bianco et al., 1986; Adeshir et al., 1987 and Kumar et al.,1991) and it is possible 
that they have different  cellular localization. Since the identified Hsp70 does not seem to have a 
classical N-terminal signal sequence its  suggested vacuolar location should be investigated further  
to conclusively ascertain its  cellular localization. 
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Figure 32. Localization of some P. falciparum proteins after fractionating of infected  
erythrocytes. Infected erythrocytes were SLO permeabilized or lysed with 0.15% saponin and the lysates obtained. 
The pellets were divided into two for each preparation; and one aliquot of each was trypsin treated and the other was 
not. The lysates (lanes 1 and 4) and the pellets without trypsin treatment (lanes 2 and 5) and with trypsin treatment 
(lanes 3 and 6) were analyzed by SDS-PAGE and immunoblotting using antisera against SERP, PfHsp70, PfBip, 
PfHsp90 and aldolase; and the protein visualized by using alkaline phosphatase conjugated secondary antibody. 
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4. Discussion. 
 Over the past 10 years ample evidence has been provided that the parasite modifies the 
properties its host erythrocyte by transporting some of its own proteins to specific destinations 
within the host cell. Some of these proteins may be involved in nutrient acquisition ( Kirk et al., 
1994) and others such as PfEMP1 are responsible for pathogenesis (Miller et al.,1994). What 
pathways are used to target the parasite products, particularly proteins, to their destinations? 
 The PV forms the interphase between the erythrocyte cytosol and the parasite. The PV has 
been postulated to be involved in various functions that are important for the parasite survival   
within the infected erythrocyte. These functions include nutrient acquisition from the erythrocyte 
cytosol and the possibly from the external milieu. Constituents of the PV are involved in 
proteolytic processes that lead to the release of PVM enclosed merozoites at the end of the 
erythrocytic cycle. The processing of merozoite surface proteins, e.g. MSP-1, that is important in 
merozoite reinvasion, also occurs within the vacuole (Blackman et al. 1991). The PVM and the 
contents of the vacuole presumably protect the parasite from potentially harmful substances in the 
host cytosol. Studies have also shown that some exported parasite proteins are sorted within the 
vacuolar space, some are retained and others that are destined for sites beyond the PVM undergo 
forward sorting to their respective destinations (Knapp et al.,1989; Ansorge et al., 1996;Wickham 
et al., 2001). Therefore the PV forms a distinct and invaluable compartment to the parasites within 
infected erythrocytes. Characterization of the proteome will provide more biochemical 
information about the proteins present and their importance to the physiology and development of 
the parasite. Such information may provide new insights into new approaches that can be used in 
the control of the disease. 
 
4.1 Experimental strategy. 
 To facilitate the characterization of the vacuolar proteins an experimental strategy that 
allows the selective labeling and identification of vacuolar space proteins was adopted. 
Streptolysin O, a bacterial toxin was used to selectively permeabilize infected erythrocytes 
(Ansorge et al., 1996; Ansorge et al., 1997). The procedure allows  the total removal of the host 
cell cytosol, the integrity of the PVM is maintained and the contents of the PV remain intact. After 
permeabilization infected erythrocytes were incubated with  non-permeant biotin derivative. These 
access the surface of the PVM after passing through the SLO generated pores on the erythrocyte 
membrane. The PVM is proposed to have proteinaceous pores that allow free movement of 
molecules with size less than 1300 Daltons (Desai and Rosenberg,1997). The biotin derivatives 
used were of sizes less than 600 Daltons and they should access the vacuolar space through the 
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pores and  react with the  soluble PV resident proteins. Since the internal parasite proteins are 
restricted by the parasite plasma membrane that is not permeated by the highly hydrophilic biotin 
derivatives they should not be biotinylated. The selectively biotin labeled PV proteins should be 
isolated and characterized using molecular and biochemical approaches. The study had the 
following specific objectives. 
 
4.2 Specific Objectives: 
4.2.1 Removal of all of the cytosolic proteins of the erythrocyte. 
 The first objective of the project was to ensure that all the cytosolic proteins of the 
erythrocyte are removed. The SLO permeabilization procedure and the subsequent washing steps 
resulted in the total removal of hemoglobin, within the detection limits as assayed photometrically. 
Hemoglobin is the most abundant cytosolic protein of the host cell and its total extraction is a 
confirmation that the extraction of the host cell cytosol is complete. This observation was 
confirmed further in 2D gels where an absolute majority of the Coomassie stained protein spots 
were also radiolabeled by L-[35 S] methionine. Since erythrocytes do not have the ability to 
synthesize proteins de novo all the radiolabeled proteins are of parasite origin. The same is true for 
silver stained 2D gels which has a higher sensitive compared to Coomassie.  None of the protein 
spots analyzed by peptide mass finger printing after MALDI-TOF-MS was identified as a human 
protein further confirming that the cytosolic proteins of the erythrocyte are removed completely. 
 
4.2.2 Verification of the existence of non-selective pores within the PVM. 
  The second objective was to verify the existence of non-selective pores within the PVM that 
allow passive bi-directional diffusion of small molecules  (Desai et al., 1993; Desai and Rosenberg 
1997).These authors used electrophysiological data to propose the existence of these pores and has 
been no previous independent biochemical data that confirm their existence. This study provides 
the first independent biochemical data confirming the presence of pores on the PVM. These results 
show that a non-permeant biotin derivative that does not permeate plasma membranes gains access 
to the parasitophorous vacuole after SLO permeabilization. The biotin labels proteins within the 
vacuolar space. This was confirmed biochemically using two PV marker proteins SERP and GBP. 
SERP is a vacuolar resident protein whereas GBP is translocated to the erythrocyte in a two-step 
process that involves the PV as a transit compartment. Control experiments confirmed that the 
integrity of the PVM is maintained after the SLO procedure and the since the biotin derivative 
used sulfo-NHS-LC-biotin and sulfo-NHS-SS-biotin are highly hydrophilic it is certain that the 
biotin derivatives gain access to the vacuolar space through the non-selective pores that are 
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proposed to be in the PVM of Plasmodium spp together with other Apicomplexans (Desai et al., 
1993; Desai and Rosenberg, 1997; Schwab et al.,1994). Since the access occurred at 4° C  it is 
clear that the biotin labeling of the proteins in the PV is a passive process that is not energy 
dependent. This is the first independent biochemical evidence confirming the presence of the 
pores on the PVM of the parasites. 
 Several models have been proposed to try to explain how the parasite acquires nutrients 
from the external medium as reviewed in section 1.1. This study provides supportive evidence for 
the existence of non-selective pores within the PVM that allow passive bi-directional diffusion of 
small molecules  (Desai et al., 1993; Desai and Rosenberg 1997). These results imply that in 
infected erythrocytes exchange of small molecules between the erythrocyte cytosol and the PV 
could be mediated through the pores.  
 
4.2.3 Specific biotinylation of vacuolar proteins. 
 The third objective was to avoid the biotinylation of internal parasite proteins. Using affinity 
chromatography purification the study clearly showed that aldolase an abundant cytosolic protein 
was non-biotin labeled. This confirmed that the biotin derivatives used are non-permeant and they 
do not pass through the parasite plasma membrane. This observation was also true for Bip an ER 
resident protein. Although the protein associated with biotin labeled proteins after affinity 
purification with streptavidin beads, immunoprecipitation analysis clearly showed that the protein 
was not biotin labeled. Further analysis of the affinity purified biotin labeled proteins showed that 
the protein could be released from the immobilized binding matrix by washing with buffer 
containing ATP. This confirmed that there was chaperonic interaction between Bip some of the 
biotin labeled proteins. Analysis of 2D gels by immunoblotting also confirmed the non-
biotinylation of Bip The non-biotinylation of Bip further confirmation that biotinylation of the 
internal parasite proteins does not occur and Bip which is an important component in the early 
events of the secretory pathway  is retained within the parasite. 
 Several abundant internal parasite proteins were identified by MALDI-TOF-MS and peptide 
mass finger printing. These included ornithine aminotransferase, enolase, actin, guanine 
nucleotide binding protein, 1cys peroxidoxin and Beta proteasome sub-unit alpha. These were 
among the most abundant proteins as detected by Coomassie staining. The analysis of the peptides 
generated from these proteins show that they were not modified by biotin, providing further 
evidence at molecular level that internal  labeling does not occur under the conditions used in the 
study.  
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 The same conclusions can also be made from immunfluorescence microscopy results where 
a distinct circular biotin labeling on the periphery of the parasite is observed. This colocalized 
with the immunofluorescent labeling for SERP a vacuolar maker protein. Immunoelectron 
microscopy detected very little or no internal biotinylation. Taken together these results confirm 
the specific labeling of the vacuolar space in SLO permeabilized infected erythrocytes and the 
absence of internal biotinylation. Therefore, on the basis of these controls, it is conceivable to 
assume that the biotin labeled  are  vacuolar proteins. 
 
4.2.4  2D Analysis and identification of biotinylated proteins.   
  The fourth specific objective of the study was to analyze  biotin labeled proteins by 2D gel 
electrophoresis, a technique for separating proteins on the basis of two independent variables 
isoelectric point and molecular mass (pI and Mr) to give a comprehensive pattern of protein 
visualized as spots in a stained gel.  The initial approach was to perform 2D gel analysis using the 
affinity purified biotin labeled vacuolar proteins. The proteins were labeled using the non-
permeant sulfo-NHS-SS-biotin after which they were affinity purified using streptavidin fixed to a 
solid matrix. The biotin labeled proteins were to be analyzed after cleavage of the proteins from 
the bound avidin-biotin complex using reducing agents. However, it was not possible to obtain 
sufficient quantities of the bound proteins from the complex using reducing agents such as DTT, 
mercaptoethanol and TCEP. The reduction or elution of the proteins was only possible after the 
addition of the detergent SDS, which rendered the samples unsuitable for 2D analysis because the 
highly negatively charged SDS interfered with the isoelectric focussing during the 1st dimension. 
 As a consequence of the above technical problem the experimental strategy was slightly changed, 
the proteins SLO permeabilized IRBC were   biotinylated with the non-cleavable sulfo-NHS-LC-
biotin and the total soluble protein sample was analyzed without an affinity purification step. This 
allowed the detection of biotin labeled protein spots in by immunodetection in western blots after 
2D electrophoresis. The resolution of the 2D gels was sufficient and reproducible to clearly 
identify a number of spots that were biotinylated and radiolabeled. These proteins could be 
confidently assigned to the parasite with vacuolar localization. 
 
4.2.5 MALDI-TOF- MS analysis. 
 The fifth and final objective was to analyze the proteins by MALDI-TOF-MS and 
subsequently identify the proteins using bioinformatic tools and data base searches including the 
recently published Plasmodium falciparum complete genome (Gardner et al., 2002.). Despite the 
modification of the proteins in the biotinylation reaction prior to 2D gel electrophoresis, it was 
 96
possible to unambiguously identify several parasite proteins by peptide mass finger printing. 
These included both biotin labeled and non-biotin labeled proteins. The accuracy of the approach 
allowed the identification of some peptides containing a lysine residue modified in the biotin 
reaction. This provided evidence for the biotinylation status of the protein at molecular level. The 
identified proteins included the non-biotinylated house keeping enzymes present in the cytosol 
such as enolase and ornithine amino transferase. The other non-biotinylated proteins included 
actin, which is also an abundant protein in the cytosol and cytoskeleton of the parasite, guanine 
nucleotide binding protein, 1cys-peroxidoxin and beta proteasome sub unit alpha. The biotin 
labeled proteins that were identified included Hsp86, also commonly referred to as Hsp90, Hsp70, 
a cysteine protease with an identical sequence to the serine rich protein (SERP) and a number of 
hypothetical proteins that are described in the recently published Plasmodium falciparum genome 
(Gardner et al., 2002). The biotin labeled proteins fulfill the experimental criteria to conclude that 
they are localized within the parasitophorous vacuole. 
 
4.3 Limitations and Expectations of the study.  
One of the major limitations of the study was the low abundance of the proteins in the PV. 
Although SLO permeabilization led to the complete removal of the host cell cytosol, in the 
permeabilized cell the volume of the lumen of the PV  compared to the entire infected erythrocyte 
is 1:10,000 (Burghaus and Lingelbach, 2001).  It was not possible to isolate large amounts of the 
biotin labeled proteins by affinity chromatography for subsequent analysis by 2D gel 
electrophoresis. Therefore the experimental strategy had to be modified to use the total soluble 
protein fraction in the 2D analysis. The disadvantage of this approach is that due to high 
abundance of the internal parasite proteins at the maximum protein loading capacity of the IPG 
strips the amount of the PV proteins is very low. Therefore in this study only the most abundant 
biotinylated proteins were characterized.. A large majority of the proteins could not be identified 
by MALD-TOF-MS due to their low abundance and this remains a major problem which has to be 
overcome in order to fully characterize the proteome of the PV.  In principal the experimental 
strategy is correct and it  can be used to selectively isolate vacuolar proteins. However, biotin may 
not be the ideal molecule to use in labeling the proteins  which are subsequently affinity purified 
in streptavidin columns.  The same experimental approach can be utilized but using different  
cross-linkers that can be easily dissociated during elution thereby releasing the labeled  proteins. 
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4.4 Characterization of novel vacuolar proteins and their possible functions. 
  Conceptually four main categories of proteins can be postulated to be localized in the PV.  
These include exclusively PV resident proteins e.g., SERP, proteins with a dual localization in 
both the parasite and the PV e.g., Sar1p and NSF, proteins that  transit the PV and are outward 
bound e.g., GBP and proteins that are present within the PV but can be internalized by the parasite 
by endocytosis or other mechanisms (Cheresh et al., 2002).  Translocation across the PVM 
requires unfolding  and chaperones are also likely to be found in the vacuole. 
 The results have shown the presence of a chaperone HSP86 which is also referred to as 
HSP90 in the vacuolar space as confirmed by both immunoblotting and masspectroscopy. Heat 
shock proteins (Hsps) are families of proteins expressed in all prokaryotic and eukaryotic 
organisms which play a critical role in the development and adaptation of cells to different 
environments (Hartl et al., 1994). They are constitutively expressed as well as induced when cells 
are exposed to a variety of stressful conditions such as temperature, nutrient deprivation, etc. They 
show a high degree of sequence identity among species and function as molecular chaperones. By 
recognizing structural elements, predominantly hydrophobic residues exposed in unfolded and 
partially denatured proteins, they stabilize he non-native conformation and facilitate their correct 
folding (Hartl, 1996). Additionally, Hsps located inside cellular organelles play critical roles in 
assisting translocation of proteins from the cytosol into these organelles (Cheng et al., 1989). 
 P. falciparum has a complex life cycle alternating between a poikilothermic invertebrate 
vector and a warm-blooded vertebrate host and it is not surprising that the parasite abundantly 
expresses Hsps (Kumar et al., 1991), where they could play a significant role during the 
adaptation of the parasites to different environments. Genes of the Hsp70 (Bianco et al., 1986; 
Kumar et al., 1988), Hsp90 (Bonnefoy et al., 1994; Su and Wellems, 1994), and Hsp60 (Syin and 
Goldman, 1996) have been characterized in the parasite. Hsp70 has been the most extensively 
studied. It is expressed in all stages of the parasite life cycle (Kumar et al., 1993; Tsuji et al., 
1994) and its expression is induced by high temperature during the erythrocytic stage (Kumar et 
al., 1991). 
 Previous analysis of the deduced protein sequence of PfHsp90 revealed a unusually large 
region of charged amino acids when compared to hsp90 from other species, with the region 
showing homology to the calcium binding domain of calreticulin, the major calcium binding 
protein of endoplasmic reticulum (Bonnefoy et al., 1994).  In this study analysis of the N-terminus 
of the identified hsp90 protein using different algorithms to predict the cellular location of the 
protein gave inconsistent results. The Psort program at http://psort.nibb.ac.jp/ predicted a signal 
peptide at its N-terminus, however the program SignalP www server at 
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http://www.cbs.dtu.dk/services/signalP/output.html predicted that the protein does not have a 
signal peptide. Analysis of the tryptic digestion peptides by MALDI-TOF-MS detected the 
presence of peptides corresponding to amino acids 1-13 and 14-27 of the N-terminal region of the 
protein. This implies that the putative signal sequence is not cleaved as would be expected of a 
protein that is secreted via the classical secretory pathway. Therefore the mechanism of its 
translocation to the PV may be similar to that of proteins that exported out of the parasite despite 
the fact that they do not carry a typical N-terminus signal sequence. Alternatively the N-terminal 
sequence acts as an ER-targeting signal that enables the protein to be recruited into the classical 
secretory pathway, however the signal is not cleaved  from the protein. 
The plasmodial  hsp90 is an ATP binding protein encoded by a single gene constitutively 
expressed in both asexual (trophozoite) and sexual (gametocyte) stage parasites. The hsp90 
protein is homologous to a previously identified 90-kDa antigen strongly recognized by both sera 
from vaccinated monkeys and monoclonal antibody (Bonnefoy et al., 1994). In these vaccination 
trials using several identified antigens, the protected monkey sera had significantly higher 
antibody titers to the hsp90 protein. No correlation could be drawn with response to any other 
antigen investigated (Bonnefoy et al., 1994). The monoclonal antibody used in the identification 
of the hsp90 mAb XIV/7 has been reported previously to react with a protein located in  the 
parasitophorous vacuole (Jendoubi et al., 1988). Recent studies appear to confirm  this 
interpretation (Banumathy et al., 2002). The vacuolar localization of PfHsp90 in this study 
confirms the proposal that molecular chaperones may be present in the PV and that they are 
involved in protein sorting activities in this compartment (Lingelbach, 1997). 
 These results support the two-step model for the translocation of proteins to destinations in 
the host cell. . Most mitochondrial proteins are encoded in the nucleus and are synthesized as 
precursor proteins on cytosolic polysomes. The study of post-translational translocation of 
precursor proteins across mitochondrial membranes show that unfolding of most proteins is 
necessary before they are inserted into membranes (Eilers and Schatz 1986). Since proteins which 
are secreted from the parasite into the vacuolar space are likely to have a folded conformation, a 
chaperone like Hsp90 may assist in the unfolding of the proteins in order to facilitate translocation 
through a membrane-bound translocator. This process would require energy and indeed   the 
translocation of GBP across the PVM has been shown to be ATP dependent (Ansorge et al., 
1996). 
  The Hsp90 proteins share a common structural plan. The amino terminal domain contains 
a binding site for ATP and for geldanamycin a representative of the ansamycin drugs, which 
specifically target Hsp90 (Whitesell et al., 1994). A divergent charged sequence separates the 
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amino terminus from a highly conserved though structurally flexible middle domain and the 
carboxyl-terminal domain. Both the N-terminus and the C-terminus have been implicated in 
binding of substrate polypeptides and substrate binding at the N-terminus is affected by 
nucleotides, GA, and the adjacent charged sequence of Hsp90 (Young et al., 1997; Scheibel et al., 
1998,1999). ATP binding and hydrolysis are necessary for the function of HSP90 in vivo as 
demonstrated in both yeast and E. coli (Prodromou et al., 1997; Oberman et al., 1998; Panaretou 
et al., 1998).  Indeed the translocation of GBP across the PVM has been shown to be dependent of 
the availability of ATP (Ansorge et al., 2000). 
   At least five different Hsp70 P. falciparum genes have been identified (Peterson et 
al., 1988; Kumar and Zheng 1992).  This study proposes the presence of Hsp70 in the 
parasitophorous vacuole as shown by biotin labeling and mass spectroscopy, however Bip an ER 
resident chaperone which is also a member of the Hsp70  protein family is  not in the vacuole 
since it was not biotin labeled. Like grp78 in mammalian cells the PfBip (Pfgrp) has a 
hydrophobic signal sequence at the amino terminus and a tetra-peptide sequence of Ser-Asp-Glu-
Leu (SDEL) which serves as a signal sequence for ER retention as compared to KDEL in 
mammalian cells (Munro and Pelham 1987) and HDEL in yeast  (Rose et al., 1989; Pelham et al., 
1988). These results confirm that Pfgrp is not present in the vacuolar space and therefore if there is 
a chaperone mediated protein-sorting activity then it is modulated by a different molecule. The 
possibility of having hsp70 in the vacuole is new since previous studies have localized the protein 
in the nucleus and cytoplasm of the parasite (Kumar et al., 1991) the cytoplasm (Bianco et 
al.,1986). The cytoplasmic hsp70 does not have an N-terminal signal sequence and the import into 
the vacuole must be depended on a different mechanism. 
  Despite the purported cytosolic location of the Hsp families as previously reported, Hsp70, 
in spite of being the most conserved protein, present in all organisms studied (Gupta and Golding 
1993) is a major immunogen in infections caused by a number of organisms including P. 
falciparum (Adeshir et al., 1987; Behr et al., 1992; Bianco et al., 1986, Kumar et al., 1990). To 
elicit an immune response the protein must be exposed to B- and T-cells which mediate these 
immunological responses. Indeed a 75kd protein with a sequence homologous to the hsp70 protein 
family has being localized on the merozoite surface (Adeshir et al., 1987). Recent experiments 
however rule out the possibility that like, many parasite encoded proteins PfHsp70 may be 
exported to the host cytoplasm as shown by saponin lysis  (Banumathy et al., 2002), this results 
were confirmed in the current study. A result that makes it difficult to conclusively ascertain the 
cellular location of the protein. However recent experiments that suggest the movement of 
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proteins into the vacuole and back into the parasite (Cheresh et al., 2002) may offer an explanation 
for the presence of the protein the vacuole. 
 The presence of Hsp90 in the vacuole may indicate the possibility of having Hsp70 also in 
the same compartment, since some cellular signaling proteins require coordinated activities of 
theHsp70 and Hsp90 molecular chaperones for their folding and conformational regulation. Many 
polypeptide chains interact cotranslationally with the chaperones of the hsp70 family which 
prevent misfolding and aggregation of the newly formed polypeptides. The newly synthesized 
polypeptides are either released for folding to their native state without the help of additional 
chaperones or are passed on to more specialized chaperone systems which includes the Hsp90 
multichaperone system (Hartl, 1996; Johnson and Craig 1997). Hsp90 receives its substrates from 
Hsp70 in a reaction that is dependent on the function of Hop (Hsp70 and Hsp90 organizing 
protein) an adaptor protein that provides specific binding sites for these two chaperones (Chang et 
al., 1997). 
 This study has localized a cysteine protease in the vacuole, and amino acid sequence 
analysis showed that the protein is identical to the serine rich protein (SERP). Serp  is localized in 
the vacuole and it contains domains that are identical cysteine proteases or related proteases. The 
result is significant and it supports previous data which suggest a role of vacuole resident 
proteases in the release of merozoites from the host cell at the end of the erythroyctic stage of 
development. Protease inhibitors have been shown to inhibit the exit of merozoites from the 
parasitophorous vacuole  (Salmon et al., 2000).  Proteases are also important in the processing of 
MSP-1 possibly within the vacuole (Holder et al., 1987). The processed form of the protein is 
localized on the membrane of the merozoite and is implicated in the invasion process. The 
identification and characterization of vacuolar localized proteases that are important in the parasite 
developmental cycle is significant since protease inhibitors are currently in use in the treatment of 
microbial infections. 
 The proteins that have been identified as putative vacuolar protein by this approach can be 
divide into two main categories; those with signal sequences at their N-terminus and those 
without. The proteins in the former category include Hsp90, cysteine protease and the hypothetical 
protein spot 5. These proteins would under normal circumstances be secreted in through the 
classical pathway. The spot 5 which was identified as a hypothetical protein with a signal 
sequence predicted to be located between amino acids 1-24 did not have any predicted metabolic 
activity or other functional motifs. However when its sequence was matched against other 
annotated proteins in the NCBI database the closest match was to a yeast gene YKR095w which 
codes for a protein accession NP_013021. The protein has high molecular mass with a total of 
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1875 amino acids. In yeast this protein is involved in translocation of macromolecules between the 
nucleoplasm and the nuclear pore complex. The other hypothetical proteins spots 7 and 8 were 
predicted not to  have signal peptides or known functional properties. 
   
Conclusions: 
SLO permeabilized cells can be used to introduce cross-linking molecules in to the PV.  
Presumably, these molecules gain access via non-selective pores within the PVM. The abundance 
of some of the vacuolar proteins clearly is sufficient to allow their identification by MALDI-TOF 
analysis. among th enovel proteinsidentified within the PV are heat shock proteins. Their  precise 
roles in the complex process involved in protein sorting within the vacuole need to be established. 
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Summary 
 
Plasmodium falciparum, the causative agent of the most severe form of human malaria, is 
a unicellular parasite which infects erythrocytes. Inside the erythrocyte the P. falciparum develops 
within a parasitophorous vacuole, the membrane of vacuole forming an interface between the 
parasite and the host cell cytosol. Although the volume of the vacuole is extremely small in 
comparison to the host and the parasite cells, respectively, it plays an essential role for parasite 
development. Putative functions of vacuolar proteins include nutrient acquisition, protein sorting 
and lytic properties required for parasite release at the end of the intraerythrocytic development. 
Although the significance of the vacuole as a separate compartment in infected erythrocytes was 
recognized many years ago, experimental attempts to selectively identify vacuolar proteins were 
limited because of the small volume of the vacuole and because the vacuole is an intermediate 
compartment between two separate cells (the parasite and the host erythrocyte) which complicates 
the use of standard cell fractionation methods. A major aim of this project was the development of 
a novel experimental strategy that would allow the selective identification of vacuolar proteins.  
In a first step, infected erythrocytes were permeabilized with streptolysin O which allowed 
complete removal of the erythrocyte cytosol. Permeabilized cells were then treated with non-
permeant biotin derivatives. These derivatives were shown to gain access to the vacuolar lumen, 
but they were excluded from the parasite cell. This was demonstrated by biochemical analyses of 
specific marker proteins located within the vacuole and within the parasite cytosol, respectively. 
The vacuolar proteins were labeled with biotin whereas the parasite cytosolic proteins, although 
they were present at higher abundance, were not labeled. These results provided the first 
biochemical evidence for the existence of non-selective pores within the vacuolar membrane that 
were postulated based on electrophysiological studies. Soluble vacuolar proteins that were 
biotinylated were isolated by affinity chromatography and analysed by SDS-PAGE. 
Secondly, infected erythrocytes were cultivated in the presence of L-[35S]- methionine to 
label parasite proteins metabolically. Following biotin treatment of permeabilized erythrocytes, 
protein extracts were subjected to reproducible 2D gelelectrophoresis. The comparison of biotin 
labeled proteins versus radiolabeled proteins allowed the identification of 17 protein spots that 
were both radiolabeled and biotinylated, and which therefore represent candidate vacuolar 
proteins. A detailed MALDI-TOF analysis of several of these spots revealed plasmodial heat 
shock protein 70, heat shock protein 90 as novel vacuolar proteins. In addition a cysteine protease, 
known to be a vacuolar protein from previous studies, was also identified. Out of the radiolabeled 
but non-biotinylated spots, MALDI-TOF analyses identified 8 cytoplasmic parasite proteins.  
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Together the results confirm the suitability of the experimental rationale used and they provide the 
basis for the full characterization of the vacuolar proteome. 
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      Zusammenfassung 
 
Plasmodium falciparum, Erreger der schwerste Form der  menschlichen Malaria, ist ein 
einzelliger Parasit, welcher Erythrozyten befällt. Im Erythrozyten entwickelt sich P.falciparum 
innerhalb einer parasitophoren Vakuole, wobei die Membran der Vakuole eine Schnittstelle 
zwischen  Parasit und  Zytosol der Wirtszelle bildet. Obwohl das Volumen der Vakuole im 
Vergleich zur Wirtszelle und dem Parasiten sehr klein ist, spielt sie eine wichtige Rolle in der 
Entwicklung des Parasiten. Mögliche Aufgaben  von Proteinen der Vakuole umfassen 
Nährstoffaufnahme, Proteinverteilung und lytische  Eigenschaften, welche am Ende der 
intraerythrozytären Entwicklung für die Freisetzung der Parasiten notwendig sind. Obwohl die 
Bedeutung der Vakuole als separates Kompartiment in infizierten Erythrozyten bereits vor vielen 
Jahren erkannt wurde, waren experimentelle Ansätze zur Identifizierung von Proteinen der 
Vakuole aufgrund des sehr geringen Volumens limitiert. Weiterhin hat die Vakuole als 
Kompartiment zwischen zwei separaten Zellen (Parasit und Erythrozyt) den Einsatz von  
gebräuchlichen Methoden der Zellfraktionierung erschwert. Das Hauptziel dieser Arbeit  war die 
Entwicklung einer neuen experimentellen Strategie, welche die selektive Identifikation von 
Proteinen der Vakuole ermöglicht. 
In einem ersten Schritt wurden infizierte Erythrozyten mit Streptolysin O permeabilisiert, 
was zur vollständigen Entfernung des Erythrozytenzytosols führt. Die permeabilisierten Zellen 
wurden dann mit nicht membrangängigen Biotinderivaten behandelt. Diese Derivate gelangten in 
den Vakuolenraum, aber nicht in das Zytosol des Parasiten. Dieses wurde durch biochemische 
Analysen bestimmter Markerproteine gezeigt, die sich innerhalb der Vakuole und innerhalb des 
Parasitenzytosols befinden. Die Proteine der Vakuole wurden mit Biotin markiert, während die 
zytosolischen Proteine des Parasiten, obwohl sie in grösseren Mengen vorkommen, nicht markiert 
wurden. Diese Ergebnisse boten den ersten biochemischen Beweis für die Existenz nicht-
selektiver Poren innerhalb der Vakuolenmembran, welche aufgrund von elektrophysiologischen 
Studien postuliert wurden. Lösliche Proteine der Vakuole, die biotinyliert wurden, konnten durch 
Affinitätschromatographie isoliert und mittels SDS-PAGE analysiert werden. 
In einem nächsten Schritt wurden infizierte Erythroyzyten in der Anwesenheit von L-[35S] 
Methionin kultiviert, um Proteine des Parasiten metabolisch zu markieren. Nach einer 
anschließenden  Behandlung permeabilisierter Erythrozyten mit Biotin wurden die Proteinextrakte 
einer reproduzierbaren 2D-Gelelektrophorese unterzogen. Der Vergleich biotinylierter Proteine 
mit radioaktiv markierten Proteinen ermöglichte die Identifikation von 17 Proteinspots, die sowohl 
radioaktiv markiert, als auch biotinyliert waren und deshalb als Proteine der Vakuole in Frage 
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kamen. Eine detaillierte MALDI-TOF Analyse mehrerer dieser Spots enthüllte Hsp70 und Hsp90 
von Plasmodium falciparum als neue Proteine der Vakuole. Zusätzlich wurde eine Cystein 
Protease, welche aufgrund früherer Studien als Vakuolenprotein bereits bekannt war, identifiziert. 
Von den radioaktiv markierten, nicht –biotinylierten Spots, identifizierte die MALDI-TOF 
Analyse 8 zytoplasmatische Parasitenproteine. 
Zusammengefaßt bestätigen die Ergebnisse die Eignung des benutzten  experimentellen 
Ansatzes und bieten die Basis fur die vollständige Charakterisierung des Vakuolenproteoms. 
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In its host erythrocyte, the malaria parasite Plasmo-
dium falciparum resides within a parasitophorous vac-
uole, the membrane of which forms a barrier between
the host cell cytosol and the parasite surface. The vacu-
ole is a unique compartment because it contains specific
proteins that are believed to be involved in cell biologi-
cal functions essential for parasite survival. As a prereq-
uisite for the characterization of the vacuolar proteome,
we have developed an experimental approach that al-
lows the selective biotinylation of soluble vacuolar pro-
teins. This approach utilizes nonpermeant biotin deriv-
atives that can be introduced into infected erythrocytes
after selective permeabilization of the erythrocyte mem-
brane with the pore-forming protein streptolysin O. The
derivatives gain access to the vacuolar lumen but not to
the parasite cytosol, thus providing supportive evidence
for the existence of nonselective pores within the vacu-
olar membrane that have been postulated based on elec-
trophysiological studies. Soluble vacuolar proteins that
are biotin-labeled can be isolated by affinity chromatog-
raphy using streptavidin-agarose.
Plasmodium falciparum, the causative agent of the most
severe form of malaria, invades human erythrocytes, where
this unicellular parasite develops within the so-called parasi-
tophorous vacuole (PV).1 The parasitophorous vacuolar mem-
brane (PVM) is formed during the process of invasion, and it
contains lipids from the erythrocyte plasma membrane (1, 2)
and, presumably, parasite-derived proteins and lipids (3). This
membrane presents a barrier between parasite and host cell
cytosol, although electrophysiological studies in Plasmodium-
infected erythrocytes suggest the existence of nonselective
pores within the PVM that allow passive bidirectional diffusion
of small molecules (4, 5). With respect to biogenesis and protein
contents, the PV differs significantly from endocytic vacuoles
(6), with the most apparent difference being the almost cytoso-
lic pH of the vacuole (7, 8). In recent years, many observations
have indicated a number of cell biologically relevant processes
within the vacuole that are important for parasite survival.
In the course of the infection, several parasite proteins are
exported into the erythrocyte, and some of these proteins, such
as the members of the PfEMP1 family, are key molecules
involved in the pathogenesis of malaria (9). For at least some
exported proteins, the PV is a transit compartment from which
they are transported into the host cell cytosol (10–12). Trans-
location across the vacuolar membrane must be a selective
process because other proteins are retained within the PV (13,
14). Recently, it has been suggested that proteins destined for
the parasite apicoplast, a unique plastid-like intracellular or-
ganelle of apicomplexan parasites, also may be trafficked via
the PV (15). Thus, the PV must contain a machinery involved in
protein sorting. Upon completion of parasite development and
multiplication, merozoites, the invasive stages, are released
from the infected cell. Release of merozoites from the PV can be
prevented by treatment of infected erythrocytes (IRBCs) with
protease inhibitors (16). In addition, evasion of merozoites is
accompanied by a specific sequential cleavage of the major
merozoite surface protein 1 that is essential for the subsequent
reinvasion of noninfected cells (17). These data suggest a role of
vacuolar proteases in the release of parasites from the infected
host cell. Collectively, the current observations underscore the
notion that the PV is a unique intracellular compartment crit-
ical for parasite survival within the host cell and that it most
likely contains novel proteins of elementary functions.
The volume of the vacuole compared with the volumes of the
parasite cytosol and the erythrocyte cytosol, respectively, is
very small. Estimates based on morphological data suggest a
1:10,000 ratio of vacuolar volume to erythrocyte cytosol in
IRBCs infected with stages of the parasite that have completed
30 h of the 48-h intraerythrocytic development (12). Cell
fractionation experiments on IRBCs infected with the same
developmental stages show that more than 70% of the total
protein are erythrocyte cytosolic proteins, predominantly he-
moglobin (18). Therefore, the isolation of vacuolar proteins is
difficult; consequently, only a few vacuolar proteins have been
identified thus far. In this report, we describe a novel strategy
for the identification of vacuolar proteins as a prerequisite for
a comprehensive proteome analysis of this compartment.
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bumin; sulfo-NHS-SS-biotin, sulfosuccinimidyl-2-(biotinamido) ethyl-
1–3-dithiopropionate; sulfo-NHS-LC-biotin, sulfosuccinimidyl-6-(bio-
tinamido) hexanoate; PfEMP1, P. falciparum erythrocyte membrane
protein 1.
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EXPERIMENTAL PROCEDURES
Biotin derivatives sulfosuccinimidyl-2-(biotinamido) ethyl-1–3-
dithiopropionate (sulfo-NHS-SS-biotin), sulfosuccinimidyl-6-(biotin-
amido) hexanoate (sulfo-NHS-LC-biotin), and streptavidin (SAv)-conju-
gated agarose beads were obtained from Pierce. L-[35S]Methionine was
obtained from Amersham Biosciences. Streptolysin O (SLO) was kindly
provided by S. Bhakdi and prepared as described elsewhere (10). Poly-
clonal rabbit antibodies directed against GBP, SERP, parasite aldolase,
and PfBiP have been described previously (12, 19). The mouse mono-
clonal antibody to band 3, clone III-136, was obtained from Sigma.
Secondary antibodies against rabbit IgG conjugated to alkaline phos-
phatase or to horseradish peroxidase were obtained from DAKO A/S.
Cy2-conjugated goat anti-mouse IgG, Cy5-conjugated goat anti-rabbit
IgG, and Cy3-conjugated streptavidin were from Jackson Immuno Re-
search Laboratories, Inc. Protein A-Sepharose beads were from Amer-
sham Biosciences.
Parasite Cultures and Permeabilization of Infected Erythrocytes—
Parasites of the P. falciparum FCBR strain were cultivated in RPMI
1640 medium (Invitrogen) containing 10% human plasma and erythro-
cytes of blood group A (Marburg Blood Bank) under standard condi-
tions (20). Trophozoite-infected erythrocytes (IRBCs) were enriched to a
parasitemia of 90% by gel floatation (21). For metabolic labeling of
newly synthesized proteins, enriched IRBCs were washed twice in
methionine-free RPMI 1640 medium and cultivated for 1 h in plasma-
free, methionine-free RPMI 1640 medium, in the presence of 50 Ci
ml1 L-[35S]methionine. IRBCs were permeabilized with SLO as de-
scribed previously (10). Briefly, 2 108 IRBCs were incubated with 3–4
hemolytic units of SLO in RPMI 1640 medium at room temperature for
6 min. Samples were centrifuged at 10,000  g for 15 s. The pellet
containing intact parasites, the vacuolar contents, and membranes was
washed with 200 l of RPMI 1640 medium before biotinylation. Com-
plete removal of the erythrocyte hemoglobin was monitored spectropho-
tometrically as described previously (10).
Biotin Labeling—For the biotinylation of intact erythrocytes, 108
parasitized or nonparasitized erythrocytes were washed three times in
PBS containing 0.6 mM CaCl2 and 1 mM MgCl2, pH 7.6 (PBS
2), and
then incubated in PBS2 containing 1 mg ml1 sulfo-NHS-SS-biotin for
30 min on ice. Cells were sedimented by centrifugation at 10,000 g for
15 s at 4 °C. The supernatant was analyzed photometrically at 412 nm
for the release of hemoglobin. To block and remove unbound biotin, cells
were washed three times in PBS2 containing 100 mM glycine. For
cleavage of extracellularly exposed membrane proteins, an aliquot of
the cells was treated with 1 mg ml1 trypsin for 15 min at 37 °C. The
protease was inactivated using soybean trypsin inhibitor at a concen-
tration of 1 mg ml1 for 15 min on ice. Cells were lysed by repeated
freezing and thawing in water supplemented with a protease inhibitor
mixture containing antipain, chymostatin, aprotinin, trypsin inhibitor,
Na-EDTA, pepstatin, leupeptin, and elastatinal, each at a concentra-
tion of 1 g ml1. A membrane fraction and a fraction of soluble proteins
were prepared by centrifugation.
For the biotinylation of internal parasite proteins and vacuolar pro-
teins, IRBCs permeabilized with SLO were washed with PBS2 and
then resuspended in an optimal volume, routinely 800 l, of distilled
water containing the above-mentioned protease inhibitors. Lysates
were prepared by three cycles of freezing and thawing. Soluble proteins
contained in the supernatant after centrifugation at 10,000  g for 15
min were biotin-labeled in PBS2 containing 1 mg ml1 sulfo-NHS-LC-
biotin for 30 min at 4 °C with frequent shaking. The solution was
centrifuged at 3,000  g using a microconcentrator (Millipore Corp.)
with a size exclusion of 5 kDa to remove any free biotin. The sample was
diluted with water containing the protease inhibitors. This step was
repeated twice.
For the labeling of soluble vacuolar proteins, permeabilized cells
were incubated with sulfo-NHS-LC-biotin as described above. The so-
lution was centrifuged at 4 °C at 1,300  g for 5 min, and the sediment
of parasite-containing vacuoles was washed three times in 100 mM
glycine in PBS2 to block the unreacted biotin derivative. After a final
wash in PBS2, cells were lysed and processed as above.
Affinity Purification of Biotin-labeled Proteins—Biotin-labeled pro-
teins from 2  108 IRBCs were incubated with streptavidin-conjugated
agarose beads at 4 °C for 2 h under constant shaking. The beads were
sedimented by centrifugation at 10,000  g for 15 s. The supernatant
was collected and stored at 20 °C until further use. Beads were
washed sequentially in buffer A (10 mM Tris-HCl, pH 7.5, 0.2% Nonidet
P-40, 2 mM EDTA, and 150 mM NaCl), buffer B (10 mM Tris-HCl, pH 7.5,
0.2% Nonidet P-40, 2 mM EDTA, and 500 mM NaCl), buffer C (10 mM
Tris-HCl, pH 7.5), and, finally, PBS2. The beads were then washed
with 10 mM HEPES buffer, pH 7.4, containing 20 mM MgCl2 and 5 mM
ATP. Bound proteins were eluted by boiling the beads in SDS-PAGE
sample buffer before analysis.
Immunoprecipitation—The marker proteins SERP and GBP were
precipitated from lysates of IRBCs as follows. After permeabilization of
IRBCs and complete removal of the erythrocyte cytosol, parasite-con-
taining vacuoles were lysed osmotically. Soluble proteins in a volume of
100 l, corresponding to 2  107 IRBCs, were diluted with 400 l of
distilled water and 500 l of solubilization buffer containing 50 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, and 4 g ml1
phenylmethylsulfonyl fluoride. The respective antisera were added, and
the mixture was incubated at room temperature for 30 min. Subse-
quently, 15 l of protein A-Sepharose beads were added and incubated
for 1 h at 4 °C. The beads were sedimented by centrifugation, and the
supernatant was collected. Proteins were precipitated from the super-
natant with 10% trichloroacetic acid on ice for 10 min. The samples
were centrifuged at 4 °C, and the precipitate was washed with ice-cold
acetone and dissolved in SDS-PAGE sample buffer. The protein A-
Sepharose beads were washed sequentially with buffers A, B, and C and
PBS2 as described above, and bound proteins were eluted by boiling
the beads in SDS-PAGE sample buffer.
Gel Electrophoresis—Routinely, proteins were dissolved in SDS sam-
ple buffer and separated on 10% or 12% gels under reducing conditions.
When proteins were labeled with the cleavable biotin derivative sulfo-
NHS-SS-biotin, separation was on 5–20% gradient gels under nonre-
ducing conditions. Protein bands were visualized by Coomassie Blue
staining before exposure to x-ray film for the detection of radiolabeled
proteins. For two-dimensional PAGE, soluble parasite and vacuolar
proteins from 2  109 permeabilized IRBCs were precipitated using 3
volumes of 10% trichloroacetic acid in acetone containing 20 mM DTT
for 1 h at20 °C. The proteins were collected by centrifugation, washed
with ice-cold acetone containing 20 mM DTT, and dried. Protein extracts
were dissolved in 300 l of a rehydration solution (8 M urea, 2 M
thiourea, 4% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfo-
nic acid, 4% DTT, 2% ASB (Calbiochem), and 2% immobilized pH
gradient buffer pH 4–7 (Amersham Biosciences)) and incubated at room
temperature for 1 h. After rehydration for 24 h under low viscosity
paraffin oil, 13-cm immobilized pH gradient strips (Amersham Bio-
sciences) covering a pH range of 4–7 were subjected to isoelectric
focusing for 28,000 V-h. After isoelectric focusing, the individual strips
were consecutively incubated in equilibration solution A and B (50 mM
Tris-HCl, pH 6.8, 8 M urea, 30% (v/v) glycerol, 2% (w/v) SDS, comple-
mented with 3.5 mg ml1 DTT (solution A) or 45 mg ml1 iodoacetamide
instead of DTT (solution B)), each for 15 min. The equilibrated strips
were transferred to 12% slab gels and separated in the second dimen-
sion. After drying of the gels, radiolabeled bands were visualized by
autoradiography.
Immunoblot Analysis—Proteins separated by SDS-PAGE or two-
dimensional PAGE were transferred to nitrocellulose membranes. For
the detection of biotin-labeled proteins, membranes were blocked using
2% BSA in PBS, pH 7.4, for 1 h at room temperature. Filters were
incubated for 20 min with alkaline phosphatase-conjugated streptavi-
din (Pharmingen) diluted 1:10,000 in 2% BSA in PBS, pH 7.4. The
membranes were washed three times in 10 mM Tris-HCl, pH 7.4, 150
mM NaCl for 5 min. Biotin-labeled proteins were stained with nitro blue
tetrazolium and 5-bromo-4-chloro-3-indolylphosphate following stand-
ard procedures. The same membranes were then incubated with spe-
cific rabbit antisera at a dilution of 1:500 for 16 h at 4 °C. Specific
marker proteins were detected after incubation with horseradish per-
oxidase-conjugated anti-rabbit IgG for 1 h at room temperature and
development of the filters using the ECL system (Amersham Bio-
sciences) following standard procedures.
Indirect Immunofluorescence Assay—Permeabilized and biotin-
treated IRBCs were spread on glass slides and air-dried. Subsequently,
they were fixed in acetone-methanol (1:1) for 10 min at 20 °C. The
slides were incubated with the primary antibodies for 2 h at room
temperature. The monoclonal anti-band 3 IgG was diluted 1:20, and the
polyclonal rabbit antisera specific for SERP and aldolase, respectively,
were diluted 1:10 in PBS, pH 7.2. After three washes with PBS, pH 7.2,
slides were probed with a mixture of the corresponding secondary
antibody (1:100) and Cy3-conjugated streptavidin (1:200) for 30 min at
room temperature in the dark. Autofluorescence and nonspecific fluo-
rescence levels were determined by viewing control samples of either
biotin-treated or untreated IRBCs not incubated with Cy3-conjugated
streptavidin and secondary antibodies. The cells were mounted in glyc-
erol containing 0.1% of the antifade reagent 1,4-diazobicyclo(2,2,2)-
octane. Fluorescence microscopy was performed using a Leica TCS SP2
laser scanning confocal microscope.
P. falciparum: Biotinylation of Vacuolar Proteins40006
RESULTS AND DISCUSSION
A Membrane-impermeable Biotin Derivative Gains Access
into Intact Infected Erythrocytes—The intracellular parasite
depends on the acquisition of nutrients from the extracellular
milieu and from the host cell cytosol. Extracellular nutrients
must be taken up across three membranes, the erythrocyte
plasma membrane, the PVM, and the parasite plasma mem-
brane. In the course of infection, the erythrocyte plasma mem-
brane undergoes major alterations. Most notably, the transport
properties of the membrane change, increasing the influx rates
for a number of low molecular weight solutes. The identifica-
tion of the proteins that mediate these novel transport proper-
ties is being pursued intensely (for current reviews, see Refs.
22–24). In preliminary experiments designed to study trans-
port of small solutes across the erythrocyte membrane, we
noticed that the membrane-impermeable sulfo-NHS-SS-biotin
gained access to the interior of erythrocytes infected with tro-
phozoite-stage parasites, but not to noninfected erythrocytes.
Intact noninfected and infected erythrocytes were incubated
with sulfo-NHS-SS-biotin. Cells were lysed in water by re-
peated freezing and thawing, and soluble proteins were sepa-
rated from the membrane fraction by centrifugation. Whereas
in noninfected cells, no biotin labeling of soluble proteins was
detectable (Fig. 1, lanes 1 and 3), soluble proteins were found to
be biotin-labeled in infected cells (Fig. 1, lanes 5 and 7). When
intact erythrocytes were treated with trypsin after the biotin
reaction, the pattern of biotin-labeled proteins in the mem-
brane fraction changed, due to proteolytic cleavage of exter-
nally exposed protein domains (Fig. 1, lanes 2, 4, 6, and 8).
More importantly, trypsin treatment had little effect on the
pattern of biotin-labeled soluble proteins in infected cells (Fig.
1, lanes 5 and 7). This result demonstrates that the protease,
unlike the biotin derivative, was excluded from the erythrocyte
cytosol. Most likely, access of biotin into intact erythrocytes is
due to the novel transport properties of the erythrocyte mem-
brane, and we are currently investigating the pathways in-
volved in this process. We never observed that biotin gained
access to vacuolar proteins in infected erythrocytes using these
experimental conditions (data not shown). We anticipate that
internalization of biotin across the intact host cell plasma
membrane is limited and that the excess of erythrocyte cytoso-
lic proteins prevented efficient labeling of vacuolar proteins.
Biotin Accumulates in the Parasitophorous Vacuole in Per-
meabilized Infected Erythrocytes—Although the vacuolar mem-
brane forms a barrier between the parasite surface and the
host cell cytosol, it is most conceivable that the PVM allows the
transport of nutrients essential for parasite survival. Using a
patch-clamp technique, Desai et al. (4) measured high conduct-
ance channels that are permeable to organic and inorganic
anions and cations. The channels are open 98% of the time, and
they are highly abundant. In bilayers, this channel allows
passage of molecules up to 1,400 Da (5), which is similar to the
nonselective pores discovered in the PVM of the taxonomically
related parasite Toxoplasma (25). The existence of these pores
in Plasmodium-infected erythrocytes has not been verified bio-
chemically, but if they exist, they should allow access of mem-
brane-impermeable biotin derivatives that are600 Da in size.
To increase access of biotin to the interior of the infected
erythrocyte, we utilized SLO to permeabilize the erythrocyte
plasma membrane. In an initial assessment of our experimen-
tal strategy, infected erythrocytes were permeabilized and, af-
ter complete removal of the erythrocyte cytosol, incubated with
the membrane-impermeable sulfo-NHS-LC-biotin, which was
detected using a fluorescent streptavidin derivative (Fig. 2).
The images show a distinct ring around the periphery of the
intracellular parasite. The biotin co-localizes with the vacuolar
marker protein SERP (Fig. 2A). This location is distinct from
the location of the erythrocyte membrane protein band 3 and
from the location of the parasite cytosolic protein aldolase (Fig.
2, B and C). In some parts, the streptavidin and the antibody to
band 3 co-localize; this is due to the fact that proteins of the
erythrocyte plasma membrane also react with the biotin. Little
if any biotin was detectable in the erythrocyte cytosol and in
the parasite cytosol, respectively. A ring-like staining around
the periphery of the parasite can be attributable to a reaction
of the biotin with membrane proteins of the PVM and with
soluble vacuolar proteins. Because the resolution of fluores-
cence microscopy does not allow discrimination between a
staining of the PVM and a lumenal staining, a more detailed
biochemical analysis was performed to assess the biotinylation
of soluble vacuolar proteins.
Biotin-labeled Parasite Proteins Bind to SAv-agarose—Be-
cause mammalian erythrocytes have lost the ability to synthe-
size proteins de novo, in infected erythrocytes, radiolabeled
amino acids are incorporated exclusively into parasite proteins.
The following experiment was designed to optimize the biotin-
ylation conditions and the selective isolation of biotinylated
proteins by SAv-agarose. Infected cells were cultivated for 30
min in the presence of L-[35S]methionine, and subsequently,
the erythrocyte plasma membrane was permeabilized with
SLO to release the soluble contents of the erythrocyte cytosol.
In all experiments, the integrity of the PVM and the parasite
plasma membrane was assessed as described previously (10).
Parasite-containing vacuoles were lysed by repeated freezing
and thawing, and the fraction of soluble proteins was collected
after centrifugation. One aliquot of the lysate was treated with
sulfo-NHS-LC-biotin, and another aliquot remained untreated.
Both samples were incubated with SAv-agarose beads, and
bound proteins were eluted by boiling the beads in SDS sample
buffer. The fractions of unbound and bound proteins were an-
alyzed by SDS-PAGE and autoradiography (Fig. 3A). No radio-
labeled proteins from the nonbiotinylated sample bound to
SAv-agarose (Fig. 3A, lane 2), whereas after biotinylation, most
radiolabeled proteins were found in the fraction of bound pro-
teins (Fig. 3A, lane 4). It is noteworthy that the pattern of
FIG. 1. Infected erythrocytes are permeable for a nonper-
meant biotin derivative. Noninfected (RBC) and infected (iRBC)
erythrocytes were incubated with sulfo-NHS-SS-biotin, and a sample
from each reaction was subsequently treated with trypsin (lanes 3, 4, 7,
and 8) to cleave externally exposed proteins. Cells were lysed and
separated into a fraction of soluble proteins (lanes 1, 3, 5, and 7) and
into a membrane fraction (lanes 2, 4, 6, and 8). Proteins, corresponding
to 2  107 cells, were electrophoresed through a 5–15% nonreducing
SDS-polyacrylamide gel, transferred to a nitrocellulose filter, and
probed with alkaline phosphatase-conjugated SAv.
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biotinylated proteins differed from that of the nonbiotinylated
proteins and that the bands appeared less focused. This obser-
vation is attributable to the variant degrees of biotin labeling of
individual polypeptide chains. To assess the effects of biotin
incorporation on the electrophoretic motility of proteins, BSA
was incubated with different molar ratios of sulfo-NHS-LC-
biotin and analyzed by SDS-PAGE. As shown in Fig. 3B, the
electrophoretic motility of BSA is altered depending on the
degree of biotinylation.
The subsequent experiments were devised to demonstrate
compartment-specific biotinylation of soluble parasite proteins
in permeabilized IRBCs. The so-called GBP, the SERP, and
parasite aldolase (PfALD) are soluble marker proteins that are
located in different compartments of the infected erythrocyte.
Aldolase is restricted to the parasite cytosol (19), SERP is
restricted to the vacuole (13), and GBP is found both inside the
vacuole and within the erythrocyte cytosol (10). In the first
step, it was confirmed that these proteins can be biotinylated
and that they bind to SAv-agarose, provided that they are
accessible to biotin. This was assessed using lysates of perme-
abilized infected erythrocytes; infected erythrocytes were per-
meabilized with SLO, and after complete removal of the eryth-
rocyte cytosol, a lysate containing soluble proteins of the
parasite cytosol and of the PV was prepared. One aliquot of
soluble proteins was treated with sulfo-NHS-LC-biotin as de-
scribed above. Another aliquot remained untreated. The sam-
ples were incubated with SAv-agarose beads, and the bound
and unbound proteins were analyzed separately by immuno-
blotting using antisera to the respective marker proteins (Fig.
4A). In the sample of nonlabeled proteins, the three marker
proteins were recovered in the fraction of unbound proteins
(Fig. 4A, compare lanes 1 and 2). After biotin treatment, GBP,
SERP, and PfALD were recovered in the fraction of bound
proteins (Fig. 4A, compare lanes 3 and 4). In the case of GBP
and SERP, recovery was almost quantitative. Although recov-
ery was not entirely complete in the case of PfALD, these
results demonstrate that the marker proteins are biotinylated
and can be isolated on SAv-agarose.
After confirmation that all marker proteins are biotinylat-
able, IRBCs were permeabilized with SLO, washed to remove
FIG. 2. Biotin localizes to the parasitophorous vacuole. Trophozoite-infected erythrocytes were permeabilized with SLO, biotin-labeled,
and spread onto microscope slides. Cells were fixed and incubated with antibodies to SERP (A), a vacuolar resident protein. Conjugated secondary
antibodies (green color) co-localize with SAv-Cy3 (red color). B and C show dual labeling of biotin and the erythrocyte membrane protein band 3
(B) or of biotin and the parasite cytosolic protein PfALD (C). Cells were imaged using a laser scanning confocal microscope. The left panels
(TM/nomarski) show the transmission images of the respective fields, and the right panels (merge) show an overlay of fluorescence images for each
of the antibodies used.
FIG. 3. A, biotin labeling of parasite proteins. Infected erythrocytes
were metabolically labeled with L-[35S]methionine. Erythrocytes were
permeabilized with SLO, and the erythrocyte cytosol was extracted.
The remaining fraction consisted of intact parasites, including an intact
PVM and parasite plasma membrane. The PVM and the parasite
plasma membrane were then lysed, and membrane proteins and soluble
proteins were separated. One aliquot of soluble proteins, corresponding
to 2  108 cells, was treated with sulfo-NHS-LC-biotin (lanes 3 and 4),
and one aliquot remained untreated (lanes 1 and 2). Proteins that
bound to SAv-agarose beads (lanes 2 and 4) and unbound proteins
(lanes 1 and 3) were analyzed by SDS-PAGE and autoradiography. B,
extensive biotin labeling increases the molecular size of proteins. BSA
was treated with sulfo-NHS-LC-biotin at different molar ratios and
analyzed by SDS-PAGE and Coomassie Blue staining (lanes 1–3) or by
reaction with peroxidase-conjugated SAv on nitrocellulose filters (lanes
4–6).
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the contents of the erythrocyte cytosol, and incubated with
sulfo-NHS-LC-biotin. Upon removal of free biotin and lysis of
parasites, soluble proteins were immunoprecipitated using
antibodies to SERP and GBP, respectively. Precipitated pro-
teins were separated by SDS-PAGE and transferred to nitro-
cellulose filters. Initially, the filters were probed with the
SERP and GBP antibodies, and their binding was detected
using an alkaline phosphatase-conjugated secondary antibody
(Fig. 4B, lanes 1 and 3). Subsequently, the filters were reprobed
with peroxidase-conjugated SAv and analyzed by chemilumi-
nescence (Fig. 4B, lanes 2 and 4). The same analysis was
carried out for PfALD, but because the antiserum against al-
dolase does not immunoprecipitate the protein, the total lysate
was separated by SDS-PAGE and analyzed (Fig. 4B, lanes 5
and 6). The antisera specifically recognized the marker pro-
teins. The bands that were detectable with SAv were of iden-
tical sizes as GBP and SERP, indicating that both proteins
were biotin-labeled. No biotin-labeled band corresponding in
size to aldolase was detectable; a protein band of smaller size
reacted with SAv, but not with the aldolase-specific antibody.
Affinity isolation of biotin-labeled proteins on SAv-agarose
beads and subsequent analysis by immunoblotting confirmed
the compartment-specific labeling of the respective proteins
(Fig. 4C). In permeabilized cells, PfALD was not labeled, and,
consequently, it was not found in the fraction of proteins bound
to SAv, whereas GBP was quantitatively labeled with biotin
and recovered. Apparently, in permeabilized cells, the accessi-
bility of the biotin to SERP is restricted; all of the biotin-labeled
SERP protein is bound to SAv-agarose beads (Fig. 4C, lanes 1
and 2); however, a substantial proportion of the SERP mole-
cules remained unbound, obviously because these molecules
have not been labeled with biotin (Fig. 4C, compare lanes 3 and
4). A 5-fold increase of biotin in the biotinylation reaction did
not result in more efficient labeling of SERP (data not shown).
It is noteworthy that in lysates, i.e. when SERP is released, the
protein is labeled and binds to SAv quantitatively (Fig. 4A).
Although it is possible that the unlabeled protein in Fig. 4C
represents an intraparasite pool of SERP en route to the par-
asite plasma membrane, we consider this possibility unlikely.
In previous experiments, we were unable to detect levels of
SERP within the parasite, unless secretion was actively inhib-
ited by the drug brefeldin A (19, 10). It is more likely that,
within the vacuole, at least a proportion of the molecule as-
sumes a tight conformation that severely compromises the
access of biotin. In no experiments did we detect labeled or
unlabeled hemoglobin, the most abundant soluble protein in
trophozoite-infected erythrocytes, indicating that the soluble
erythrocyte contents had been removed efficiently from perme-
abilized cells.
The Chaperone PfBiP Associates with Biotin-labeled Pro-
teins—Although in none of our experiments using SLO-perme-
abilized erythrocytes were we able to detect biotin-labeled al-
dolase, we analyzed the fraction of SAv-agarose-bound proteins
for the presence of several other intraparasite proteins. In the
fraction of proteins that were isolated by affinity chromatogra-
phy on SAv-agarose beads, we consistently detected PfBiP (26),
the plasmodial homologue of BiP, a molecular chaperone and
endoplasmic reticulum resident protein in eukaryotic cells (Fig.
5A). Because it is possible that some of this protein may not be
retained within the parasite’s secretory pathway and hence
may be transported into the vacuole, we investigated whether
PfBiP was biotin-labeled. Permeabilized cells were treated
with sulfo-NHS-LC-biotin and subsequently lysed, and PfBiP
was immunoprecipitated. The precipitated proteins were sep-
arated by SDS-PAGE and transferred to nitrocellulose filters.
In the first reaction, binding of the anti-PfBiP antiserum was
determined using an alkaline phosphatase-conjugated second-
ary antibody (Fig. 5B, lane 1). In a second reaction, biotin was
detected by chemiluminescence using peroxidase-conjugated
SAv (Fig. 5B, lane 2). Under these conditions, biotin was un-
detectable, suggesting that recovery of PfBiP in the fraction of
proteins that bound to SAv-agarose was due to an interaction of
the chaperone with other biotin-labeled proteins. PfBiP did not
bind to SAv-agarose beads in the absence of the biotin (Fig. 5A),
ruling out the possibility that the protein directly interacted
with SAv or the resin. Most likely, when cell lysates are pre-
pared, intraparasite chaperones such as PfBiP associate with
biotinylated proteins bound to SAv-agarose beads and are co-
isolated. In the subsequent experiments, the protocol was re-
vised to reduce the possibility of mistaking intraparasite chap-
erones as putative vacuolar resident proteins. Chaperones are
released from their substrates in a process that requires the
hydrolysis of ATP. Therefore, SAv-agarose beads were washed
in the presence of 5 mM ATP before electrophoretic analysis.
This step eliminated the co-isolation of PfBiP almost entirely,
FIG. 4. Selective biotin labeling of vacuolar marker proteins.
A, to confirm that the marker proteins can be biotinylated in solution,
a soluble protein fraction was prepared and processed as described for
Fig. 3A. The fraction of proteins bound to SAv-agarose beads (lanes 1
and 3) and the fraction of unbound proteins (lanes 2 and 4) were
analyzed by immunoblotting for the presence of the marker proteins
SERP, GBP, and PfALD. B and C, infected erythrocytes were perme-
abilized with SLO. After complete extraction of the erythrocyte cytosol,
the cellular fraction consisting of intact parasites and the intact PV was
incubated with sulfo-NHS-LC-biotin and lysed after removal of free
biotin. B, proteins were immunoprecipitated using antisera against
GBP and SERP, respectively, separated by SDS-PAGE, and transferred
to nitrocellulose filters (lanes 1–4). The filters were first probed with
antisera that were detected in a color reaction using alkaline phos-
phatase-conjugated secondary antibodies (lanes 1 and 3). The same
filters were reprobed with peroxidase-conjugated SAv, which was sub-
sequently detected by a chemiluminescence reaction (lanes 2 and 4).
The incorporation of biotin into aldolase was analyzed in the same way
(lanes 5 and 6), except that soluble proteins were separated electro-
phoretically without prior immunoprecipitation. C, the lysate was re-
acted with SAv-agarose beads, and the fractions of bound (lanes 1 and
3) and unbound (lanes 2 and 4) proteins were analyzed as described in
B for the incorporation of biotin (lanes 1 and 2) and the presence of the
respective marker proteins (lanes 3 and 4).
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but it had no effect on the isolation of SERP (Fig. 5C) or of other
biotin-labeled proteins.
Two-dimensional Gel Electrophoretic Analysis of Biotin-la-
beled Parasite Proteins—As a prerequisite for the identification
of novel vacuolar proteins, IRBCs were labeled metabolically
with L-[35S]methionine, permeabilized with SLO, and treated
with sulfo-NHS-LC-biotin. After cell lysis, soluble proteins
were separated in triplicate on different two-dimensional gels
using a pH gradient of 4–7 in the first dimension. To estimate
the relative abundance of proteins in permeabilized erythro-
cytes, one gel was silver-stained (Fig. 6A), and one gel was
stained with Coomassie Blue (Fig. 6B). As expected, silver
staining revealed the most complex protein pattern. The most
abundant proteins were also detectable using the less sensitive
Coomassie Blue stain. To compare biotinylated proteins versus
total parasite proteins, proteins of a third gel were transferred
to a nitrocellulose filter. The filter was exposed to x-ray films to
analyze the pattern of radiolabeled proteins (Fig. 6C). Subse-
quently, biotin-labeled proteins were detected using alkaline
phosphatase-conjugated SAv (Fig. 6D). A comparison of the
biotin-labeled proteins and the radiolabeled proteins clearly
demonstrates that the pattern of biotin-labeled proteins is less
complex and that it does not simply reflect the pattern of the
most abundant radiolabeled proteins. In contrast, the most
intensely radiolabeled proteins appear not to be biotin-labeled.
Considering that cytosolic housekeeping proteins of the para-
site, such as enzymes of the glycolytic pathway, are likely to be
highly abundant, this result underscores the notion that the
incorporation of the biotin is selective. In fact, when a matrix-
assisted laser desorption ionization time-of-flight analysis was
carried out using the two most prominent spots (I and II), they
were identified unequivocally as P. falciparum enolase and as
P. falciparum ornithine aminotransferase, respectively (data
not shown). Biotin-labeled proteins form characteristic strings
of individual spots. We attribute this pattern to various degrees
of biotin incorporation into the same polypeptide chain. Be-
cause each sulfo-NHS-LC-biotin adds a negative charge, mole-
cules with a high incorporation of the derivative are expected to
migrate toward the acidic end of the gradient. The shift to the
acidic end of the gradient also correlates with a slight increase
in molecular size. A detailed comparison reveals 12 prominent
spots, circled in Fig. 6, AD, which represent highly abundant
parasite proteins that are detectable by Coomassie Blue stain-
ing. Nine of these spots appear negatively stained in Fig. 6D
because of the high local concentration of nonbiotinylated pro-
tein. Thirty-nine protein spots were identified that were both
biotinylated and radiolabeled and that therefore fulfill the cri-
teria expected for vacuolar proteins. Some of these spots may
represent identical polypeptides that are biotinylated to vari-
ous degrees. In conclusion, the accessibility of nonpermeant
biotin derivatives to the vacuolar lumen in permeabilized
IRBCs has allowed the identification of candidate vacuolar
proteins. These proteins are restricted in number, and they
segregate into a distinct two-dimensional pattern. The se-
quencing of the parasite’s genome has almost been completed.
This will allow the rapid identification of the genes encoding
vacuolar proteins, as a prerequisite for a molecular under-
standing of the cell biological functions of this unusual com-
partment in the infected erythrocyte.
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FIG. 5. Co-isolation of PfBiP with biotinylated proteins. A, in-
fected erythrocytes were permeabilized, and one aliquot of the cells was
treated with sulfo-NHS-LC-biotin. Lysates of cells were prepared and
incubated with SAv-agarose beads. The fraction of unbound proteins
(lanes 1 and 3) and the fraction of bound proteins (lanes 2 and 4) were
analyzed for the presence of PfBiP using a specific antiserum. Lanes 1
and 2, untreated sample; lanes 3 and 4, biotinylated proteins. B, PfBip
was immunoprecipitated from a sample of biotin-treated cells, and the
precipitate was analyzed by immunoblotting using either the specific
antiserum (lane 1) or peroxidase-conjugated SAv (lane 2). C, biotiny-
lated proteins were bound to SAv beads, and the beads were washed
with either HEPES buffer (lanes 1 and 2) or HEPES buffer containing
5 mM ATP (lanes 3 and 4). Proteins that remained bound to the beads
(lanes 2 and 4) and unbound proteins (lanes 1 and 3) were analyzed for
the presence of SERP and PfBiP.
FIG. 6. Protein pattern of putative vacuolar proteins. Proteins
in intact infected erythrocytes were metabolically labeled, and cells
were permeabilized and treated with biotin. The fraction of soluble
proteins, each corresponding to 2  109 infected erythrocytes, was
subjected to two-dimensional gel electrophoresis using a pH gradient of
4–7 in the first dimension and 12% SDS-PAGE in the second dimen-
sion. A, silver-stained gel. B, Coomassie Blue-stained gel. C and D,
proteins from a third two-dimensional gel were transferred to a nitro-
cellulose filter. The filter was first exposed to x-ray film to visualize
metabolically labeled parasite proteins (C) and subsequently reacted
with alkaline phosphatase-conjugated SAv to visualize biotinylated
proteins (D). The most prominent spots that were identified as parasite
proteins are marked with circles. Proteins that are both biotinylated
and radiolabeled are indicated by Arabic numerals; spots that may
represent identical polypeptides at various degrees of biotinylation are
marked with lowercase letters. I, P. falciparum enolase; II, P. falcipa-
rum ornithine aminotransferase.
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